id	sid	tid	token	lemma	pos
ajlm-2362	1	1	abstract	abstract	ADJ
ajlm-2362	1	2	introduction	introduction	NOUN
ajlm-2362	1	3	methods	method	NOUN
ajlm-2362	1	4	results	result	VERB
ajlm-2362	1	5	discussion	discussion	NOUN
ajlm-2362	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2362	1	7	references	reference	NOUN
ajlm-2362	1	8	about	about	ADP
ajlm-2362	1	9	the	the	DET
ajlm-2362	1	10	author(s	author(s	NOUN
ajlm-2362	1	11	)	)	PUNCT
ajlm-2362	1	12	aderonke	aderonke	NOUN
ajlm-2362	1	13	o.	o.	PROPN
ajlm-2362	1	14	oluwo	oluwo	NOUN
ajlm-2362	1	15	dental	dental	ADJ
ajlm-2362	1	16	division	division	NOUN
ajlm-2362	1	17	,	,	PUNCT
ajlm-2362	1	18	massey	massey	PROPN
ajlm-2362	1	19	street	street	PROPN
ajlm-2362	1	20	children	children	PROPN
ajlm-2362	1	21	’s	’s	PART
ajlm-2362	1	22	hospital	hospital	NOUN
ajlm-2362	1	23	,	,	PUNCT
ajlm-2362	1	24	lagos	lagos	PROPN
ajlm-2362	1	25	,	,	PUNCT
ajlm-2362	1	26	nigeria	nigeria	PROPN
ajlm-2362	1	27	mary	mary	PROPN
ajlm-2362	1	28	a.	a.	PROPN
ajlm-2362	1	29	lawal	lawal	PROPN
ajlm-2362	1	30	medical	medical	PROPN
ajlm-2362	1	31	division	division	NOUN
ajlm-2362	1	32	,	,	PUNCT
ajlm-2362	1	33	massey	massey	PROPN
ajlm-2362	1	34	street	street	PROPN
ajlm-2362	1	35	children	children	PROPN
ajlm-2362	1	36	’s	’s	PART
ajlm-2362	1	37	hospital	hospital	NOUN
ajlm-2362	1	38	,	,	PUNCT
ajlm-2362	1	39	lagos	lagos	PROPN
ajlm-2362	1	40	,	,	PUNCT
ajlm-2362	1	41	nigeria	nigeria	PROPN
ajlm-2362	1	42	cecilia	cecilia	PROPN
ajlm-2362	1	43	a.	a.	PROPN
ajlm-2362	1	44	mabogunje	mabogunje	PROPN
ajlm-2362	1	45	medical	medical	PROPN
ajlm-2362	1	46	division	division	NOUN
ajlm-2362	1	47	,	,	PUNCT
ajlm-2362	1	48	massey	massey	PROPN
ajlm-2362	1	49	street	street	PROPN
ajlm-2362	1	50	children	children	PROPN
ajlm-2362	1	51	’s	’s	PART
ajlm-2362	1	52	hospital	hospital	NOUN
ajlm-2362	1	53	,	,	PUNCT
ajlm-2362	1	54	lagos	lagos	PROPN
ajlm-2362	1	55	,	,	PUNCT
ajlm-2362	1	56	nigeria	nigeria	PROPN
ajlm-2362	1	57	olubunmi	olubunmi	PROPN
ajlm-2362	1	58	t.	t.	PROPN
ajlm-2362	1	59	okurame	okurame	PROPN
ajlm-2362	1	60	laboratory	laboratory	PROPN
ajlm-2362	1	61	unit	unit	NOUN
ajlm-2362	1	62	,	,	PUNCT
ajlm-2362	1	63	massey	massey	PROPN
ajlm-2362	1	64	street	street	PROPN
ajlm-2362	1	65	children	children	PROPN
ajlm-2362	1	66	’s	’s	PART
ajlm-2362	1	67	hospital	hospital	NOUN
ajlm-2362	1	68	,	,	PUNCT
ajlm-2362	1	69	lagos	lago	NOUN
ajlm-2362	1	70	,	,	PUNCT
ajlm-2362	1	71	nigeria	nigeria	PROPN
ajlm-2362	1	72	citation	citation	NOUN
ajlm-2362	1	73	oluwo	oluwo	PROPN
ajlm-2362	1	74	ao	ao	PROPN
ajlm-2362	1	75	,	,	PUNCT
ajlm-2362	1	76	lawal	lawal	PROPN
ajlm-2362	1	77	ma	ma	PROPN
ajlm-2362	1	78	,	,	PUNCT
ajlm-2362	1	79	mabogunje	mabogunje	PROPN
ajlm-2362	1	80	ca	ca	PROPN
ajlm-2362	1	81	,	,	PUNCT
ajlm-2362	1	82	okurame	okurame	ADJ
ajlm-2362	1	83	ot	ot	INTJ
ajlm-2362	1	84	.	.	PUNCT
ajlm-2362	1	85	antibiotic	antibiotic	ADJ
ajlm-2362	1	86	susceptibility	susceptibility	NOUN
ajlm-2362	1	87	pattern	pattern	NOUN
ajlm-2362	1	88	among	among	ADP
ajlm-2362	1	89	children	child	NOUN
ajlm-2362	1	90	admitted	admit	VERB
ajlm-2362	1	91	to	to	ADP
ajlm-2362	1	92	a	a	DET
ajlm-2362	1	93	hospital	hospital	NOUN
ajlm-2362	1	94	in	in	ADP
ajlm-2362	1	95	nigeria	nigeria	PROPN
ajlm-2362	1	96	:	:	PUNCT
ajlm-2362	1	97	a	a	DET
ajlm-2362	1	98	retrospective	retrospective	ADJ
ajlm-2362	1	99	study	study	NOUN
ajlm-2362	1	100	.	.	PUNCT
ajlm-2362	2	1	afr	afr	PROPN
ajlm-2362	2	2	j	j	PROPN
ajlm-2362	2	3	lab	lab	PROPN
ajlm-2362	2	4	med	me	VERB
ajlm-2362	2	5	.	.	PUNCT
ajlm-2362	3	1	2024;13(1	2024;13(1	NUM
ajlm-2362	3	2	)	)	PUNCT
ajlm-2362	3	3	,	,	PUNCT
ajlm-2362	3	4	a2362	a2362	PROPN
ajlm-2362	3	5	.	.	PUNCT
ajlm-2362	3	6	https://doi.org/10.4102/ajlm.v13i1.2362	https://doi.org/10.4102/ajlm.v13i1.2362	VERB
ajlm-2362	3	7	original	original	ADJ
ajlm-2362	3	8	research	research	NOUN
ajlm-2362	3	9	antibiotic	antibiotic	ADJ
ajlm-2362	3	10	susceptibility	susceptibility	NOUN
ajlm-2362	3	11	pattern	pattern	NOUN
ajlm-2362	3	12	among	among	ADP
ajlm-2362	3	13	children	child	NOUN
ajlm-2362	3	14	admitted	admit	VERB
ajlm-2362	3	15	to	to	ADP
ajlm-2362	3	16	a	a	DET
ajlm-2362	3	17	hospital	hospital	NOUN
ajlm-2362	3	18	in	in	ADP
ajlm-2362	3	19	nigeria	nigeria	PROPN
ajlm-2362	3	20	:	:	PUNCT
ajlm-2362	4	1	a	a	DET
ajlm-2362	4	2	retrospective	retrospective	ADJ
ajlm-2362	4	3	study	study	NOUN
ajlm-2362	4	4	aderonke	aderonke	NOUN
ajlm-2362	4	5	o.	o.	PROPN
ajlm-2362	4	6	oluwo	oluwo	PROPN
ajlm-2362	4	7	,	,	PUNCT
ajlm-2362	4	8	mary	mary	PROPN
ajlm-2362	4	9	a.	a.	PROPN
ajlm-2362	4	10	lawal	lawal	PROPN
ajlm-2362	4	11	,	,	PUNCT
ajlm-2362	4	12	cecilia	cecilia	PROPN
ajlm-2362	4	13	a.	a.	PROPN
ajlm-2362	4	14	mabogunje	mabogunje	PROPN
ajlm-2362	4	15	,	,	PUNCT
ajlm-2362	4	16	olubunmi	olubunmi	ADP
ajlm-2362	4	17	t.	t.	PROPN
ajlm-2362	4	18	okurame	okurame	PROPN
ajlm-2362	4	19	received	receive	VERB
ajlm-2362	4	20	:	:	PUNCT
ajlm-2362	4	21	06	06	NUM
ajlm-2362	4	22	nov	nov	PROPN
ajlm-2362	4	23	.	.	PROPN
ajlm-2362	4	24	2023	2023	NUM
ajlm-2362	4	25	;	;	PUNCT
ajlm-2362	4	26	accepted	accept	VERB
ajlm-2362	4	27	:	:	PUNCT
ajlm-2362	4	28	24	24	NUM
ajlm-2362	4	29	may	may	PROPN
ajlm-2362	4	30	2024	2024	NUM
ajlm-2362	4	31	;	;	PUNCT
ajlm-2362	4	32	published	publish	VERB
ajlm-2362	4	33	:	:	PUNCT
ajlm-2362	4	34	20	20	NUM
ajlm-2362	4	35	aug	aug	PROPN
ajlm-2362	4	36	.	.	PROPN
ajlm-2362	4	37	2024	2024	NUM
ajlm-2362	4	38	copyright	copyright	NOUN
ajlm-2362	4	39	:	:	PUNCT
ajlm-2362	4	40	©	©	PROPN
ajlm-2362	4	41	2024	2024	NUM
ajlm-2362	4	42	.	.	PUNCT
ajlm-2362	5	1	the	the	DET
ajlm-2362	5	2	author(s	author(s	PROPN
ajlm-2362	5	3	)	)	PUNCT
ajlm-2362	5	4	.	.	PUNCT
ajlm-2362	6	1	licensee	licensee	NOUN
ajlm-2362	6	2	:	:	PUNCT
ajlm-2362	6	3	aosis	aosis	NOUN
ajlm-2362	6	4	.	.	PUNCT
ajlm-2362	7	1	this	this	PRON
ajlm-2362	7	2	is	be	AUX
ajlm-2362	7	3	an	an	DET
ajlm-2362	7	4	open	open	ADJ
ajlm-2362	7	5	access	access	NOUN
ajlm-2362	7	6	article	article	NOUN
ajlm-2362	7	7	distributed	distribute	VERB
ajlm-2362	7	8	under	under	ADP
ajlm-2362	7	9	the	the	DET
ajlm-2362	7	10	terms	term	NOUN
ajlm-2362	7	11	of	of	ADP
ajlm-2362	7	12	the	the	DET
ajlm-2362	7	13	creative	creative	ADJ
ajlm-2362	7	14	commons	common	NOUN
ajlm-2362	7	15	attribution	attribution	NOUN
ajlm-2362	7	16	license	license	NOUN
ajlm-2362	7	17	,	,	PUNCT
ajlm-2362	7	18	which	which	PRON
ajlm-2362	7	19	permits	permit	VERB
ajlm-2362	7	20	unrestricted	unrestricted	ADJ
ajlm-2362	7	21	use	use	NOUN
ajlm-2362	7	22	,	,	PUNCT
ajlm-2362	7	23	distribution	distribution	NOUN
ajlm-2362	7	24	,	,	PUNCT
ajlm-2362	7	25	and	and	CCONJ
ajlm-2362	7	26	reproduction	reproduction	NOUN
ajlm-2362	7	27	in	in	ADP
ajlm-2362	7	28	any	any	DET
ajlm-2362	7	29	medium	medium	NOUN
ajlm-2362	7	30	,	,	PUNCT
ajlm-2362	7	31	provided	provide	VERB
ajlm-2362	7	32	the	the	DET
ajlm-2362	7	33	original	original	ADJ
ajlm-2362	7	34	work	work	NOUN
ajlm-2362	7	35	is	be	AUX
ajlm-2362	7	36	properly	properly	ADV
ajlm-2362	7	37	cited	cite	VERB
ajlm-2362	7	38	.	.	PUNCT
ajlm-2362	8	1	abstract	abstract	ADJ
ajlm-2362	8	2	background	background	NOUN
ajlm-2362	8	3	:	:	PUNCT
ajlm-2362	8	4	the	the	DET
ajlm-2362	8	5	impact	impact	NOUN
ajlm-2362	8	6	of	of	ADP
ajlm-2362	8	7	antimicrobial	antimicrobial	ADJ
ajlm-2362	8	8	resistance	resistance	NOUN
ajlm-2362	8	9	on	on	ADP
ajlm-2362	8	10	children	child	NOUN
ajlm-2362	8	11	living	live	VERB
ajlm-2362	8	12	in	in	ADP
ajlm-2362	8	13	resource	resource	NOUN
ajlm-2362	8	14	-	-	PUNCT
ajlm-2362	8	15	limited	limit	VERB
ajlm-2362	8	16	countries	country	NOUN
ajlm-2362	8	17	has	have	AUX
ajlm-2362	8	18	been	be	AUX
ajlm-2362	8	19	underreported	underreporte	VERB
ajlm-2362	8	20	,	,	PUNCT
ajlm-2362	8	21	despite	despite	SCONJ
ajlm-2362	8	22	its	its	PRON
ajlm-2362	8	23	established	establish	VERB
ajlm-2362	8	24	global	global	ADJ
ajlm-2362	8	25	threat	threat	NOUN
ajlm-2362	8	26	.	.	PUNCT
ajlm-2362	9	1	objective	objective	NOUN
ajlm-2362	9	2	:	:	PUNCT
ajlm-2362	9	3	this	this	DET
ajlm-2362	9	4	retrospective	retrospective	ADJ
ajlm-2362	9	5	study	study	NOUN
ajlm-2362	9	6	aimed	aim	VERB
ajlm-2362	9	7	to	to	PART
ajlm-2362	9	8	describe	describe	VERB
ajlm-2362	9	9	the	the	DET
ajlm-2362	9	10	trend	trend	NOUN
ajlm-2362	9	11	of	of	ADP
ajlm-2362	9	12	antibiotic	antibiotic	ADJ
ajlm-2362	9	13	susceptibility	susceptibility	NOUN
ajlm-2362	9	14	in	in	ADP
ajlm-2362	9	15	the	the	DET
ajlm-2362	9	16	paediatric	paediatric	ADJ
ajlm-2362	9	17	age	age	NOUN
ajlm-2362	9	18	group	group	NOUN
ajlm-2362	9	19	.	.	PUNCT
ajlm-2362	10	1	methods	method	NOUN
ajlm-2362	10	2	:	:	PUNCT
ajlm-2362	10	3	sensitivity	sensitivity	NOUN
ajlm-2362	10	4	test	test	NOUN
ajlm-2362	10	5	report	report	NOUN
ajlm-2362	10	6	data	datum	NOUN
ajlm-2362	10	7	consisting	consist	VERB
ajlm-2362	10	8	of	of	ADP
ajlm-2362	10	9	300	300	NUM
ajlm-2362	10	10	paediatric	paediatric	ADJ
ajlm-2362	10	11	patients	patient	NOUN
ajlm-2362	10	12	aged	age	VERB
ajlm-2362	10	13	18	18	NUM
ajlm-2362	10	14	hours	hour	NOUN
ajlm-2362	10	15	to	to	ADP
ajlm-2362	10	16	192	192	NUM
ajlm-2362	10	17	months	month	NOUN
ajlm-2362	10	18	were	be	AUX
ajlm-2362	10	19	retrieved	retrieve	VERB
ajlm-2362	10	20	from	from	ADP
ajlm-2362	10	21	the	the	DET
ajlm-2362	10	22	microbiology	microbiology	NOUN
ajlm-2362	10	23	laboratory	laboratory	NOUN
ajlm-2362	10	24	records	record	NOUN
ajlm-2362	10	25	at	at	ADP
ajlm-2362	10	26	a	a	DET
ajlm-2362	10	27	state	state	NOUN
ajlm-2362	10	28	-	-	PUNCT
ajlm-2362	10	29	owned	own	VERB
ajlm-2362	10	30	children	child	NOUN
ajlm-2362	10	31	’s	’s	PART
ajlm-2362	10	32	hospital	hospital	NOUN
ajlm-2362	10	33	in	in	ADP
ajlm-2362	10	34	nigeria	nigeria	PROPN
ajlm-2362	10	35	over	over	ADP
ajlm-2362	10	36	a	a	DET
ajlm-2362	10	37	period	period	NOUN
ajlm-2362	10	38	of	of	ADP
ajlm-2362	10	39	4	4	NUM
ajlm-2362	10	40	months	month	NOUN
ajlm-2362	10	41	starting	start	VERB
ajlm-2362	10	42	from	from	ADP
ajlm-2362	10	43	december	december	PROPN
ajlm-2362	10	44	2021	2021	NUM
ajlm-2362	10	45	to	to	ADP
ajlm-2362	10	46	march	march	PROPN
ajlm-2362	10	47	2022	2022	NUM
ajlm-2362	10	48	.	.	PUNCT
ajlm-2362	11	1	five	five	NUM
ajlm-2362	11	2	genera	genera	NOUN
ajlm-2362	11	3	(	(	PUNCT
ajlm-2362	11	4	escherichia	escherichia	NOUN
ajlm-2362	11	5	coli	coli	NOUN
ajlm-2362	11	6	,	,	PUNCT
ajlm-2362	11	7	klebsiella	klebsiella	PROPN
ajlm-2362	11	8	spp	spp	PROPN
ajlm-2362	11	9	.	.	PROPN
ajlm-2362	11	10	,	,	PUNCT
ajlm-2362	11	11	pseudomonas	pseudomona	VERB
ajlm-2362	11	12	spp	spp	NOUN
ajlm-2362	11	13	.	.	PROPN
ajlm-2362	11	14	,	,	PUNCT
ajlm-2362	11	15	staphylococcus	staphylococcus	NOUN
ajlm-2362	11	16	aureus	aureus	NOUN
ajlm-2362	11	17	and	and	CCONJ
ajlm-2362	11	18	streptococcus	streptococcus	VERB
ajlm-2362	11	19	spp	spp	NOUN
ajlm-2362	11	20	.	.	PUNCT
ajlm-2362	11	21	)	)	PUNCT
ajlm-2362	11	22	were	be	AUX
ajlm-2362	11	23	cultured	cultured	ADJ
ajlm-2362	11	24	as	as	SCONJ
ajlm-2362	11	25	recommended	recommend	VERB
ajlm-2362	11	26	by	by	ADP
ajlm-2362	11	27	the	the	DET
ajlm-2362	11	28	clinical	clinical	ADJ
ajlm-2362	11	29	laboratory	laboratory	PROPN
ajlm-2362	11	30	standard	standard	PROPN
ajlm-2362	11	31	institute	institute	PROPN
ajlm-2362	11	32	,	,	PUNCT
ajlm-2362	11	33	using	use	VERB
ajlm-2362	11	34	the	the	DET
ajlm-2362	11	35	kirby	kirby	PROPN
ajlm-2362	11	36	bauer	bauer	PROPN
ajlm-2362	11	37	disc	disc	PROPN
ajlm-2362	11	38	diffusion	diffusion	NOUN
ajlm-2362	11	39	method	method	NOUN
ajlm-2362	11	40	.	.	PUNCT
ajlm-2362	12	1	antimicrobial	antimicrobial	ADJ
ajlm-2362	12	2	susceptibility	susceptibility	NOUN
ajlm-2362	12	3	testing	testing	NOUN
ajlm-2362	12	4	was	be	AUX
ajlm-2362	12	5	carried	carry	VERB
ajlm-2362	12	6	out	out	ADP
ajlm-2362	12	7	on	on	ADP
ajlm-2362	12	8	isolates	isolate	NOUN
ajlm-2362	12	9	using	use	VERB
ajlm-2362	12	10	15	15	NUM
ajlm-2362	12	11	different	different	ADJ
ajlm-2362	12	12	antibiotics	antibiotic	NOUN
ajlm-2362	12	13	.	.	PUNCT
ajlm-2362	13	1	results	result	NOUN
ajlm-2362	13	2	:	:	PUNCT
ajlm-2362	13	3	staphylococcus	staphylococcus	NOUN
ajlm-2362	13	4	aureus	aureus	PROPN
ajlm-2362	13	5	was	be	AUX
ajlm-2362	13	6	the	the	DET
ajlm-2362	13	7	most	most	ADV
ajlm-2362	13	8	frequent	frequent	ADJ
ajlm-2362	13	9	pathogen	pathogen	NOUN
ajlm-2362	13	10	isolated	isolate	VERB
ajlm-2362	13	11	32.1	32.1	NUM
ajlm-2362	13	12	%	%	NOUN
ajlm-2362	13	13	(	(	PUNCT
ajlm-2362	13	14	50/156	50/156	NUM
ajlm-2362	13	15	)	)	PUNCT
ajlm-2362	13	16	and	and	CCONJ
ajlm-2362	13	17	pseudomonas	pseudomona	VERB
ajlm-2362	13	18	spp	spp	NOUN
ajlm-2362	13	19	.	.	PUNCT
ajlm-2362	14	1	was	be	AUX
ajlm-2362	14	2	the	the	DET
ajlm-2362	14	3	least	least	ADV
ajlm-2362	14	4	frequent	frequent	ADJ
ajlm-2362	14	5	pathogen	pathogen	NOUN
ajlm-2362	14	6	isolated	isolate	VERB
ajlm-2362	14	7	7.1	7.1	NUM
ajlm-2362	14	8	%	%	NOUN
ajlm-2362	14	9	(	(	PUNCT
ajlm-2362	14	10	11/156	11/156	NUM
ajlm-2362	14	11	)	)	PUNCT
ajlm-2362	14	12	in	in	ADP
ajlm-2362	14	13	all	all	DET
ajlm-2362	14	14	samples	sample	NOUN
ajlm-2362	14	15	.	.	PUNCT
ajlm-2362	15	1	the	the	DET
ajlm-2362	15	2	isolates	isolate	NOUN
ajlm-2362	15	3	with	with	ADP
ajlm-2362	15	4	the	the	DET
ajlm-2362	15	5	highest	high	ADJ
ajlm-2362	15	6	rate	rate	NOUN
ajlm-2362	15	7	of	of	ADP
ajlm-2362	15	8	resistance	resistance	NOUN
ajlm-2362	15	9	to	to	ADP
ajlm-2362	15	10	the	the	DET
ajlm-2362	15	11	tested	test	VERB
ajlm-2362	15	12	antibiotics	antibiotic	NOUN
ajlm-2362	15	13	were	be	AUX
ajlm-2362	15	14	s.	s.	PROPN
ajlm-2362	15	15	aureus	aureus	PROPN
ajlm-2362	15	16	32.1	32.1	NUM
ajlm-2362	15	17	%	%	NOUN
ajlm-2362	15	18	(	(	PUNCT
ajlm-2362	15	19	50/156	50/156	NUM
ajlm-2362	15	20	)	)	PUNCT
ajlm-2362	15	21	,	,	PUNCT
ajlm-2362	15	22	e.	e.	PROPN
ajlm-2362	15	23	coli	coli	PROPN
ajlm-2362	15	24	28.2	28.2	NUM
ajlm-2362	15	25	%	%	NOUN
ajlm-2362	15	26	(	(	PUNCT
ajlm-2362	15	27	44/156	44/156	NOUN
ajlm-2362	15	28	)	)	PUNCT
ajlm-2362	15	29	and	and	CCONJ
ajlm-2362	15	30	klebsiella	klebsiella	PROPN
ajlm-2362	15	31	spp	spp	PROPN
ajlm-2362	15	32	.	.	PUNCT
ajlm-2362	16	1	20.5	20.5	NUM
ajlm-2362	16	2	%	%	NOUN
ajlm-2362	16	3	(	(	PUNCT
ajlm-2362	16	4	32/156	32/156	NUM
ajlm-2362	16	5	)	)	PUNCT
ajlm-2362	16	6	.	.	PUNCT
ajlm-2362	17	1	isolates	isolate	NOUN
ajlm-2362	17	2	in	in	ADP
ajlm-2362	17	3	all	all	DET
ajlm-2362	17	4	age	age	NOUN
ajlm-2362	17	5	groups	group	NOUN
ajlm-2362	17	6	were	be	AUX
ajlm-2362	17	7	more	more	ADV
ajlm-2362	17	8	resistant	resistant	ADJ
ajlm-2362	17	9	to	to	ADP
ajlm-2362	17	10	ampicillin	ampicillin	PROPN
ajlm-2362	17	11	,	,	PUNCT
ajlm-2362	17	12	amoxicillin	amoxicillin	PROPN
ajlm-2362	17	13	+	+	CCONJ
ajlm-2362	17	14	clavulanic	clavulanic	ADJ
ajlm-2362	17	15	acid	acid	NOUN
ajlm-2362	17	16	,	,	PUNCT
ajlm-2362	17	17	cefuroxime	cefuroxime	ADJ
ajlm-2362	17	18	and	and	CCONJ
ajlm-2362	17	19	cefepime	cefepime	NOUN
ajlm-2362	17	20	.	.	PUNCT
ajlm-2362	18	1	conclusion	conclusion	NOUN
ajlm-2362	18	2	:	:	PUNCT
ajlm-2362	18	3	antibiotic	antibiotic	ADJ
ajlm-2362	18	4	resistance	resistance	NOUN
ajlm-2362	18	5	is	be	AUX
ajlm-2362	18	6	high	high	ADJ
ajlm-2362	18	7	,	,	PUNCT
ajlm-2362	18	8	especially	especially	ADV
ajlm-2362	18	9	the	the	DET
ajlm-2362	18	10	younger	young	ADJ
ajlm-2362	18	11	nigerian	nigerian	ADJ
ajlm-2362	18	12	children	child	NOUN
ajlm-2362	18	13	.	.	PUNCT
ajlm-2362	19	1	strict	strict	ADJ
ajlm-2362	19	2	antibiotic	antibiotic	ADJ
ajlm-2362	19	3	protocols	protocol	NOUN
ajlm-2362	19	4	should	should	AUX
ajlm-2362	19	5	be	be	AUX
ajlm-2362	19	6	adhered	adhere	VERB
ajlm-2362	19	7	to	to	ADP
ajlm-2362	19	8	especially	especially	ADV
ajlm-2362	19	9	in	in	ADP
ajlm-2362	19	10	the	the	DET
ajlm-2362	19	11	use	use	NOUN
ajlm-2362	19	12	of	of	ADP
ajlm-2362	19	13	empirical	empirical	ADJ
ajlm-2362	19	14	antibiotic	antibiotic	ADJ
ajlm-2362	19	15	therapy	therapy	NOUN
ajlm-2362	19	16	in	in	ADP
ajlm-2362	19	17	hospitals	hospital	NOUN
ajlm-2362	19	18	.	.	PUNCT
ajlm-2362	20	1	what	what	PRON
ajlm-2362	20	2	this	this	DET
ajlm-2362	20	3	study	study	NOUN
ajlm-2362	20	4	adds	add	VERB
ajlm-2362	20	5	:	:	PUNCT
ajlm-2362	20	6	our	our	PRON
ajlm-2362	20	7	study	study	NOUN
ajlm-2362	20	8	reveals	reveal	VERB
ajlm-2362	20	9	a	a	DET
ajlm-2362	20	10	higher	high	ADJ
ajlm-2362	20	11	trend	trend	NOUN
ajlm-2362	20	12	of	of	ADP
ajlm-2362	20	13	antibiotic	antibiotic	ADJ
ajlm-2362	20	14	resistance	resistance	NOUN
ajlm-2362	20	15	,	,	PUNCT
ajlm-2362	20	16	especially	especially	ADV
ajlm-2362	20	17	in	in	ADP
ajlm-2362	20	18	younger	young	ADJ
ajlm-2362	20	19	children	child	NOUN
ajlm-2362	20	20	.	.	PUNCT
ajlm-2362	21	1	it	it	PRON
ajlm-2362	21	2	further	far	ADV
ajlm-2362	21	3	shows	show	VERB
ajlm-2362	21	4	that	that	SCONJ
ajlm-2362	21	5	the	the	DET
ajlm-2362	21	6	pathogens	pathogen	NOUN
ajlm-2362	21	7	are	be	AUX
ajlm-2362	21	8	most	most	ADV
ajlm-2362	21	9	resistant	resistant	ADJ
ajlm-2362	21	10	to	to	ADP
ajlm-2362	21	11	the	the	DET
ajlm-2362	21	12	most	most	ADV
ajlm-2362	21	13	available	available	ADJ
ajlm-2362	21	14	empirical	empirical	ADJ
ajlm-2362	21	15	antibiotics	antibiotic	NOUN
ajlm-2362	21	16	in	in	ADP
ajlm-2362	21	17	nigeria	nigeria	PROPN
ajlm-2362	21	18	.	.	PUNCT
ajlm-2362	22	1	keywords	keyword	NOUN
ajlm-2362	22	2	:	:	PUNCT
ajlm-2362	22	3	antibiotic	antibiotic	ADJ
ajlm-2362	22	4	resistance	resistance	NOUN
ajlm-2362	22	5	;	;	PUNCT
ajlm-2362	22	6	children	child	NOUN
ajlm-2362	22	7	;	;	PUNCT
ajlm-2362	22	8	bacteria	bacteria	NOUN
ajlm-2362	22	9	pathogens	pathogen	NOUN
ajlm-2362	22	10	;	;	PUNCT
ajlm-2362	22	11	susceptibility	susceptibility	NOUN
ajlm-2362	22	12	pattern	pattern	NOUN
ajlm-2362	22	13	;	;	PUNCT
ajlm-2362	22	14	antibiotic	antibiotic	ADJ
ajlm-2362	22	15	therapy	therapy	NOUN
ajlm-2362	22	16	.	.	PUNCT
ajlm-2362	23	1	introduction	introduction	NOUN
ajlm-2362	23	2	antimicrobial	antimicrobial	ADJ
ajlm-2362	23	3	resistance	resistance	NOUN
ajlm-2362	23	4	(	(	PUNCT
ajlm-2362	23	5	amr	amr	NOUN
ajlm-2362	23	6	)	)	PUNCT
ajlm-2362	23	7	is	be	AUX
ajlm-2362	23	8	a	a	DET
ajlm-2362	23	9	global	global	ADJ
ajlm-2362	23	10	public	public	ADJ
ajlm-2362	23	11	health	health	NOUN
ajlm-2362	23	12	issue	issue	NOUN
ajlm-2362	23	13	for	for	ADP
ajlm-2362	23	14	both	both	CCONJ
ajlm-2362	23	15	epidemiologic	epidemiologic	ADJ
ajlm-2362	23	16	and	and	CCONJ
ajlm-2362	23	17	economic	economic	ADJ
ajlm-2362	23	18	reasons.1	reasons.1	VERB
ajlm-2362	23	19	the	the	DET
ajlm-2362	23	20	world	world	PROPN
ajlm-2362	23	21	health	health	NOUN
ajlm-2362	23	22	organization	organization	NOUN
ajlm-2362	23	23	(	(	PUNCT
ajlm-2362	23	24	who	who	PRON
ajlm-2362	23	25	)	)	PUNCT
ajlm-2362	23	26	estimates	estimate	VERB
ajlm-2362	23	27	about	about	ADP
ajlm-2362	23	28	700	700	NUM
ajlm-2362	23	29	000	000	NUM
ajlm-2362	23	30	deaths	death	NOUN
ajlm-2362	23	31	yearly	yearly	ADV
ajlm-2362	23	32	due	due	ADP
ajlm-2362	23	33	to	to	ADP
ajlm-2362	23	34	multi	multi	ADJ
ajlm-2362	23	35	-	-	ADJ
ajlm-2362	23	36	drug	drug	ADJ
ajlm-2362	23	37	resistance	resistance	NOUN
ajlm-2362	23	38	,	,	PUNCT
ajlm-2362	23	39	with	with	ADP
ajlm-2362	23	40	200	200	NUM
ajlm-2362	23	41	000	000	NUM
ajlm-2362	23	42	deaths	death	NOUN
ajlm-2362	23	43	occurring	occur	VERB
ajlm-2362	23	44	in	in	ADP
ajlm-2362	23	45	neonates.2	neonates.2	ADJ
ajlm-2362	23	46	antimicrobial	antimicrobial	ADJ
ajlm-2362	23	47	resistance	resistance	NOUN
ajlm-2362	23	48	,	,	PUNCT
ajlm-2362	23	49	described	describe	VERB
ajlm-2362	23	50	as	as	ADP
ajlm-2362	23	51	a	a	DET
ajlm-2362	23	52	global	global	ADJ
ajlm-2362	23	53	crisis	crisis	NOUN
ajlm-2362	23	54	,	,	PUNCT
ajlm-2362	23	55	is	be	AUX
ajlm-2362	23	56	causing	cause	VERB
ajlm-2362	23	57	difficulty	difficulty	NOUN
ajlm-2362	23	58	in	in	ADP
ajlm-2362	23	59	the	the	DET
ajlm-2362	23	60	treatment	treatment	NOUN
ajlm-2362	23	61	of	of	ADP
ajlm-2362	23	62	common	common	ADJ
ajlm-2362	23	63	bacterial	bacterial	ADJ
ajlm-2362	23	64	infections	infection	NOUN
ajlm-2362	23	65	in	in	ADP
ajlm-2362	23	66	children	child	NOUN
ajlm-2362	23	67	and	and	CCONJ
ajlm-2362	23	68	is	be	AUX
ajlm-2362	23	69	,	,	PUNCT
ajlm-2362	23	70	in	in	ADP
ajlm-2362	23	71	some	some	DET
ajlm-2362	23	72	instances	instance	NOUN
ajlm-2362	23	73	,	,	PUNCT
ajlm-2362	23	74	making	make	VERB
ajlm-2362	23	75	treatment	treatment	NOUN
ajlm-2362	23	76	impossible.1,2	impossible.1,2	ADJ
ajlm-2362	23	77	this	this	PRON
ajlm-2362	23	78	has	have	AUX
ajlm-2362	23	79	led	lead	VERB
ajlm-2362	23	80	to	to	ADP
ajlm-2362	23	81	fatal	fatal	ADJ
ajlm-2362	23	82	outcomes	outcome	NOUN
ajlm-2362	23	83	as	as	ADP
ajlm-2362	23	84	evident	evident	ADJ
ajlm-2362	23	85	in	in	ADP
ajlm-2362	23	86	an	an	DET
ajlm-2362	23	87	increase	increase	NOUN
ajlm-2362	23	88	in	in	ADP
ajlm-2362	23	89	mortality	mortality	NOUN
ajlm-2362	23	90	and	and	CCONJ
ajlm-2362	23	91	morbidity	morbidity	NOUN
ajlm-2362	23	92	among	among	ADP
ajlm-2362	23	93	the	the	DET
ajlm-2362	23	94	paediatric	paediatric	ADJ
ajlm-2362	23	95	age	age	NOUN
ajlm-2362	23	96	group.1,3	group.1,3	ADJ
ajlm-2362	23	97	antibiotics	antibiotic	NOUN
ajlm-2362	23	98	are	be	AUX
ajlm-2362	23	99	among	among	ADP
ajlm-2362	23	100	the	the	DET
ajlm-2362	23	101	most	most	ADV
ajlm-2362	23	102	prescribed	prescribed	ADJ
ajlm-2362	23	103	drugs	drug	NOUN
ajlm-2362	23	104	,	,	PUNCT
ajlm-2362	23	105	both	both	PRON
ajlm-2362	23	106	in	in	ADP
ajlm-2362	23	107	the	the	DET
ajlm-2362	23	108	hospital	hospital	NOUN
ajlm-2362	23	109	and	and	CCONJ
ajlm-2362	23	110	within	within	ADP
ajlm-2362	23	111	the	the	DET
ajlm-2362	23	112	community	community	NOUN
ajlm-2362	23	113	,	,	PUNCT
ajlm-2362	23	114	in	in	ADP
ajlm-2362	23	115	the	the	DET
ajlm-2362	23	116	paediatric	paediatric	ADJ
ajlm-2362	23	117	age	age	NOUN
ajlm-2362	23	118	group.3	group.3	AUX
ajlm-2362	23	119	the	the	DET
ajlm-2362	23	120	factors	factor	NOUN
ajlm-2362	23	121	that	that	PRON
ajlm-2362	23	122	guide	guide	VERB
ajlm-2362	23	123	such	such	ADJ
ajlm-2362	23	124	prescriptions	prescription	NOUN
ajlm-2362	23	125	are	be	AUX
ajlm-2362	23	126	often	often	ADV
ajlm-2362	23	127	invalid	invalid	ADJ
ajlm-2362	23	128	,	,	PUNCT
ajlm-2362	23	129	especially	especially	ADV
ajlm-2362	23	130	in	in	ADP
ajlm-2362	23	131	sub	sub	ADJ
ajlm-2362	23	132	-	-	ADJ
ajlm-2362	23	133	saharan	saharan	ADJ
ajlm-2362	23	134	africa	africa	PROPN
ajlm-2362	23	135	,	,	PUNCT
ajlm-2362	23	136	where	where	SCONJ
ajlm-2362	23	137	self	self	NOUN
ajlm-2362	23	138	-	-	PUNCT
ajlm-2362	23	139	medication	medication	NOUN
ajlm-2362	23	140	is	be	AUX
ajlm-2362	23	141	high	high	ADJ
ajlm-2362	23	142	and	and	CCONJ
ajlm-2362	23	143	the	the	DET
ajlm-2362	23	144	use	use	NOUN
ajlm-2362	23	145	of	of	ADP
ajlm-2362	23	146	unmeasured	unmeasured	ADJ
ajlm-2362	23	147	herbal	herbal	ADJ
ajlm-2362	23	148	medication	medication	NOUN
ajlm-2362	23	149	is	be	AUX
ajlm-2362	23	150	common	common	ADJ
ajlm-2362	23	151	practice.4	practice.4	NOUN
ajlm-2362	23	152	the	the	DET
ajlm-2362	23	153	inadequate	inadequate	ADJ
ajlm-2362	23	154	microbiology	microbiology	NOUN
ajlm-2362	23	155	laboratories	laboratory	NOUN
ajlm-2362	23	156	and	and	CCONJ
ajlm-2362	23	157	equipment	equipment	NOUN
ajlm-2362	23	158	often	often	ADV
ajlm-2362	23	159	justifies	justify	VERB
ajlm-2362	23	160	the	the	DET
ajlm-2362	23	161	empirical	empirical	ADJ
ajlm-2362	23	162	use	use	NOUN
ajlm-2362	23	163	of	of	ADP
ajlm-2362	23	164	antibiotics	antibiotic	NOUN
ajlm-2362	23	165	in	in	ADP
ajlm-2362	23	166	children.5,6,7	children.5,6,7	NOUN
ajlm-2362	23	167	the	the	DET
ajlm-2362	23	168	development	development	NOUN
ajlm-2362	23	169	of	of	ADP
ajlm-2362	23	170	bacterial	bacterial	ADJ
ajlm-2362	23	171	resistance	resistance	NOUN
ajlm-2362	23	172	mechanisms	mechanism	NOUN
ajlm-2362	23	173	is	be	AUX
ajlm-2362	23	174	a	a	DET
ajlm-2362	23	175	normal	normal	ADJ
ajlm-2362	23	176	process	process	NOUN
ajlm-2362	23	177	,	,	PUNCT
ajlm-2362	23	178	regardless	regardless	ADV
ajlm-2362	23	179	of	of	ADP
ajlm-2362	23	180	resistance	resistance	NOUN
ajlm-2362	23	181	gene	gene	NOUN
ajlm-2362	23	182	acquisition	acquisition	NOUN
ajlm-2362	23	183	or	or	CCONJ
ajlm-2362	23	184	gene	gene	NOUN
ajlm-2362	23	185	mutation	mutation	NOUN
ajlm-2362	23	186	;	;	PUNCT
ajlm-2362	23	187	however	however	ADV
ajlm-2362	23	188	,	,	PUNCT
ajlm-2362	23	189	inappropriate	inappropriate	ADJ
ajlm-2362	23	190	or	or	CCONJ
ajlm-2362	23	191	unregulated	unregulated	ADJ
ajlm-2362	23	192	use	use	NOUN
ajlm-2362	23	193	is	be	AUX
ajlm-2362	23	194	believed	believe	VERB
ajlm-2362	23	195	to	to	PART
ajlm-2362	23	196	hasten	hasten	VERB
ajlm-2362	23	197	the	the	DET
ajlm-2362	23	198	process.1	process.1	PROPN
ajlm-2362	23	199	abuse	abuse	NOUN
ajlm-2362	23	200	of	of	ADP
ajlm-2362	23	201	antibacterial	antibacterial	ADJ
ajlm-2362	23	202	agents	agent	NOUN
ajlm-2362	23	203	in	in	ADP
ajlm-2362	23	204	humans	human	NOUN
ajlm-2362	23	205	provides	provide	VERB
ajlm-2362	23	206	a	a	DET
ajlm-2362	23	207	selective	selective	ADJ
ajlm-2362	23	208	pressure	pressure	NOUN
ajlm-2362	23	209	that	that	PRON
ajlm-2362	23	210	promotes	promote	VERB
ajlm-2362	23	211	and	and	CCONJ
ajlm-2362	23	212	spreads	spread	VERB
ajlm-2362	23	213	resistant	resistant	ADJ
ajlm-2362	23	214	strains.1	strains.1	NOUN
ajlm-2362	23	215	unnecessary	unnecessary	ADJ
ajlm-2362	23	216	prescriptions	prescription	NOUN
ajlm-2362	23	217	used	use	VERB
ajlm-2362	23	218	in	in	ADP
ajlm-2362	23	219	the	the	DET
ajlm-2362	23	220	management	management	NOUN
ajlm-2362	23	221	of	of	ADP
ajlm-2362	23	222	viral	viral	ADJ
ajlm-2362	23	223	infections	infection	NOUN
ajlm-2362	23	224	and	and	CCONJ
ajlm-2362	23	225	other	other	ADJ
ajlm-2362	23	226	non	non	ADJ
ajlm-2362	23	227	-	-	ADJ
ajlm-2362	23	228	communicable	communicable	ADJ
ajlm-2362	23	229	diseases	disease	NOUN
ajlm-2362	23	230	,	,	PUNCT
ajlm-2362	23	231	coupled	couple	VERB
ajlm-2362	23	232	with	with	ADP
ajlm-2362	23	233	inappropriate	inappropriate	ADJ
ajlm-2362	23	234	dosage	dosage	NOUN
ajlm-2362	23	235	,	,	PUNCT
ajlm-2362	23	236	have	have	AUX
ajlm-2362	23	237	contributed	contribute	VERB
ajlm-2362	23	238	to	to	ADP
ajlm-2362	23	239	an	an	DET
ajlm-2362	23	240	increase	increase	NOUN
ajlm-2362	23	241	in	in	ADP
ajlm-2362	23	242	the	the	DET
ajlm-2362	23	243	development	development	NOUN
ajlm-2362	23	244	of	of	ADP
ajlm-2362	23	245	multi	multi	ADJ
ajlm-2362	23	246	-	-	ADJ
ajlm-2362	23	247	drug	drug	ADJ
ajlm-2362	23	248	resistant	resistant	ADJ
ajlm-2362	23	249	bacteria	bacteria	NOUN
ajlm-2362	23	250	species.5,6,7	species.5,6,7	PUNCT
ajlm-2362	23	251	a	a	DET
ajlm-2362	23	252	lack	lack	NOUN
ajlm-2362	23	253	of	of	ADP
ajlm-2362	23	254	equipped	equip	VERB
ajlm-2362	23	255	laboratories	laboratory	NOUN
ajlm-2362	23	256	,	,	PUNCT
ajlm-2362	23	257	coupled	couple	VERB
ajlm-2362	23	258	with	with	ADP
ajlm-2362	23	259	non	non	NOUN
ajlm-2362	23	260	-	-	NOUN
ajlm-2362	23	261	adherence	adherence	NOUN
ajlm-2362	23	262	to	to	ADP
ajlm-2362	23	263	infection	infection	NOUN
ajlm-2362	23	264	prevention	prevention	NOUN
ajlm-2362	23	265	and	and	CCONJ
ajlm-2362	23	266	control	control	NOUN
ajlm-2362	23	267	practices	practice	NOUN
ajlm-2362	23	268	,	,	PUNCT
ajlm-2362	23	269	increases	increase	VERB
ajlm-2362	23	270	the	the	DET
ajlm-2362	23	271	risk	risk	NOUN
ajlm-2362	23	272	of	of	ADP
ajlm-2362	23	273	amr	amr	NOUN
ajlm-2362	23	274	,	,	PUNCT
ajlm-2362	23	275	reduces	reduce	VERB
ajlm-2362	23	276	the	the	DET
ajlm-2362	23	277	quality	quality	NOUN
ajlm-2362	23	278	of	of	ADP
ajlm-2362	23	279	care	care	NOUN
ajlm-2362	23	280	,	,	PUNCT
ajlm-2362	23	281	and	and	CCONJ
ajlm-2362	23	282	increases	increase	VERB
ajlm-2362	23	283	paediatric	paediatric	ADJ
ajlm-2362	23	284	morbidity	morbidity	NOUN
ajlm-2362	23	285	and	and	CCONJ
ajlm-2362	23	286	mortality.5,8,9,10	mortality.5,8,9,10	NOUN
ajlm-2362	23	287	in	in	ADP
ajlm-2362	23	288	the	the	DET
ajlm-2362	23	289	west	west	ADJ
ajlm-2362	23	290	african	african	ADJ
ajlm-2362	23	291	region	region	NOUN
ajlm-2362	23	292	,	,	PUNCT
ajlm-2362	23	293	absence	absence	NOUN
ajlm-2362	23	294	of	of	ADP
ajlm-2362	23	295	monitoring	monitoring	NOUN
ajlm-2362	23	296	of	of	ADP
ajlm-2362	23	297	licensed	licensed	ADJ
ajlm-2362	23	298	pharmaceutical	pharmaceutical	ADJ
ajlm-2362	23	299	vendors	vendor	NOUN
ajlm-2362	23	300	has	have	AUX
ajlm-2362	23	301	given	give	VERB
ajlm-2362	23	302	way	way	NOUN
ajlm-2362	23	303	to	to	ADP
ajlm-2362	23	304	availability	availability	NOUN
ajlm-2362	23	305	of	of	ADP
ajlm-2362	23	306	many	many	ADJ
ajlm-2362	23	307	firstand	firstand	ADJ
ajlm-2362	23	308	second	second	ADJ
ajlm-2362	23	309	-	-	PUNCT
ajlm-2362	23	310	line	line	NOUN
ajlm-2362	23	311	antibiotics	antibiotic	NOUN
ajlm-2362	23	312	as	as	ADP
ajlm-2362	23	313	over	over	ADP
ajlm-2362	23	314	-	-	PUNCT
ajlm-2362	23	315	the	the	DET
ajlm-2362	23	316	-	-	PUNCT
ajlm-2362	23	317	counter	counter	NOUN
ajlm-2362	23	318	medications	medication	NOUN
ajlm-2362	23	319	.	.	PUNCT
ajlm-2362	24	1	this	this	DET
ajlm-2362	24	2	unguided	unguided	ADJ
ajlm-2362	24	3	practice	practice	NOUN
ajlm-2362	24	4	,	,	PUNCT
ajlm-2362	24	5	alongside	alongside	ADP
ajlm-2362	24	6	the	the	DET
ajlm-2362	24	7	widespread	widespread	ADJ
ajlm-2362	24	8	patronage	patronage	NOUN
ajlm-2362	24	9	of	of	ADP
ajlm-2362	24	10	drug	drug	NOUN
ajlm-2362	24	11	hawkers	hawker	NOUN
ajlm-2362	24	12	,	,	PUNCT
ajlm-2362	24	13	reduces	reduce	VERB
ajlm-2362	24	14	the	the	DET
ajlm-2362	24	15	strength	strength	NOUN
ajlm-2362	24	16	of	of	ADP
ajlm-2362	24	17	antimicrobial	antimicrobial	ADJ
ajlm-2362	24	18	surveillance	surveillance	NOUN
ajlm-2362	24	19	within	within	ADP
ajlm-2362	24	20	the	the	DET
ajlm-2362	24	21	region	region	NOUN
ajlm-2362	24	22	.	.	PUNCT
ajlm-2362	25	1	likewise	likewise	ADV
ajlm-2362	25	2	,	,	PUNCT
ajlm-2362	25	3	the	the	DET
ajlm-2362	25	4	pattern	pattern	NOUN
ajlm-2362	25	5	of	of	ADP
ajlm-2362	25	6	antibiotic	antibiotic	ADJ
ajlm-2362	25	7	resistance	resistance	NOUN
ajlm-2362	25	8	is	be	AUX
ajlm-2362	25	9	not	not	PART
ajlm-2362	25	10	well	well	ADV
ajlm-2362	25	11	studied	study	VERB
ajlm-2362	25	12	in	in	ADP
ajlm-2362	25	13	children	child	NOUN
ajlm-2362	25	14	,	,	PUNCT
ajlm-2362	25	15	despite	despite	SCONJ
ajlm-2362	25	16	the	the	DET
ajlm-2362	25	17	high	high	ADJ
ajlm-2362	25	18	usage	usage	NOUN
ajlm-2362	25	19	of	of	ADP
ajlm-2362	25	20	antibiotics	antibiotic	NOUN
ajlm-2362	25	21	in	in	ADP
ajlm-2362	25	22	this	this	DET
ajlm-2362	25	23	age	age	NOUN
ajlm-2362	25	24	group	group	NOUN
ajlm-2362	25	25	.	.	PUNCT
ajlm-2362	26	1	the	the	DET
ajlm-2362	26	2	african	african	ADJ
ajlm-2362	26	3	continent	continent	NOUN
ajlm-2362	26	4	has	have	VERB
ajlm-2362	26	5	a	a	DET
ajlm-2362	26	6	major	major	ADJ
ajlm-2362	26	7	setback	setback	NOUN
ajlm-2362	26	8	in	in	ADP
ajlm-2362	26	9	accrued	accrue	VERB
ajlm-2362	26	10	data	datum	NOUN
ajlm-2362	26	11	on	on	ADP
ajlm-2362	26	12	amr.9	amr.9	ADP
ajlm-2362	26	13	the	the	PRON
ajlm-2362	26	14	who	who	PRON
ajlm-2362	26	15	considers	consider	VERB
ajlm-2362	26	16	africa	africa	PROPN
ajlm-2362	26	17	to	to	PART
ajlm-2362	26	18	have	have	VERB
ajlm-2362	26	19	a	a	DET
ajlm-2362	26	20	wide	wide	ADJ
ajlm-2362	26	21	gap	gap	NOUN
ajlm-2362	26	22	on	on	ADP
ajlm-2362	26	23	recorded	record	VERB
ajlm-2362	26	24	prevalence	prevalence	NOUN
ajlm-2362	26	25	of	of	ADP
ajlm-2362	26	26	amr	amr	NOUN
ajlm-2362	26	27	as	as	ADP
ajlm-2362	26	28	compared	compare	VERB
ajlm-2362	26	29	to	to	ADP
ajlm-2362	26	30	most	most	ADJ
ajlm-2362	26	31	other	other	ADJ
ajlm-2362	26	32	continents.11	continents.11	NOUN
ajlm-2362	26	33	this	this	PRON
ajlm-2362	26	34	can	can	AUX
ajlm-2362	26	35	be	be	AUX
ajlm-2362	26	36	attributed	attribute	VERB
ajlm-2362	26	37	to	to	ADP
ajlm-2362	26	38	weak	weak	ADJ
ajlm-2362	26	39	national	national	ADJ
ajlm-2362	26	40	surveillance	surveillance	NOUN
ajlm-2362	26	41	systems	system	NOUN
ajlm-2362	26	42	in	in	ADP
ajlm-2362	26	43	many	many	ADJ
ajlm-2362	26	44	african	african	ADJ
ajlm-2362	26	45	nations	nation	NOUN
ajlm-2362	26	46	.	.	PUNCT
ajlm-2362	27	1	for	for	ADP
ajlm-2362	27	2	instance	instance	NOUN
ajlm-2362	27	3	,	,	PUNCT
ajlm-2362	27	4	in	in	ADP
ajlm-2362	27	5	a	a	DET
ajlm-2362	27	6	2023	2023	NUM
ajlm-2362	27	7	who	who	PRON
ajlm-2362	27	8	survey,12	survey,12	VERB
ajlm-2362	27	9	the	the	DET
ajlm-2362	27	10	one	one	NUM
ajlm-2362	27	11	health	health	NOUN
ajlm-2362	27	12	approach	approach	NOUN
ajlm-2362	27	13	created	create	VERB
ajlm-2362	27	14	by	by	ADP
ajlm-2362	27	15	the	the	DET
ajlm-2362	27	16	organisation	organisation	NOUN
ajlm-2362	27	17	was	be	AUX
ajlm-2362	27	18	found	find	VERB
ajlm-2362	27	19	to	to	PART
ajlm-2362	27	20	be	be	AUX
ajlm-2362	27	21	efficient	efficient	ADJ
ajlm-2362	27	22	in	in	ADP
ajlm-2362	27	23	only	only	ADV
ajlm-2362	27	24	eight	eight	NUM
ajlm-2362	27	25	african	african	ADJ
ajlm-2362	27	26	countries.12	countries.12	NOUN
ajlm-2362	27	27	the	the	DET
ajlm-2362	27	28	one	one	NUM
ajlm-2362	27	29	health	health	NOUN
ajlm-2362	27	30	approach	approach	NOUN
ajlm-2362	27	31	aims	aim	VERB
ajlm-2362	27	32	to	to	PART
ajlm-2362	27	33	prevent	prevent	VERB
ajlm-2362	27	34	and	and	CCONJ
ajlm-2362	27	35	control	control	VERB
ajlm-2362	27	36	amr	amr	NOUN
ajlm-2362	27	37	by	by	ADP
ajlm-2362	27	38	employing	employ	VERB
ajlm-2362	27	39	stakeholders	stakeholder	NOUN
ajlm-2362	27	40	in	in	ADP
ajlm-2362	27	41	different	different	ADJ
ajlm-2362	27	42	disciplines	discipline	NOUN
ajlm-2362	27	43	and	and	CCONJ
ajlm-2362	27	44	sectors	sector	NOUN
ajlm-2362	27	45	to	to	PART
ajlm-2362	27	46	work	work	VERB
ajlm-2362	27	47	together	together	ADV
ajlm-2362	27	48	through	through	ADP
ajlm-2362	27	49	surveillance	surveillance	NOUN
ajlm-2362	27	50	and	and	CCONJ
ajlm-2362	27	51	shared	share	VERB
ajlm-2362	27	52	databases.12	databases.12	PROPN
ajlm-2362	27	53	an	an	DET
ajlm-2362	27	54	earlier	early	ADJ
ajlm-2362	27	55	report	report	NOUN
ajlm-2362	27	56	on	on	ADP
ajlm-2362	27	57	central	central	ADJ
ajlm-2362	27	58	and	and	CCONJ
ajlm-2362	27	59	east	east	ADJ
ajlm-2362	27	60	african	african	ADJ
ajlm-2362	27	61	nations	nation	NOUN
ajlm-2362	27	62	clearly	clearly	ADV
ajlm-2362	27	63	defined	define	VERB
ajlm-2362	27	64	the	the	DET
ajlm-2362	27	65	inadequacy	inadequacy	NOUN
ajlm-2362	27	66	in	in	ADP
ajlm-2362	27	67	antimicrobial	antimicrobial	ADJ
ajlm-2362	27	68	susceptibility	susceptibility	NOUN
ajlm-2362	27	69	testing.13	testing.13	PROPN
ajlm-2362	27	70	this	this	DET
ajlm-2362	27	71	report	report	NOUN
ajlm-2362	27	72	also	also	ADV
ajlm-2362	27	73	indicated	indicate	VERB
ajlm-2362	27	74	that	that	SCONJ
ajlm-2362	27	75	the	the	DET
ajlm-2362	27	76	amr	amr	NOUN
ajlm-2362	27	77	pattern	pattern	NOUN
ajlm-2362	27	78	in	in	ADP
ajlm-2362	27	79	these	these	DET
ajlm-2362	27	80	regions	region	NOUN
ajlm-2362	27	81	may	may	AUX
ajlm-2362	27	82	be	be	AUX
ajlm-2362	27	83	more	more	ADV
ajlm-2362	27	84	ubiquitous	ubiquitous	ADJ
ajlm-2362	27	85	than	than	ADP
ajlm-2362	27	86	documented.13	documented.13	NOUN
ajlm-2362	27	87	recent	recent	ADJ
ajlm-2362	27	88	efforts	effort	NOUN
ajlm-2362	27	89	to	to	PART
ajlm-2362	27	90	define	define	VERB
ajlm-2362	27	91	the	the	DET
ajlm-2362	27	92	map	map	NOUN
ajlm-2362	27	93	of	of	ADP
ajlm-2362	27	94	amr	amr	PROPN
ajlm-2362	27	95	(	(	PUNCT
ajlm-2362	27	96	especially	especially	ADV
ajlm-2362	27	97	in	in	ADP
ajlm-2362	27	98	the	the	DET
ajlm-2362	27	99	paediatric	paediatric	ADJ
ajlm-2362	27	100	group	group	NOUN
ajlm-2362	27	101	)	)	PUNCT
ajlm-2362	27	102	in	in	ADP
ajlm-2362	27	103	sub	sub	ADJ
ajlm-2362	27	104	-	-	ADJ
ajlm-2362	27	105	saharan	saharan	ADJ
ajlm-2362	27	106	africa	africa	PROPN
ajlm-2362	27	107	have	have	AUX
ajlm-2362	27	108	proven	prove	VERB
ajlm-2362	27	109	difficult	difficult	ADJ
ajlm-2362	27	110	because	because	SCONJ
ajlm-2362	27	111	of	of	ADP
ajlm-2362	27	112	limited	limited	ADJ
ajlm-2362	27	113	data	datum	NOUN
ajlm-2362	27	114	across	across	ADP
ajlm-2362	27	115	west	west	ADJ
ajlm-2362	27	116	african	african	ADJ
ajlm-2362	27	117	states	state	NOUN
ajlm-2362	27	118	,	,	PUNCT
ajlm-2362	27	119	thus	thus	ADV
ajlm-2362	27	120	affecting	affect	VERB
ajlm-2362	27	121	the	the	DET
ajlm-2362	27	122	formation	formation	NOUN
ajlm-2362	27	123	of	of	ADP
ajlm-2362	27	124	comprehensive	comprehensive	ADJ
ajlm-2362	27	125	national	national	ADJ
ajlm-2362	27	126	guidelines	guideline	NOUN
ajlm-2362	27	127	and	and	CCONJ
ajlm-2362	27	128	protocol.6,10	protocol.6,10	NOUN
ajlm-2362	27	129	the	the	DET
ajlm-2362	27	130	paucity	paucity	NOUN
ajlm-2362	27	131	of	of	ADP
ajlm-2362	27	132	knowledge	knowledge	NOUN
ajlm-2362	27	133	on	on	ADP
ajlm-2362	27	134	the	the	DET
ajlm-2362	27	135	trends	trend	NOUN
ajlm-2362	27	136	of	of	ADP
ajlm-2362	27	137	amr	amr	PROPN
ajlm-2362	27	138	in	in	ADP
ajlm-2362	27	139	nigerian	nigerian	ADJ
ajlm-2362	27	140	children	child	NOUN
ajlm-2362	27	141	has	have	AUX
ajlm-2362	27	142	necessitated	necessitate	VERB
ajlm-2362	27	143	this	this	DET
ajlm-2362	27	144	research	research	NOUN
ajlm-2362	27	145	.	.	PUNCT
ajlm-2362	28	1	this	this	DET
ajlm-2362	28	2	study	study	NOUN
ajlm-2362	28	3	therefore	therefore	ADV
ajlm-2362	28	4	aims	aim	VERB
ajlm-2362	28	5	to	to	PART
ajlm-2362	28	6	determine	determine	VERB
ajlm-2362	28	7	the	the	DET
ajlm-2362	28	8	trend	trend	NOUN
ajlm-2362	28	9	of	of	ADP
ajlm-2362	28	10	antibiotic	antibiotic	ADJ
ajlm-2362	28	11	susceptibility	susceptibility	NOUN
ajlm-2362	28	12	of	of	ADP
ajlm-2362	28	13	identified	identify	VERB
ajlm-2362	28	14	pathogens	pathogen	NOUN
ajlm-2362	28	15	cultured	culture	VERB
ajlm-2362	28	16	from	from	ADP
ajlm-2362	28	17	different	different	ADJ
ajlm-2362	28	18	clinical	clinical	ADJ
ajlm-2362	28	19	specimens	specimen	NOUN
ajlm-2362	28	20	in	in	ADP
ajlm-2362	28	21	a	a	DET
ajlm-2362	28	22	sample	sample	NOUN
ajlm-2362	28	23	of	of	ADP
ajlm-2362	28	24	hospitalised	hospitalise	VERB
ajlm-2362	28	25	nigerian	nigerian	ADJ
ajlm-2362	28	26	paediatric	paediatric	ADJ
ajlm-2362	28	27	patients	patient	NOUN
ajlm-2362	28	28	.	.	PUNCT
ajlm-2362	29	1	methods	method	NOUN
ajlm-2362	29	2	ethical	ethical	ADJ
ajlm-2362	29	3	considerations	consideration	NOUN
ajlm-2362	29	4	ethical	ethical	ADJ
ajlm-2362	29	5	approval	approval	NOUN
ajlm-2362	29	6	was	be	AUX
ajlm-2362	29	7	obtained	obtain	VERB
ajlm-2362	29	8	from	from	ADP
ajlm-2362	29	9	the	the	DET
ajlm-2362	29	10	lagos	lagos	PROPN
ajlm-2362	29	11	state	state	PROPN
ajlm-2362	29	12	university	university	PROPN
ajlm-2362	29	13	teaching	teaching	NOUN
ajlm-2362	29	14	hospital	hospital	NOUN
ajlm-2362	29	15	health	health	NOUN
ajlm-2362	29	16	research	research	NOUN
ajlm-2362	29	17	and	and	CCONJ
ajlm-2362	29	18	ethics	ethic	NOUN
ajlm-2362	29	19	committee	committee	PROPN
ajlm-2362	29	20	(	(	PUNCT
ajlm-2362	29	21	lrec/06/10/2193	lrec/06/10/2193	PROPN
ajlm-2362	29	22	)	)	PUNCT
ajlm-2362	29	23	.	.	PUNCT
ajlm-2362	30	1	the	the	DET
ajlm-2362	30	2	ethical	ethical	ADJ
ajlm-2362	30	3	approval	approval	NOUN
ajlm-2362	30	4	was	be	AUX
ajlm-2362	30	5	obtained	obtain	VERB
ajlm-2362	30	6	in	in	ADP
ajlm-2362	30	7	a	a	DET
ajlm-2362	30	8	written	write	VERB
ajlm-2362	30	9	format	format	NOUN
ajlm-2362	30	10	after	after	ADP
ajlm-2362	30	11	submission	submission	NOUN
ajlm-2362	30	12	of	of	ADP
ajlm-2362	30	13	a	a	DET
ajlm-2362	30	14	detailed	detailed	ADJ
ajlm-2362	30	15	study	study	NOUN
ajlm-2362	30	16	proposal	proposal	NOUN
ajlm-2362	30	17	and	and	CCONJ
ajlm-2362	30	18	before	before	ADP
ajlm-2362	30	19	data	data	NOUN
ajlm-2362	30	20	collection	collection	NOUN
ajlm-2362	30	21	.	.	PUNCT
ajlm-2362	31	1	all	all	DET
ajlm-2362	31	2	data	data	NOUN
ajlm-2362	31	3	-	-	PUNCT
ajlm-2362	31	4	collecting	collect	VERB
ajlm-2362	31	5	procedures	procedure	NOUN
ajlm-2362	31	6	followed	follow	VERB
ajlm-2362	31	7	the	the	DET
ajlm-2362	31	8	guidelines	guideline	NOUN
ajlm-2362	31	9	of	of	ADP
ajlm-2362	31	10	the	the	DET
ajlm-2362	31	11	national	national	PROPN
ajlm-2362	31	12	health	health	PROPN
ajlm-2362	31	13	research	research	PROPN
ajlm-2362	31	14	ethics	ethic	NOUN
ajlm-2362	31	15	committee	committee	PROPN
ajlm-2362	31	16	,	,	PUNCT
ajlm-2362	31	17	nigeria	nigeria	PROPN
ajlm-2362	31	18	(	(	PUNCT
ajlm-2362	31	19	www.nhrec.net	www.nhrec.net	PROPN
ajlm-2362	31	20	)	)	PUNCT
ajlm-2362	31	21	.	.	PUNCT
ajlm-2362	32	1	as	as	SCONJ
ajlm-2362	32	2	this	this	DET
ajlm-2362	32	3	retrospective	retrospective	ADJ
ajlm-2362	32	4	study	study	NOUN
ajlm-2362	32	5	involved	involve	VERB
ajlm-2362	32	6	data	datum	NOUN
ajlm-2362	32	7	of	of	ADP
ajlm-2362	32	8	collected	collect	VERB
ajlm-2362	32	9	specimens	specimen	NOUN
ajlm-2362	32	10	with	with	ADP
ajlm-2362	32	11	laboratory	laboratory	NOUN
ajlm-2362	32	12	codes	code	NOUN
ajlm-2362	32	13	from	from	ADP
ajlm-2362	32	14	routine	routine	ADJ
ajlm-2362	32	15	clinical	clinical	ADJ
ajlm-2362	32	16	practices	practice	NOUN
ajlm-2362	32	17	,	,	PUNCT
ajlm-2362	32	18	informed	inform	VERB
ajlm-2362	32	19	consent	consent	NOUN
ajlm-2362	32	20	was	be	AUX
ajlm-2362	32	21	waived	waive	VERB
ajlm-2362	32	22	by	by	ADP
ajlm-2362	32	23	the	the	DET
ajlm-2362	32	24	lagos	lagos	PROPN
ajlm-2362	32	25	state	state	PROPN
ajlm-2362	32	26	university	university	PROPN
ajlm-2362	32	27	teaching	teaching	NOUN
ajlm-2362	32	28	hospital	hospital	NOUN
ajlm-2362	32	29	health	health	NOUN
ajlm-2362	32	30	research	research	NOUN
ajlm-2362	32	31	and	and	CCONJ
ajlm-2362	32	32	ethics	ethic	NOUN
ajlm-2362	32	33	committee	committee	PROPN
ajlm-2362	32	34	according	accord	VERB
ajlm-2362	32	35	to	to	ADP
ajlm-2362	32	36	the	the	DET
ajlm-2362	32	37	declaration	declaration	NOUN
ajlm-2362	32	38	of	of	ADP
ajlm-2362	32	39	helsinki	helsinki	PROPN
ajlm-2362	32	40	.	.	PUNCT
ajlm-2362	33	1	data	data	PROPN
ajlm-2362	33	2	access	access	NOUN
ajlm-2362	33	3	authorisation	authorisation	NOUN
ajlm-2362	33	4	and	and	CCONJ
ajlm-2362	33	5	restriction	restriction	NOUN
ajlm-2362	33	6	of	of	ADP
ajlm-2362	33	7	sensitive	sensitive	ADJ
ajlm-2362	33	8	records	record	NOUN
ajlm-2362	33	9	were	be	AUX
ajlm-2362	33	10	duly	duly	ADV
ajlm-2362	33	11	observed	observe	VERB
ajlm-2362	33	12	according	accord	VERB
ajlm-2362	33	13	to	to	ADP
ajlm-2362	33	14	the	the	DET
ajlm-2362	33	15	national	national	PROPN
ajlm-2362	33	16	data	data	PROPN
ajlm-2362	33	17	protection	protection	NOUN
ajlm-2362	33	18	and	and	CCONJ
ajlm-2362	33	19	privacy	privacy	NOUN
ajlm-2362	33	20	regulation	regulation	NOUN
ajlm-2362	33	21	.	.	PUNCT
ajlm-2362	34	1	authorised	authorise	VERB
ajlm-2362	34	2	data	data	NOUN
ajlm-2362	34	3	records	record	NOUN
ajlm-2362	34	4	were	be	AUX
ajlm-2362	34	5	kept	keep	VERB
ajlm-2362	34	6	in	in	ADP
ajlm-2362	34	7	a	a	DET
ajlm-2362	34	8	locked	locked	ADJ
ajlm-2362	34	9	file	file	NOUN
ajlm-2362	34	10	cabinet	cabinet	NOUN
ajlm-2362	34	11	accessible	accessible	ADJ
ajlm-2362	34	12	only	only	ADV
ajlm-2362	34	13	to	to	ADP
ajlm-2362	34	14	the	the	DET
ajlm-2362	34	15	principal	principal	ADJ
ajlm-2362	34	16	investigator	investigator	NOUN
ajlm-2362	34	17	.	.	PUNCT
ajlm-2362	35	1	study	study	NOUN
ajlm-2362	35	2	design	design	NOUN
ajlm-2362	35	3	and	and	CCONJ
ajlm-2362	35	4	population	population	NOUN
ajlm-2362	35	5	this	this	PRON
ajlm-2362	35	6	was	be	AUX
ajlm-2362	35	7	a	a	DET
ajlm-2362	35	8	retrospective	retrospective	ADJ
ajlm-2362	35	9	study	study	NOUN
ajlm-2362	35	10	to	to	PART
ajlm-2362	35	11	describe	describe	VERB
ajlm-2362	35	12	the	the	DET
ajlm-2362	35	13	pattern	pattern	NOUN
ajlm-2362	35	14	of	of	ADP
ajlm-2362	35	15	susceptibility	susceptibility	NOUN
ajlm-2362	35	16	to	to	ADP
ajlm-2362	35	17	antibacterial	antibacterial	ADJ
ajlm-2362	35	18	agents	agent	NOUN
ajlm-2362	35	19	in	in	ADP
ajlm-2362	35	20	children	child	NOUN
ajlm-2362	35	21	over	over	ADP
ajlm-2362	35	22	the	the	DET
ajlm-2362	35	23	period	period	NOUN
ajlm-2362	35	24	from	from	ADP
ajlm-2362	35	25	december	december	PROPN
ajlm-2362	35	26	2021	2021	NUM
ajlm-2362	35	27	to	to	ADP
ajlm-2362	35	28	march	march	PROPN
ajlm-2362	35	29	2022	2022	NUM
ajlm-2362	35	30	.	.	PUNCT
ajlm-2362	36	1	the	the	DET
ajlm-2362	36	2	study	study	NOUN
ajlm-2362	36	3	population	population	NOUN
ajlm-2362	36	4	comprised	comprise	VERB
ajlm-2362	36	5	inpatients	inpatient	NOUN
ajlm-2362	36	6	admitted	admit	VERB
ajlm-2362	36	7	at	at	ADP
ajlm-2362	36	8	the	the	DET
ajlm-2362	36	9	massey	massey	PROPN
ajlm-2362	36	10	street	street	PROPN
ajlm-2362	36	11	children	child	NOUN
ajlm-2362	36	12	’s	’s	PART
ajlm-2362	36	13	hospital	hospital	NOUN
ajlm-2362	36	14	in	in	ADP
ajlm-2362	36	15	lagos	lagos	PROPN
ajlm-2362	36	16	,	,	PUNCT
ajlm-2362	36	17	south	south	ADJ
ajlm-2362	36	18	-	-	PUNCT
ajlm-2362	36	19	western	western	ADJ
ajlm-2362	36	20	nigeria	nigeria	PROPN
ajlm-2362	36	21	.	.	PUNCT
ajlm-2362	37	1	the	the	DET
ajlm-2362	37	2	hospital	hospital	NOUN
ajlm-2362	37	3	is	be	AUX
ajlm-2362	37	4	currently	currently	ADV
ajlm-2362	37	5	the	the	DET
ajlm-2362	37	6	only	only	ADJ
ajlm-2362	37	7	public	public	ADJ
ajlm-2362	37	8	children	child	NOUN
ajlm-2362	37	9	’s	’s	PART
ajlm-2362	37	10	hospital	hospital	NOUN
ajlm-2362	37	11	in	in	ADP
ajlm-2362	37	12	the	the	DET
ajlm-2362	37	13	state	state	NOUN
ajlm-2362	37	14	.	.	PUNCT
ajlm-2362	38	1	it	it	PRON
ajlm-2362	38	2	is	be	AUX
ajlm-2362	38	3	located	locate	VERB
ajlm-2362	38	4	in	in	ADP
ajlm-2362	38	5	a	a	DET
ajlm-2362	38	6	densely	densely	ADV
ajlm-2362	38	7	populated	populated	ADJ
ajlm-2362	38	8	suburb	suburb	NOUN
ajlm-2362	38	9	of	of	ADP
ajlm-2362	38	10	the	the	DET
ajlm-2362	38	11	state	state	NOUN
ajlm-2362	38	12	and	and	CCONJ
ajlm-2362	38	13	cares	care	VERB
ajlm-2362	38	14	for	for	ADP
ajlm-2362	38	15	patients	patient	NOUN
ajlm-2362	38	16	from	from	ADP
ajlm-2362	38	17	all	all	ADV
ajlm-2362	38	18	over	over	ADP
ajlm-2362	38	19	the	the	DET
ajlm-2362	38	20	state	state	NOUN
ajlm-2362	38	21	and	and	CCONJ
ajlm-2362	38	22	its	its	PRON
ajlm-2362	38	23	environs	environ	NOUN
ajlm-2362	38	24	.	.	PUNCT
ajlm-2362	39	1	clinical	clinical	ADJ
ajlm-2362	39	2	care	care	NOUN
ajlm-2362	39	3	and	and	CCONJ
ajlm-2362	39	4	laboratory	laboratory	NOUN
ajlm-2362	39	5	procedures	procedure	NOUN
ajlm-2362	39	6	clinical	clinical	ADJ
ajlm-2362	39	7	specimens	specimen	NOUN
ajlm-2362	39	8	,	,	PUNCT
ajlm-2362	39	9	including	include	VERB
ajlm-2362	39	10	blood	blood	NOUN
ajlm-2362	39	11	,	,	PUNCT
ajlm-2362	39	12	cerebrospinal	cerebrospinal	ADJ
ajlm-2362	39	13	fluid	fluid	NOUN
ajlm-2362	39	14	,	,	PUNCT
ajlm-2362	39	15	ear	ear	NOUN
ajlm-2362	39	16	swabs	swab	NOUN
ajlm-2362	39	17	,	,	PUNCT
ajlm-2362	39	18	urine	urine	NOUN
ajlm-2362	39	19	,	,	PUNCT
ajlm-2362	39	20	and	and	CCONJ
ajlm-2362	39	21	stool	stool	NOUN
ajlm-2362	39	22	,	,	PUNCT
ajlm-2362	39	23	were	be	AUX
ajlm-2362	39	24	collected	collect	VERB
ajlm-2362	39	25	from	from	ADP
ajlm-2362	39	26	hospitalised	hospitalise	VERB
ajlm-2362	39	27	patients	patient	NOUN
ajlm-2362	39	28	,	,	PUNCT
ajlm-2362	39	29	according	accord	VERB
ajlm-2362	39	30	to	to	ADP
ajlm-2362	39	31	their	their	PRON
ajlm-2362	39	32	disease	disease	NOUN
ajlm-2362	39	33	condition	condition	NOUN
ajlm-2362	39	34	,	,	PUNCT
ajlm-2362	39	35	as	as	ADP
ajlm-2362	39	36	part	part	NOUN
ajlm-2362	39	37	of	of	ADP
ajlm-2362	39	38	clinical	clinical	ADJ
ajlm-2362	39	39	care	care	NOUN
ajlm-2362	39	40	by	by	ADP
ajlm-2362	39	41	the	the	DET
ajlm-2362	39	42	managing	manage	VERB
ajlm-2362	39	43	physician	physician	NOUN
ajlm-2362	39	44	,	,	PUNCT
ajlm-2362	39	45	and	and	CCONJ
ajlm-2362	39	46	submitted	submit	VERB
ajlm-2362	39	47	to	to	ADP
ajlm-2362	39	48	the	the	DET
ajlm-2362	39	49	microbiological	microbiological	ADJ
ajlm-2362	39	50	testing	testing	NOUN
ajlm-2362	39	51	unit	unit	NOUN
ajlm-2362	39	52	.	.	PUNCT
ajlm-2362	40	1	at	at	ADP
ajlm-2362	40	2	the	the	DET
ajlm-2362	40	3	study	study	NOUN
ajlm-2362	40	4	site	site	NOUN
ajlm-2362	40	5	,	,	PUNCT
ajlm-2362	40	6	cultures	culture	NOUN
ajlm-2362	40	7	including	include	VERB
ajlm-2362	40	8	urine	urine	NOUN
ajlm-2362	40	9	,	,	PUNCT
ajlm-2362	40	10	ear	ear	NOUN
ajlm-2362	40	11	,	,	PUNCT
ajlm-2362	40	12	and	and	CCONJ
ajlm-2362	40	13	cerebrospinal	cerebrospinal	ADJ
ajlm-2362	40	14	fluid	fluid	NOUN
ajlm-2362	40	15	followed	follow	VERB
ajlm-2362	40	16	standard	standard	ADJ
ajlm-2362	40	17	microbiological	microbiological	ADJ
ajlm-2362	40	18	methods	method	NOUN
ajlm-2362	40	19	such	such	ADJ
ajlm-2362	40	20	as	as	ADP
ajlm-2362	40	21	morphology	morphology	NOUN
ajlm-2362	40	22	on	on	ADP
ajlm-2362	40	23	culture	culture	NOUN
ajlm-2362	40	24	media	medium	NOUN
ajlm-2362	40	25	,	,	PUNCT
ajlm-2362	40	26	gram	gram	NOUN
ajlm-2362	40	27	staining	staining	NOUN
ajlm-2362	40	28	,	,	PUNCT
ajlm-2362	40	29	and	and	CCONJ
ajlm-2362	40	30	conventional	conventional	ADJ
ajlm-2362	40	31	biochemical	biochemical	ADJ
ajlm-2362	40	32	testing	testing	NOUN
ajlm-2362	40	33	.	.	PUNCT
ajlm-2362	41	1	blood	blood	NOUN
ajlm-2362	41	2	culture	culture	NOUN
ajlm-2362	41	3	was	be	AUX
ajlm-2362	41	4	performed	perform	VERB
ajlm-2362	41	5	according	accord	VERB
ajlm-2362	41	6	to	to	ADP
ajlm-2362	41	7	the	the	DET
ajlm-2362	41	8	bd	bd	PROPN
ajlm-2362	41	9	bactectm	bactectm	ADJ
ajlm-2362	41	10	automated	automate	VERB
ajlm-2362	41	11	blood	blood	NOUN
ajlm-2362	41	12	culture	culture	NOUN
ajlm-2362	41	13	systems	system	NOUN
ajlm-2362	41	14	(	(	PUNCT
ajlm-2362	41	15	becton	becton	PROPN
ajlm-2362	41	16	,	,	PUNCT
ajlm-2362	41	17	dickinson	dickinson	NOUN
ajlm-2362	41	18	and	and	CCONJ
ajlm-2362	41	19	company	company	NOUN
ajlm-2362	41	20	,	,	PUNCT
ajlm-2362	41	21	sparks	spark	VERB
ajlm-2362	41	22	,	,	PUNCT
ajlm-2362	41	23	maryland	maryland	PROPN
ajlm-2362	41	24	,	,	PUNCT
ajlm-2362	41	25	united	united	PROPN
ajlm-2362	41	26	states	states	PROPN
ajlm-2362	41	27	)	)	PUNCT
ajlm-2362	41	28	.	.	PUNCT
ajlm-2362	42	1	all	all	DET
ajlm-2362	42	2	cultures	culture	NOUN
ajlm-2362	42	3	were	be	AUX
ajlm-2362	42	4	cultured	cultured	ADJ
ajlm-2362	42	5	aerobically	aerobically	ADV
ajlm-2362	42	6	,	,	PUNCT
ajlm-2362	42	7	at	at	ADP
ajlm-2362	42	8	37	37	NUM
ajlm-2362	42	9	°	°	ADP
ajlm-2362	42	10	c	c	NOUN
ajlm-2362	42	11	for	for	ADP
ajlm-2362	42	12	18	18	NUM
ajlm-2362	42	13	h	h	NOUN
ajlm-2362	42	14	–	–	PUNCT
ajlm-2362	42	15	24	24	NUM
ajlm-2362	42	16	h	h	NOUN
ajlm-2362	42	17	,	,	PUNCT
ajlm-2362	42	18	and	and	CCONJ
ajlm-2362	42	19	negative	negative	ADJ
ajlm-2362	42	20	cultures	culture	NOUN
ajlm-2362	42	21	were	be	AUX
ajlm-2362	42	22	incubated	incubate	VERB
ajlm-2362	42	23	for	for	ADP
ajlm-2362	42	24	up	up	ADP
ajlm-2362	42	25	to	to	PART
ajlm-2362	42	26	5	5	NUM
ajlm-2362	42	27	days	day	NOUN
ajlm-2362	42	28	for	for	ADP
ajlm-2362	42	29	bacteria	bacteria	NOUN
ajlm-2362	42	30	growth	growth	NOUN
ajlm-2362	42	31	before	before	ADP
ajlm-2362	42	32	being	be	AUX
ajlm-2362	42	33	reported	report	VERB
ajlm-2362	42	34	as	as	ADP
ajlm-2362	42	35	negative	negative	ADJ
ajlm-2362	42	36	.	.	PUNCT
ajlm-2362	43	1	antimicrobial	antimicrobial	ADJ
ajlm-2362	43	2	susceptibility	susceptibility	NOUN
ajlm-2362	43	3	testing	test	VERB
ajlm-2362	43	4	the	the	DET
ajlm-2362	43	5	in	in	ADV
ajlm-2362	43	6	-	-	PUNCT
ajlm-2362	43	7	vitro	vitro	X
ajlm-2362	43	8	antibiotic	antibiotic	ADJ
ajlm-2362	43	9	susceptibility	susceptibility	NOUN
ajlm-2362	43	10	of	of	ADP
ajlm-2362	43	11	the	the	DET
ajlm-2362	43	12	identified	identify	VERB
ajlm-2362	43	13	pathogens	pathogen	NOUN
ajlm-2362	43	14	was	be	AUX
ajlm-2362	43	15	performed	perform	VERB
ajlm-2362	43	16	as	as	SCONJ
ajlm-2362	43	17	recommended	recommend	VERB
ajlm-2362	43	18	by	by	ADP
ajlm-2362	43	19	the	the	DET
ajlm-2362	43	20	clinical	clinical	ADJ
ajlm-2362	43	21	laboratory	laboratory	NOUN
ajlm-2362	43	22	standard	standard	NOUN
ajlm-2362	43	23	institute,14	institute,14	ADV
ajlm-2362	43	24	using	use	VERB
ajlm-2362	43	25	the	the	DET
ajlm-2362	43	26	kirby	kirby	PROPN
ajlm-2362	43	27	bauer	bauer	PROPN
ajlm-2362	43	28	disc	disc	PROPN
ajlm-2362	43	29	diffusion	diffusion	NOUN
ajlm-2362	43	30	method	method	NOUN
ajlm-2362	43	31	on	on	ADP
ajlm-2362	43	32	mueller	mueller	PROPN
ajlm-2362	43	33	-	-	PUNCT
ajlm-2362	43	34	hinton	hinton	PROPN
ajlm-2362	43	35	agar	agar	NOUN
ajlm-2362	43	36	(	(	PUNCT
ajlm-2362	43	37	himedia	himedia	PROPN
ajlm-2362	43	38	laboratories	laboratory	NOUN
ajlm-2362	43	39	pvt	pvt	PROPN
ajlm-2362	43	40	,	,	PUNCT
ajlm-2362	43	41	mumbai	mumbai	PROPN
ajlm-2362	43	42	,	,	PUNCT
ajlm-2362	43	43	india	india	PROPN
ajlm-2362	43	44	)	)	PUNCT
ajlm-2362	43	45	.	.	PUNCT
ajlm-2362	44	1	five	five	NUM
ajlm-2362	44	2	genera	genera	NOUN
ajlm-2362	44	3	(	(	PUNCT
ajlm-2362	44	4	escherichia	escherichia	NOUN
ajlm-2362	44	5	coli	coli	NOUN
ajlm-2362	44	6	,	,	PUNCT
ajlm-2362	44	7	klebsiella	klebsiella	PROPN
ajlm-2362	44	8	spp	spp	PROPN
ajlm-2362	44	9	.	.	PROPN
ajlm-2362	44	10	,	,	PUNCT
ajlm-2362	44	11	pseudomonas	pseudomona	VERB
ajlm-2362	44	12	spp	spp	NOUN
ajlm-2362	44	13	.	.	PROPN
ajlm-2362	45	1	,	,	PUNCT
ajlm-2362	45	2	staphylococcus	staphylococcus	NOUN
ajlm-2362	45	3	aureus	aureus	NOUN
ajlm-2362	45	4	,	,	PUNCT
ajlm-2362	45	5	and	and	CCONJ
ajlm-2362	45	6	streptococcus	streptococcus	VERB
ajlm-2362	45	7	spp	spp	NOUN
ajlm-2362	45	8	.	.	PUNCT
ajlm-2362	45	9	)	)	PUNCT
ajlm-2362	45	10	were	be	AUX
ajlm-2362	45	11	isolated	isolate	VERB
ajlm-2362	45	12	and	and	CCONJ
ajlm-2362	45	13	tested	test	VERB
ajlm-2362	45	14	for	for	ADP
ajlm-2362	45	15	antibiotic	antibiotic	ADJ
ajlm-2362	45	16	susceptibility	susceptibility	NOUN
ajlm-2362	45	17	using	use	VERB
ajlm-2362	45	18	15	15	NUM
ajlm-2362	45	19	antibiotics	antibiotic	NOUN
ajlm-2362	45	20	by	by	ADP
ajlm-2362	45	21	disc	disc	NOUN
ajlm-2362	45	22	diffusion	diffusion	NOUN
ajlm-2362	45	23	method	method	NOUN
ajlm-2362	45	24	.	.	PUNCT
ajlm-2362	46	1	the	the	DET
ajlm-2362	46	2	following	follow	VERB
ajlm-2362	46	3	antibiotic	antibiotic	ADJ
ajlm-2362	46	4	agents	agent	NOUN
ajlm-2362	46	5	were	be	AUX
ajlm-2362	46	6	tested	test	VERB
ajlm-2362	46	7	:	:	PUNCT
ajlm-2362	46	8	ampicillin	ampicillin	NOUN
ajlm-2362	46	9	(	(	PUNCT
ajlm-2362	46	10	10	10	NUM
ajlm-2362	46	11	µg	µg	NOUN
ajlm-2362	46	12	)	)	PUNCT
ajlm-2362	46	13	,	,	PUNCT
ajlm-2362	46	14	amoxicillin	amoxicillin	PROPN
ajlm-2362	46	15	/	/	SYM
ajlm-2362	46	16	clavulanic	clavulanic	ADJ
ajlm-2362	46	17	acid	acid	NOUN
ajlm-2362	46	18	(	(	PUNCT
ajlm-2362	46	19	20/10	20/10	NUM
ajlm-2362	46	20	µg	µg	NOUN
ajlm-2362	46	21	)	)	PUNCT
ajlm-2362	46	22	,	,	PUNCT
ajlm-2362	46	23	cefotaxime	cefotaxime	NOUN
ajlm-2362	46	24	(	(	PUNCT
ajlm-2362	46	25	30	30	NUM
ajlm-2362	46	26	µg	µg	NOUN
ajlm-2362	46	27	)	)	PUNCT
ajlm-2362	46	28	,	,	PUNCT
ajlm-2362	46	29	cefepime	cefepime	X
ajlm-2362	46	30	(	(	PUNCT
ajlm-2362	46	31	30	30	NUM
ajlm-2362	46	32	µg	µg	NOUN
ajlm-2362	46	33	)	)	PUNCT
ajlm-2362	46	34	,	,	PUNCT
ajlm-2362	46	35	oxacillin	oxacillin	NOUN
ajlm-2362	46	36	(	(	PUNCT
ajlm-2362	46	37	1	1	NUM
ajlm-2362	46	38	µg	µg	NOUN
ajlm-2362	46	39	)	)	PUNCT
ajlm-2362	46	40	,	,	PUNCT
ajlm-2362	46	41	azithromycin	azithromycin	PROPN
ajlm-2362	46	42	(	(	PUNCT
ajlm-2362	46	43	2	2	NUM
ajlm-2362	46	44	µg	µg	NOUN
ajlm-2362	46	45	)	)	PUNCT
ajlm-2362	46	46	,	,	PUNCT
ajlm-2362	46	47	clindamycin	clindamycin	NOUN
ajlm-2362	46	48	(	(	PUNCT
ajlm-2362	46	49	2	2	NUM
ajlm-2362	46	50	µg	µg	NOUN
ajlm-2362	46	51	)	)	PUNCT
ajlm-2362	46	52	,	,	PUNCT
ajlm-2362	46	53	cefuroxime	cefuroxime	ADJ
ajlm-2362	46	54	(	(	PUNCT
ajlm-2362	46	55	30	30	NUM
ajlm-2362	46	56	µg	µg	NOUN
ajlm-2362	46	57	)	)	PUNCT
ajlm-2362	46	58	,	,	PUNCT
ajlm-2362	46	59	ceftriaxone	ceftriaxone	NOUN
ajlm-2362	46	60	(	(	PUNCT
ajlm-2362	46	61	30	30	NUM
ajlm-2362	46	62	µg	µg	NOUN
ajlm-2362	46	63	)	)	PUNCT
ajlm-2362	46	64	,	,	PUNCT
ajlm-2362	46	65	erythromycin	erythromycin	NOUN
ajlm-2362	46	66	(	(	PUNCT
ajlm-2362	46	67	15	15	NUM
ajlm-2362	46	68	µg	µg	NOUN
ajlm-2362	46	69	)	)	PUNCT
ajlm-2362	46	70	,	,	PUNCT
ajlm-2362	46	71	cefoxitin	cefoxitin	NOUN
ajlm-2362	46	72	(	(	PUNCT
ajlm-2362	46	73	10	10	NUM
ajlm-2362	46	74	µg	µg	NOUN
ajlm-2362	46	75	)	)	PUNCT
ajlm-2362	46	76	,	,	PUNCT
ajlm-2362	46	77	meropenem	meropenem	PROPN
ajlm-2362	46	78	(	(	PUNCT
ajlm-2362	46	79	10	10	NUM
ajlm-2362	46	80	µg	µg	NOUN
ajlm-2362	46	81	)	)	PUNCT
ajlm-2362	46	82	,	,	PUNCT
ajlm-2362	46	83	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2362	46	84	(	(	PUNCT
ajlm-2362	46	85	5	5	NUM
ajlm-2362	46	86	µg	µg	NOUN
ajlm-2362	46	87	)	)	PUNCT
ajlm-2362	46	88	,	,	PUNCT
ajlm-2362	46	89	ofloxacin	ofloxacin	NOUN
ajlm-2362	46	90	(	(	PUNCT
ajlm-2362	46	91	5	5	NUM
ajlm-2362	46	92	µg	µg	NOUN
ajlm-2362	46	93	)	)	PUNCT
ajlm-2362	46	94	,	,	PUNCT
ajlm-2362	46	95	and	and	CCONJ
ajlm-2362	46	96	ampicillin	ampicillin	NOUN
ajlm-2362	46	97	+	+	CCONJ
ajlm-2362	46	98	sulbactam	sulbactam	NOUN
ajlm-2362	46	99	(	(	PUNCT
ajlm-2362	46	100	10	10	NUM
ajlm-2362	46	101	µg	µg	NOUN
ajlm-2362	46	102	)	)	PUNCT
ajlm-2362	46	103	.	.	PUNCT
ajlm-2362	47	1	gram	gram	NOUN
ajlm-2362	47	2	-	-	PUNCT
ajlm-2362	47	3	negative	negative	ADJ
ajlm-2362	47	4	bacteria	bacteria	NOUN
ajlm-2362	47	5	e.	e.	PROPN
ajlm-2362	47	6	coli	coli	PROPN
ajlm-2362	47	7	and	and	CCONJ
ajlm-2362	47	8	klebsiella	klebsiella	PROPN
ajlm-2362	47	9	spp	spp	PROPN
ajlm-2362	47	10	.	.	PROPN
ajlm-2362	47	11	were	be	AUX
ajlm-2362	47	12	screened	screen	VERB
ajlm-2362	47	13	for	for	ADP
ajlm-2362	47	14	extended	extend	VERB
ajlm-2362	47	15	-	-	PUNCT
ajlm-2362	47	16	spectrum	spectrum	NOUN
ajlm-2362	47	17	beta	beta	NOUN
ajlm-2362	47	18	-	-	PUNCT
ajlm-2362	47	19	lactamase	lactamase	NOUN
ajlm-2362	47	20	production	production	NOUN
ajlm-2362	47	21	using	use	VERB
ajlm-2362	47	22	ceftazidime	ceftazidime	NOUN
ajlm-2362	47	23	(	(	PUNCT
ajlm-2362	47	24	30	30	NUM
ajlm-2362	47	25	µg	µg	NOUN
ajlm-2362	47	26	)	)	PUNCT
ajlm-2362	47	27	.	.	PUNCT
ajlm-2362	48	1	the	the	DET
ajlm-2362	48	2	double	double	ADJ
ajlm-2362	48	3	-	-	PUNCT
ajlm-2362	48	4	disk	disk	NOUN
ajlm-2362	48	5	synergy	synergy	NOUN
ajlm-2362	48	6	test	test	NOUN
ajlm-2362	48	7	for	for	ADP
ajlm-2362	48	8	ceftazidime	ceftazidime	NOUN
ajlm-2362	48	9	(	(	PUNCT
ajlm-2362	48	10	30	30	NUM
ajlm-2362	48	11	µg	µg	NOUN
ajlm-2362	48	12	)	)	PUNCT
ajlm-2362	48	13	,	,	PUNCT
ajlm-2362	48	14	and	and	CCONJ
ajlm-2362	48	15	co	co	NOUN
ajlm-2362	48	16	-	-	NOUN
ajlm-2362	48	17	amoxicillin	amoxicillin	NOUN
ajlm-2362	48	18	/	/	SYM
ajlm-2362	48	19	clavulanic	clavulanic	NOUN
ajlm-2362	48	20	acid	acid	NOUN
ajlm-2362	48	21	(	(	PUNCT
ajlm-2362	48	22	20/10	20/10	NUM
ajlm-2362	48	23	µg	µg	PRON
ajlm-2362	48	24	)	)	PUNCT
ajlm-2362	48	25	was	be	AUX
ajlm-2362	48	26	used	use	VERB
ajlm-2362	48	27	to	to	PART
ajlm-2362	48	28	confirm	confirm	VERB
ajlm-2362	48	29	extended	extend	VERB
ajlm-2362	48	30	-	-	PUNCT
ajlm-2362	48	31	spectrum	spectrum	NOUN
ajlm-2362	48	32	beta	beta	NOUN
ajlm-2362	48	33	-	-	PUNCT
ajlm-2362	48	34	lactamase	lactamase	NOUN
ajlm-2362	48	35	production	production	NOUN
ajlm-2362	48	36	.	.	PUNCT
ajlm-2362	49	1	methicillin	methicillin	NOUN
ajlm-2362	49	2	-	-	PUNCT
ajlm-2362	49	3	resistant	resistant	ADJ
ajlm-2362	49	4	s.	s.	PROPN
ajlm-2362	49	5	aureus	aureus	PROPN
ajlm-2362	49	6	was	be	AUX
ajlm-2362	49	7	detected	detect	VERB
ajlm-2362	49	8	using	use	VERB
ajlm-2362	49	9	the	the	DET
ajlm-2362	49	10	cefoxitin	cefoxitin	NOUN
ajlm-2362	49	11	(	(	PUNCT
ajlm-2362	49	12	30	30	NUM
ajlm-2362	49	13	µg	µg	NOUN
ajlm-2362	49	14	)	)	PUNCT
ajlm-2362	49	15	disc	disc	NOUN
ajlm-2362	49	16	diffusion	diffusion	NOUN
ajlm-2362	49	17	test	test	NOUN
ajlm-2362	49	18	.	.	PUNCT
ajlm-2362	50	1	the	the	DET
ajlm-2362	50	2	susceptibility	susceptibility	NOUN
ajlm-2362	50	3	interpretation	interpretation	NOUN
ajlm-2362	50	4	(	(	PUNCT
ajlm-2362	50	5	susceptible	susceptible	ADJ
ajlm-2362	50	6	,	,	PUNCT
ajlm-2362	50	7	intermediate	intermediate	ADJ
ajlm-2362	50	8	,	,	PUNCT
ajlm-2362	50	9	resistant	resistant	ADJ
ajlm-2362	50	10	)	)	PUNCT
ajlm-2362	50	11	of	of	ADP
ajlm-2362	50	12	zone	zone	NOUN
ajlm-2362	50	13	clearance	clearance	NOUN
ajlm-2362	50	14	was	be	AUX
ajlm-2362	50	15	according	accord	VERB
ajlm-2362	50	16	to	to	ADP
ajlm-2362	50	17	the	the	DET
ajlm-2362	50	18	clinical	clinical	ADJ
ajlm-2362	50	19	and	and	CCONJ
ajlm-2362	50	20	laboratory	laboratory	NOUN
ajlm-2362	50	21	standards	standard	NOUN
ajlm-2362	50	22	institute	institute	PROPN
ajlm-2362	50	23	guidelines.14	guidelines.14	PROPN
ajlm-2362	50	24	the	the	DET
ajlm-2362	50	25	american	american	ADJ
ajlm-2362	50	26	type	type	NOUN
ajlm-2362	50	27	culture	culture	NOUN
ajlm-2362	50	28	collection	collection	NOUN
ajlm-2362	50	29	e.	e.	PROPN
ajlm-2362	50	30	coli	coli	PROPN
ajlm-2362	50	31	25922	25922	NUM
ajlm-2362	50	32	and	and	CCONJ
ajlm-2362	50	33	s.	s.	PROPN
ajlm-2362	50	34	aureus	aureus	PROPN
ajlm-2362	50	35	25923	25923	NUM
ajlm-2362	50	36	were	be	AUX
ajlm-2362	50	37	used	use	VERB
ajlm-2362	50	38	as	as	ADP
ajlm-2362	50	39	quality	quality	NOUN
ajlm-2362	50	40	control	control	NOUN
ajlm-2362	50	41	strains	strain	VERB
ajlm-2362	50	42	for	for	ADP
ajlm-2362	50	43	all	all	DET
ajlm-2362	50	44	laboratory	laboratory	NOUN
ajlm-2362	50	45	methods	method	NOUN
ajlm-2362	50	46	.	.	PUNCT
ajlm-2362	51	1	isolates	isolate	NOUN
ajlm-2362	51	2	with	with	ADP
ajlm-2362	51	3	intermediate	intermediate	ADJ
ajlm-2362	51	4	or	or	CCONJ
ajlm-2362	51	5	resistant	resistant	ADJ
ajlm-2362	51	6	results	result	NOUN
ajlm-2362	51	7	on	on	ADP
ajlm-2362	51	8	antibiotic	antibiotic	ADJ
ajlm-2362	51	9	susceptibility	susceptibility	NOUN
ajlm-2362	51	10	were	be	AUX
ajlm-2362	51	11	classified	classify	VERB
ajlm-2362	51	12	as	as	ADP
ajlm-2362	51	13	resistant	resistant	ADJ
ajlm-2362	51	14	strains	strain	NOUN
ajlm-2362	51	15	during	during	ADP
ajlm-2362	51	16	data	datum	NOUN
ajlm-2362	51	17	analysis	analysis	NOUN
ajlm-2362	51	18	.	.	PUNCT
ajlm-2362	52	1	data	datum	NOUN
ajlm-2362	52	2	collection	collection	NOUN
ajlm-2362	52	3	we	we	PRON
ajlm-2362	52	4	extracted	extract	VERB
ajlm-2362	52	5	data	datum	NOUN
ajlm-2362	52	6	from	from	ADP
ajlm-2362	52	7	case	case	NOUN
ajlm-2362	52	8	record	record	NOUN
ajlm-2362	52	9	files	file	NOUN
ajlm-2362	52	10	and	and	CCONJ
ajlm-2362	52	11	microbiology	microbiology	NOUN
ajlm-2362	52	12	laboratory	laboratory	NOUN
ajlm-2362	52	13	medical	medical	ADJ
ajlm-2362	52	14	records	record	NOUN
ajlm-2362	52	15	for	for	ADP
ajlm-2362	52	16	300	300	NUM
ajlm-2362	52	17	paediatric	paediatric	ADJ
ajlm-2362	52	18	patients	patient	NOUN
ajlm-2362	52	19	aged	age	VERB
ajlm-2362	52	20	18	18	NUM
ajlm-2362	52	21	hours	hour	NOUN
ajlm-2362	52	22	to	to	ADP
ajlm-2362	52	23	14	14	NUM
ajlm-2362	52	24	years	year	NOUN
ajlm-2362	52	25	,	,	PUNCT
ajlm-2362	52	26	who	who	PRON
ajlm-2362	52	27	were	be	AUX
ajlm-2362	52	28	admitted	admit	VERB
ajlm-2362	52	29	and	and	CCONJ
ajlm-2362	52	30	tested	test	VERB
ajlm-2362	52	31	in	in	ADP
ajlm-2362	52	32	the	the	DET
ajlm-2362	52	33	laboratory	laboratory	NOUN
ajlm-2362	52	34	unit	unit	NOUN
ajlm-2362	52	35	of	of	ADP
ajlm-2362	52	36	the	the	DET
ajlm-2362	52	37	hospital	hospital	NOUN
ajlm-2362	52	38	during	during	ADP
ajlm-2362	52	39	the	the	DET
ajlm-2362	52	40	study	study	NOUN
ajlm-2362	52	41	dates	date	NOUN
ajlm-2362	52	42	.	.	PUNCT
ajlm-2362	53	1	information	information	NOUN
ajlm-2362	53	2	on	on	ADP
ajlm-2362	53	3	patients	patient	NOUN
ajlm-2362	53	4	’	'	PUNCT
ajlm-2362	53	5	socio	socio	NOUN
ajlm-2362	53	6	-	-	PUNCT
ajlm-2362	53	7	demographic	demographic	ADJ
ajlm-2362	53	8	characteristics	characteristic	NOUN
ajlm-2362	53	9	,	,	PUNCT
ajlm-2362	53	10	including	include	VERB
ajlm-2362	53	11	age	age	NOUN
ajlm-2362	53	12	and	and	CCONJ
ajlm-2362	53	13	gender	gender	NOUN
ajlm-2362	53	14	,	,	PUNCT
ajlm-2362	53	15	was	be	AUX
ajlm-2362	53	16	obtained	obtain	VERB
ajlm-2362	53	17	from	from	ADP
ajlm-2362	53	18	the	the	DET
ajlm-2362	53	19	patient	patient	NOUN
ajlm-2362	53	20	’s	’s	PART
ajlm-2362	53	21	medical	medical	ADJ
ajlm-2362	53	22	records	record	NOUN
ajlm-2362	53	23	.	.	PUNCT
ajlm-2362	54	1	patients	patient	NOUN
ajlm-2362	54	2	with	with	ADP
ajlm-2362	54	3	missing	miss	VERB
ajlm-2362	54	4	registration	registration	NOUN
ajlm-2362	54	5	numbers	number	NOUN
ajlm-2362	54	6	,	,	PUNCT
ajlm-2362	54	7	incomplete	incomplete	ADJ
ajlm-2362	54	8	medical	medical	ADJ
ajlm-2362	54	9	records	record	NOUN
ajlm-2362	54	10	,	,	PUNCT
ajlm-2362	54	11	and	and	CCONJ
ajlm-2362	54	12	those	those	PRON
ajlm-2362	54	13	attending	attend	VERB
ajlm-2362	54	14	the	the	DET
ajlm-2362	54	15	highly	highly	ADV
ajlm-2362	54	16	active	active	ADJ
ajlm-2362	54	17	antiretroviral	antiretroviral	ADJ
ajlm-2362	54	18	therapy	therapy	NOUN
ajlm-2362	54	19	clinic	clinic	NOUN
ajlm-2362	54	20	were	be	AUX
ajlm-2362	54	21	excluded	exclude	VERB
ajlm-2362	54	22	from	from	ADP
ajlm-2362	54	23	the	the	DET
ajlm-2362	54	24	study	study	NOUN
ajlm-2362	54	25	.	.	PUNCT
ajlm-2362	55	1	antimicrobial	antimicrobial	ADJ
ajlm-2362	55	2	sensitivity	sensitivity	NOUN
ajlm-2362	55	3	test	test	NOUN
ajlm-2362	55	4	report	report	NOUN
ajlm-2362	55	5	data	datum	NOUN
ajlm-2362	55	6	were	be	AUX
ajlm-2362	55	7	collected	collect	VERB
ajlm-2362	55	8	from	from	ADP
ajlm-2362	55	9	the	the	DET
ajlm-2362	55	10	microbiology	microbiology	NOUN
ajlm-2362	55	11	records	record	NOUN
ajlm-2362	55	12	of	of	ADP
ajlm-2362	55	13	the	the	DET
ajlm-2362	55	14	laboratory	laboratory	NOUN
ajlm-2362	55	15	unit	unit	NOUN
ajlm-2362	55	16	of	of	ADP
ajlm-2362	55	17	the	the	DET
ajlm-2362	55	18	hospital	hospital	NOUN
ajlm-2362	55	19	.	.	PUNCT
ajlm-2362	56	1	bacterial	bacterial	ADJ
ajlm-2362	56	2	profiles	profile	NOUN
ajlm-2362	56	3	were	be	AUX
ajlm-2362	56	4	obtained	obtain	VERB
ajlm-2362	56	5	by	by	ADP
ajlm-2362	56	6	reviewing	review	VERB
ajlm-2362	56	7	the	the	DET
ajlm-2362	56	8	laboratory	laboratory	NOUN
ajlm-2362	56	9	culture	culture	NOUN
ajlm-2362	56	10	database	database	NOUN
ajlm-2362	56	11	.	.	PUNCT
ajlm-2362	57	1	data	datum	NOUN
ajlm-2362	57	2	analysis	analysis	NOUN
ajlm-2362	57	3	we	we	PRON
ajlm-2362	57	4	entered	enter	VERB
ajlm-2362	57	5	the	the	DET
ajlm-2362	57	6	participants	participant	NOUN
ajlm-2362	57	7	’	'	PUNCT
ajlm-2362	57	8	demographic	demographic	ADJ
ajlm-2362	57	9	characteristics	characteristic	NOUN
ajlm-2362	57	10	,	,	PUNCT
ajlm-2362	57	11	pathogen	pathogen	NOUN
ajlm-2362	57	12	isolated	isolate	VERB
ajlm-2362	57	13	,	,	PUNCT
ajlm-2362	57	14	and	and	CCONJ
ajlm-2362	57	15	susceptibility	susceptibility	NOUN
ajlm-2362	57	16	pattern	pattern	NOUN
ajlm-2362	57	17	of	of	ADP
ajlm-2362	57	18	all	all	DET
ajlm-2362	57	19	isolates	isolate	NOUN
ajlm-2362	57	20	into	into	ADP
ajlm-2362	57	21	a	a	DET
ajlm-2362	57	22	microsoft	microsoft	PROPN
ajlm-2362	57	23	excel	excel	PROPN
ajlm-2362	57	24	spreadsheet	spreadsheet	NOUN
ajlm-2362	57	25	(	(	PUNCT
ajlm-2362	57	26	v.16.0	v.16.0	PROPN
ajlm-2362	57	27	,	,	PUNCT
ajlm-2362	57	28	redmond	redmond	PROPN
ajlm-2362	57	29	,	,	PUNCT
ajlm-2362	57	30	washington	washington	PROPN
ajlm-2362	57	31	,	,	PUNCT
ajlm-2362	57	32	united	united	PROPN
ajlm-2362	57	33	states	states	PROPN
ajlm-2362	57	34	)	)	PUNCT
ajlm-2362	57	35	.	.	PUNCT
ajlm-2362	58	1	participants	participant	NOUN
ajlm-2362	58	2	were	be	AUX
ajlm-2362	58	3	divided	divide	VERB
ajlm-2362	58	4	into	into	ADP
ajlm-2362	58	5	5	5	NUM
ajlm-2362	58	6	subgroups	subgroup	NOUN
ajlm-2362	58	7	according	accord	VERB
ajlm-2362	58	8	to	to	ADP
ajlm-2362	58	9	their	their	PRON
ajlm-2362	58	10	paediatric	paediatric	ADJ
ajlm-2362	58	11	age	age	NOUN
ajlm-2362	58	12	:	:	PUNCT
ajlm-2362	58	13	neonate	neonate	NOUN
ajlm-2362	58	14	(	(	PUNCT
ajlm-2362	58	15	0–1	0–1	NUM
ajlm-2362	58	16	month	month	NOUN
ajlm-2362	58	17	)	)	PUNCT
ajlm-2362	58	18	,	,	PUNCT
ajlm-2362	58	19	infant	infant	NOUN
ajlm-2362	58	20	(	(	PUNCT
ajlm-2362	58	21	˃	˃	NOUN
ajlm-2362	58	22	1	1	NUM
ajlm-2362	58	23	month	month	NOUN
ajlm-2362	58	24	–	–	PUNCT
ajlm-2362	58	25	12	12	NUM
ajlm-2362	58	26	months	month	NOUN
ajlm-2362	58	27	)	)	PUNCT
ajlm-2362	58	28	,	,	PUNCT
ajlm-2362	58	29	preschooler	preschooler	NOUN
ajlm-2362	58	30	(	(	PUNCT
ajlm-2362	58	31	˃	˃	NOUN
ajlm-2362	58	32	12	12	NUM
ajlm-2362	58	33	months	month	NOUN
ajlm-2362	58	34	–	–	PUNCT
ajlm-2362	58	35	60	60	NUM
ajlm-2362	58	36	months	month	NOUN
ajlm-2362	58	37	)	)	PUNCT
ajlm-2362	58	38	,	,	PUNCT
ajlm-2362	58	39	school	school	NOUN
ajlm-2362	58	40	age	age	NOUN
ajlm-2362	58	41	(	(	PUNCT
ajlm-2362	58	42	˃	˃	NOUN
ajlm-2362	58	43	60	60	NUM
ajlm-2362	58	44	months	month	NOUN
ajlm-2362	58	45	–	–	PUNCT
ajlm-2362	58	46	120	120	NUM
ajlm-2362	58	47	months	month	NOUN
ajlm-2362	58	48	)	)	PUNCT
ajlm-2362	58	49	,	,	PUNCT
ajlm-2362	58	50	adolescent	adolescent	ADJ
ajlm-2362	58	51	(	(	PUNCT
ajlm-2362	58	52	˃	˃	NOUN
ajlm-2362	58	53	120	120	NUM
ajlm-2362	58	54	months	month	NOUN
ajlm-2362	58	55	–	–	PUNCT
ajlm-2362	58	56	192	192	NUM
ajlm-2362	58	57	months	month	NOUN
ajlm-2362	58	58	)	)	PUNCT
ajlm-2362	58	59	.	.	PUNCT
ajlm-2362	59	1	data	datum	NOUN
ajlm-2362	59	2	were	be	AUX
ajlm-2362	59	3	analysed	analyse	VERB
ajlm-2362	59	4	using	use	VERB
ajlm-2362	59	5	ibm	ibm	PROPN
ajlm-2362	59	6	®	®	NOUN
ajlm-2362	59	7	spss	spss	PROPN
ajlm-2362	59	8	®	®	PROPN
ajlm-2362	59	9	version	version	NOUN
ajlm-2362	59	10	29	29	NUM
ajlm-2362	59	11	(	(	PUNCT
ajlm-2362	59	12	armonk	armonk	PROPN
ajlm-2362	59	13	,	,	PUNCT
ajlm-2362	59	14	new	new	PROPN
ajlm-2362	59	15	york	york	PROPN
ajlm-2362	59	16	,	,	PUNCT
ajlm-2362	59	17	united	united	PROPN
ajlm-2362	59	18	states	states	PROPN
ajlm-2362	59	19	)	)	PUNCT
ajlm-2362	59	20	.	.	PUNCT
ajlm-2362	60	1	the	the	DET
ajlm-2362	60	2	variables	variable	NOUN
ajlm-2362	60	3	(	(	PUNCT
ajlm-2362	60	4	socio	socio	NOUN
ajlm-2362	60	5	-	-	ADJ
ajlm-2362	60	6	demographic	demographic	ADJ
ajlm-2362	60	7	and	and	CCONJ
ajlm-2362	60	8	clinical	clinical	ADJ
ajlm-2362	60	9	characteristics	characteristic	NOUN
ajlm-2362	60	10	,	,	PUNCT
ajlm-2362	60	11	bacterial	bacterial	ADJ
ajlm-2362	60	12	isolates	isolate	NOUN
ajlm-2362	60	13	,	,	PUNCT
ajlm-2362	60	14	and	and	CCONJ
ajlm-2362	60	15	antibiotic	antibiotic	ADJ
ajlm-2362	60	16	susceptibility	susceptibility	NOUN
ajlm-2362	60	17	)	)	PUNCT
ajlm-2362	60	18	were	be	AUX
ajlm-2362	60	19	expressed	express	VERB
ajlm-2362	60	20	as	as	ADP
ajlm-2362	60	21	frequencies	frequency	NOUN
ajlm-2362	60	22	,	,	PUNCT
ajlm-2362	60	23	percentages	percentage	NOUN
ajlm-2362	60	24	,	,	PUNCT
ajlm-2362	60	25	mean	mean	PROPN
ajlm-2362	60	26	±	±	NUM
ajlm-2362	60	27	s.d	s.d	PROPN
ajlm-2362	60	28	.	.	PROPN
ajlm-2362	60	29	,	,	PUNCT
ajlm-2362	60	30	and	and	CCONJ
ajlm-2362	60	31	ratios	ratio	NOUN
ajlm-2362	60	32	,	,	PUNCT
ajlm-2362	60	33	as	as	SCONJ
ajlm-2362	60	34	considered	consider	VERB
ajlm-2362	60	35	applicable	applicable	ADJ
ajlm-2362	60	36	.	.	PUNCT
ajlm-2362	61	1	results	result	VERB
ajlm-2362	61	2	a	a	DET
ajlm-2362	61	3	total	total	NOUN
ajlm-2362	61	4	of	of	ADP
ajlm-2362	61	5	300	300	NUM
ajlm-2362	61	6	participants	participant	NOUN
ajlm-2362	61	7	were	be	AUX
ajlm-2362	61	8	enrolled	enrol	VERB
ajlm-2362	61	9	in	in	ADP
ajlm-2362	61	10	this	this	DET
ajlm-2362	61	11	study	study	NOUN
ajlm-2362	61	12	(	(	PUNCT
ajlm-2362	61	13	table	table	NOUN
ajlm-2362	61	14	1	1	NUM
ajlm-2362	61	15	)	)	PUNCT
ajlm-2362	61	16	.	.	PUNCT
ajlm-2362	62	1	there	there	PRON
ajlm-2362	62	2	were	be	VERB
ajlm-2362	62	3	169	169	NUM
ajlm-2362	62	4	(	(	PUNCT
ajlm-2362	62	5	56.4	56.4	NUM
ajlm-2362	62	6	%	%	NOUN
ajlm-2362	62	7	)	)	PUNCT
ajlm-2362	62	8	boys	boy	NOUN
ajlm-2362	62	9	and	and	CCONJ
ajlm-2362	62	10	131	131	NUM
ajlm-2362	62	11	(	(	PUNCT
ajlm-2362	62	12	43.6	43.6	NUM
ajlm-2362	62	13	%	%	NOUN
ajlm-2362	62	14	)	)	PUNCT
ajlm-2362	62	15	girls	girl	NOUN
ajlm-2362	62	16	,	,	PUNCT
ajlm-2362	62	17	with	with	ADP
ajlm-2362	62	18	a	a	DET
ajlm-2362	62	19	ratio	ratio	NOUN
ajlm-2362	62	20	of	of	ADP
ajlm-2362	62	21	1.3:1	1.3:1	NUM
ajlm-2362	62	22	.	.	PUNCT
ajlm-2362	63	1	the	the	DET
ajlm-2362	63	2	mean	mean	ADJ
ajlm-2362	63	3	age	age	NOUN
ajlm-2362	63	4	of	of	ADP
ajlm-2362	63	5	the	the	DET
ajlm-2362	63	6	participants	participant	NOUN
ajlm-2362	63	7	was	be	AUX
ajlm-2362	63	8	41.13	41.13	NUM
ajlm-2362	63	9	±	±	NUM
ajlm-2362	63	10	52.69	52.69	NUM
ajlm-2362	63	11	months	month	NOUN
ajlm-2362	63	12	(	(	PUNCT
ajlm-2362	63	13	range	range	NOUN
ajlm-2362	63	14	0–192	0–192	NUM
ajlm-2362	63	15	months	month	NOUN
ajlm-2362	63	16	)	)	PUNCT
ajlm-2362	63	17	with	with	ADP
ajlm-2362	63	18	the	the	DET
ajlm-2362	63	19	largest	large	ADJ
ajlm-2362	63	20	number	number	NOUN
ajlm-2362	63	21	in	in	ADP
ajlm-2362	63	22	the	the	DET
ajlm-2362	63	23	neonatal	neonatal	ADJ
ajlm-2362	63	24	group	group	NOUN
ajlm-2362	63	25	,	,	PUNCT
ajlm-2362	63	26	and	and	CCONJ
ajlm-2362	63	27	the	the	DET
ajlm-2362	63	28	smallest	small	ADJ
ajlm-2362	63	29	number	number	NOUN
ajlm-2362	63	30	in	in	ADP
ajlm-2362	63	31	the	the	DET
ajlm-2362	63	32	adolescent	adolescent	ADJ
ajlm-2362	63	33	group	group	NOUN
ajlm-2362	63	34	.	.	PUNCT
ajlm-2362	64	1	blood	blood	NOUN
ajlm-2362	64	2	(	(	PUNCT
ajlm-2362	64	3	51.7	51.7	NUM
ajlm-2362	64	4	%	%	NOUN
ajlm-2362	64	5	)	)	PUNCT
ajlm-2362	64	6	and	and	CCONJ
ajlm-2362	64	7	urine	urine	NOUN
ajlm-2362	64	8	(	(	PUNCT
ajlm-2362	64	9	30.3	30.3	NUM
ajlm-2362	64	10	%	%	NOUN
ajlm-2362	64	11	)	)	PUNCT
ajlm-2362	64	12	cultures	culture	NOUN
ajlm-2362	64	13	accounted	account	VERB
ajlm-2362	64	14	for	for	ADP
ajlm-2362	64	15	the	the	DET
ajlm-2362	64	16	most	most	ADV
ajlm-2362	64	17	requested	request	VERB
ajlm-2362	64	18	microbiological	microbiological	ADJ
ajlm-2362	64	19	test	test	NOUN
ajlm-2362	64	20	.	.	PUNCT
ajlm-2362	65	1	of	of	ADP
ajlm-2362	65	2	the	the	DET
ajlm-2362	65	3	300	300	NUM
ajlm-2362	65	4	culture	culture	NOUN
ajlm-2362	65	5	results	result	NOUN
ajlm-2362	65	6	,	,	PUNCT
ajlm-2362	65	7	156	156	NUM
ajlm-2362	65	8	(	(	PUNCT
ajlm-2362	65	9	52.0	52.0	NUM
ajlm-2362	65	10	%	%	NOUN
ajlm-2362	65	11	)	)	PUNCT
ajlm-2362	65	12	were	be	AUX
ajlm-2362	65	13	culture	culture	NOUN
ajlm-2362	65	14	positive	positive	ADJ
ajlm-2362	65	15	while	while	SCONJ
ajlm-2362	65	16	144	144	NUM
ajlm-2362	65	17	(	(	PUNCT
ajlm-2362	65	18	48.0	48.0	NUM
ajlm-2362	65	19	%	%	NOUN
ajlm-2362	65	20	)	)	PUNCT
ajlm-2362	65	21	were	be	AUX
ajlm-2362	65	22	culture	culture	NOUN
ajlm-2362	65	23	negative	negative	ADJ
ajlm-2362	65	24	.	.	PUNCT
ajlm-2362	66	1	the	the	DET
ajlm-2362	66	2	highest	high	ADJ
ajlm-2362	66	3	percentage	percentage	NOUN
ajlm-2362	66	4	of	of	ADP
ajlm-2362	66	5	positive	positive	ADJ
ajlm-2362	66	6	samples	sample	NOUN
ajlm-2362	66	7	was	be	AUX
ajlm-2362	66	8	found	find	VERB
ajlm-2362	66	9	in	in	ADP
ajlm-2362	66	10	the	the	DET
ajlm-2362	66	11	neonatal	neonatal	ADJ
ajlm-2362	66	12	group	group	NOUN
ajlm-2362	66	13	(	(	PUNCT
ajlm-2362	66	14	34.6	34.6	NUM
ajlm-2362	66	15	%	%	NOUN
ajlm-2362	66	16	)	)	PUNCT
ajlm-2362	66	17	.	.	PUNCT
ajlm-2362	67	1	overall	overall	ADV
ajlm-2362	67	2	,	,	PUNCT
ajlm-2362	67	3	children	child	NOUN
ajlm-2362	67	4	in	in	ADP
ajlm-2362	67	5	the	the	DET
ajlm-2362	67	6	younger	young	ADJ
ajlm-2362	67	7	age	age	NOUN
ajlm-2362	67	8	groups	group	NOUN
ajlm-2362	67	9	,	,	PUNCT
ajlm-2362	67	10	including	include	VERB
ajlm-2362	67	11	neonates	neonate	NOUN
ajlm-2362	67	12	(	(	PUNCT
ajlm-2362	67	13	18.0	18.0	NUM
ajlm-2362	67	14	%	%	NOUN
ajlm-2362	67	15	)	)	PUNCT
ajlm-2362	67	16	,	,	PUNCT
ajlm-2362	67	17	infants	infant	NOUN
ajlm-2362	67	18	(	(	PUNCT
ajlm-2362	67	19	10.7	10.7	NUM
ajlm-2362	67	20	%	%	NOUN
ajlm-2362	67	21	)	)	PUNCT
ajlm-2362	67	22	,	,	PUNCT
ajlm-2362	67	23	and	and	CCONJ
ajlm-2362	67	24	preschool	preschool	ADJ
ajlm-2362	67	25	children	child	NOUN
ajlm-2362	67	26	(	(	PUNCT
ajlm-2362	67	27	11.3	11.3	NUM
ajlm-2362	67	28	%	%	NOUN
ajlm-2362	67	29	)	)	PUNCT
ajlm-2362	67	30	accounted	account	VERB
ajlm-2362	67	31	for	for	ADP
ajlm-2362	67	32	most	most	ADJ
ajlm-2362	67	33	of	of	ADP
ajlm-2362	67	34	the	the	DET
ajlm-2362	67	35	positive	positive	ADJ
ajlm-2362	67	36	samples	sample	NOUN
ajlm-2362	67	37	(	(	PUNCT
ajlm-2362	67	38	table	table	NOUN
ajlm-2362	67	39	1	1	NUM
ajlm-2362	67	40	)	)	PUNCT
ajlm-2362	67	41	.	.	PUNCT
ajlm-2362	68	1	table	table	NOUN
ajlm-2362	68	2	1	1	NUM
ajlm-2362	68	3	:	:	PUNCT
ajlm-2362	68	4	 	 	SPACE
ajlm-2362	68	5	socio	socio	NOUN
ajlm-2362	68	6	-	-	ADJ
ajlm-2362	68	7	demographic	demographic	ADJ
ajlm-2362	68	8	and	and	CCONJ
ajlm-2362	68	9	clinical	clinical	ADJ
ajlm-2362	68	10	data	datum	NOUN
ajlm-2362	68	11	of	of	ADP
ajlm-2362	68	12	subjects	subject	NOUN
ajlm-2362	68	13	in	in	ADP
ajlm-2362	68	14	lagos	lago	NOUN
ajlm-2362	68	15	,	,	PUNCT
ajlm-2362	68	16	south	south	ADJ
ajlm-2362	68	17	-	-	PUNCT
ajlm-2362	68	18	western	western	ADJ
ajlm-2362	68	19	nigeria	nigeria	PROPN
ajlm-2362	68	20	,	,	PUNCT
ajlm-2362	68	21	from	from	ADP
ajlm-2362	68	22	december	december	PROPN
ajlm-2362	68	23	2021	2021	NUM
ajlm-2362	68	24	to	to	ADP
ajlm-2362	68	25	march	march	PROPN
ajlm-2362	68	26	2022	2022	NUM
ajlm-2362	68	27	.	.	PUNCT
ajlm-2362	69	1	age	age	NOUN
ajlm-2362	69	2	distribution	distribution	NOUN
ajlm-2362	69	3	among	among	ADP
ajlm-2362	69	4	culture	culture	NOUN
ajlm-2362	69	5	-	-	PUNCT
ajlm-2362	69	6	positive	positive	ADJ
ajlm-2362	69	7	samples	sample	NOUN
ajlm-2362	69	8	of	of	ADP
ajlm-2362	69	9	the	the	DET
ajlm-2362	69	10	156	156	NUM
ajlm-2362	69	11	(	(	PUNCT
ajlm-2362	69	12	52.0	52.0	NUM
ajlm-2362	69	13	%	%	NOUN
ajlm-2362	69	14	)	)	PUNCT
ajlm-2362	69	15	positive	positive	ADJ
ajlm-2362	69	16	samples	sample	NOUN
ajlm-2362	69	17	,	,	PUNCT
ajlm-2362	69	18	boys	boy	NOUN
ajlm-2362	69	19	had	have	VERB
ajlm-2362	69	20	a	a	DET
ajlm-2362	69	21	higher	high	ADJ
ajlm-2362	69	22	percentage	percentage	NOUN
ajlm-2362	69	23	of	of	ADP
ajlm-2362	69	24	positive	positive	ADJ
ajlm-2362	69	25	samples	sample	NOUN
ajlm-2362	69	26	in	in	ADP
ajlm-2362	69	27	the	the	DET
ajlm-2362	69	28	neonate	neonate	NOUN
ajlm-2362	69	29	(	(	PUNCT
ajlm-2362	69	30	37.8	37.8	NUM
ajlm-2362	69	31	%	%	NOUN
ajlm-2362	69	32	)	)	PUNCT
ajlm-2362	69	33	,	,	PUNCT
ajlm-2362	69	34	preschool	preschool	NOUN
ajlm-2362	69	35	(	(	PUNCT
ajlm-2362	69	36	23.2	23.2	NUM
ajlm-2362	69	37	%	%	NOUN
ajlm-2362	69	38	)	)	PUNCT
ajlm-2362	69	39	,	,	PUNCT
ajlm-2362	69	40	and	and	CCONJ
ajlm-2362	69	41	adolescent	adolescent	ADJ
ajlm-2362	69	42	(	(	PUNCT
ajlm-2362	69	43	11.5	11.5	NUM
ajlm-2362	69	44	%	%	NOUN
ajlm-2362	69	45	)	)	PUNCT
ajlm-2362	69	46	groups	group	NOUN
ajlm-2362	69	47	;	;	PUNCT
ajlm-2362	69	48	the	the	DET
ajlm-2362	69	49	infant	infant	NOUN
ajlm-2362	69	50	(	(	PUNCT
ajlm-2362	69	51	23.0	23.0	NUM
ajlm-2362	69	52	%	%	NOUN
ajlm-2362	69	53	)	)	PUNCT
ajlm-2362	69	54	and	and	CCONJ
ajlm-2362	69	55	school	school	NOUN
ajlm-2362	69	56	-	-	PUNCT
ajlm-2362	69	57	age	age	NOUN
ajlm-2362	69	58	(	(	PUNCT
ajlm-2362	69	59	18.9	18.9	NUM
ajlm-2362	69	60	%	%	NOUN
ajlm-2362	69	61	)	)	PUNCT
ajlm-2362	69	62	groups	group	NOUN
ajlm-2362	69	63	recorded	record	VERB
ajlm-2362	69	64	a	a	DET
ajlm-2362	69	65	slightly	slightly	ADV
ajlm-2362	69	66	higher	high	ADJ
ajlm-2362	69	67	percentage	percentage	NOUN
ajlm-2362	69	68	of	of	ADP
ajlm-2362	69	69	positive	positive	ADJ
ajlm-2362	69	70	samples	sample	NOUN
ajlm-2362	69	71	among	among	ADP
ajlm-2362	69	72	girls	girl	NOUN
ajlm-2362	69	73	(	(	PUNCT
ajlm-2362	69	74	table	table	NOUN
ajlm-2362	69	75	2	2	NUM
ajlm-2362	69	76	)	)	PUNCT
ajlm-2362	69	77	.	.	PUNCT
ajlm-2362	70	1	staphylococcus	staphylococcus	NOUN
ajlm-2362	70	2	aureus	aureus	PROPN
ajlm-2362	70	3	was	be	AUX
ajlm-2362	70	4	the	the	DET
ajlm-2362	70	5	most	most	ADV
ajlm-2362	70	6	frequent	frequent	ADJ
ajlm-2362	70	7	organism	organism	NOUN
ajlm-2362	70	8	isolated	isolate	VERB
ajlm-2362	70	9	(	(	PUNCT
ajlm-2362	70	10	32.1	32.1	NUM
ajlm-2362	70	11	%	%	NOUN
ajlm-2362	70	12	)	)	PUNCT
ajlm-2362	70	13	,	,	PUNCT
ajlm-2362	70	14	and	and	CCONJ
ajlm-2362	70	15	pseudomonas	pseudomona	VERB
ajlm-2362	70	16	spp	spp	NOUN
ajlm-2362	70	17	.	.	PUNCT
ajlm-2362	71	1	was	be	AUX
ajlm-2362	71	2	the	the	DET
ajlm-2362	71	3	least	least	ADV
ajlm-2362	71	4	frequent	frequent	ADJ
ajlm-2362	71	5	organism	organism	NOUN
ajlm-2362	71	6	isolated	isolate	VERB
ajlm-2362	71	7	(	(	PUNCT
ajlm-2362	71	8	7.1	7.1	NUM
ajlm-2362	71	9	%	%	NOUN
ajlm-2362	71	10	)	)	PUNCT
ajlm-2362	71	11	among	among	ADP
ajlm-2362	71	12	all	all	DET
ajlm-2362	71	13	samples	sample	NOUN
ajlm-2362	71	14	(	(	PUNCT
ajlm-2362	71	15	table	table	NOUN
ajlm-2362	71	16	2	2	NUM
ajlm-2362	71	17	)	)	PUNCT
ajlm-2362	71	18	.	.	PUNCT
ajlm-2362	72	1	staphylococcus	staphylococcus	NOUN
ajlm-2362	72	2	aureus	aureus	PROPN
ajlm-2362	72	3	was	be	AUX
ajlm-2362	72	4	the	the	DET
ajlm-2362	72	5	most	most	ADV
ajlm-2362	72	6	frequently	frequently	ADV
ajlm-2362	72	7	isolated	isolate	VERB
ajlm-2362	72	8	organism	organism	NOUN
ajlm-2362	72	9	in	in	ADP
ajlm-2362	72	10	the	the	DET
ajlm-2362	72	11	neonatal	neonatal	ADJ
ajlm-2362	72	12	(	(	PUNCT
ajlm-2362	72	13	13.5	13.5	NUM
ajlm-2362	72	14	%	%	NOUN
ajlm-2362	72	15	)	)	PUNCT
ajlm-2362	72	16	and	and	CCONJ
ajlm-2362	72	17	adolescent	adolescent	ADJ
ajlm-2362	72	18	(	(	PUNCT
ajlm-2362	72	19	3.2	3.2	NUM
ajlm-2362	72	20	%	%	NOUN
ajlm-2362	72	21	)	)	PUNCT
ajlm-2362	72	22	groups	group	NOUN
ajlm-2362	72	23	,	,	PUNCT
ajlm-2362	72	24	whereas	whereas	SCONJ
ajlm-2362	72	25	e.	e.	PROPN
ajlm-2362	72	26	coli	coli	PROPN
ajlm-2362	72	27	was	be	AUX
ajlm-2362	72	28	the	the	DET
ajlm-2362	72	29	most	most	ADV
ajlm-2362	72	30	isolated	isolated	ADJ
ajlm-2362	72	31	organism	organism	NOUN
ajlm-2362	72	32	in	in	ADP
ajlm-2362	72	33	all	all	DET
ajlm-2362	72	34	the	the	DET
ajlm-2362	72	35	age	age	NOUN
ajlm-2362	72	36	groups	group	NOUN
ajlm-2362	72	37	except	except	SCONJ
ajlm-2362	72	38	for	for	ADP
ajlm-2362	72	39	the	the	DET
ajlm-2362	72	40	neonatal	neonatal	ADJ
ajlm-2362	72	41	(	(	PUNCT
ajlm-2362	72	42	7.1	7.1	NUM
ajlm-2362	72	43	%	%	NOUN
ajlm-2362	72	44	)	)	PUNCT
ajlm-2362	72	45	adolescent	adolescent	ADJ
ajlm-2362	72	46	(	(	PUNCT
ajlm-2362	72	47	0.6	0.6	NUM
ajlm-2362	72	48	%	%	NOUN
ajlm-2362	72	49	)	)	PUNCT
ajlm-2362	72	50	age	age	NOUN
ajlm-2362	72	51	groups	group	NOUN
ajlm-2362	72	52	.	.	PUNCT
ajlm-2362	73	1	pseudomonas	pseudomona	NOUN
ajlm-2362	73	2	spp	spp	PROPN
ajlm-2362	73	3	.	.	PUNCT
ajlm-2362	73	4	was	be	AUX
ajlm-2362	73	5	not	not	PART
ajlm-2362	73	6	isolated	isolate	VERB
ajlm-2362	73	7	among	among	ADP
ajlm-2362	73	8	infants	infant	NOUN
ajlm-2362	73	9	and	and	CCONJ
ajlm-2362	73	10	was	be	AUX
ajlm-2362	73	11	infrequently	infrequently	ADV
ajlm-2362	73	12	detected	detect	VERB
ajlm-2362	73	13	in	in	ADP
ajlm-2362	73	14	the	the	DET
ajlm-2362	73	15	neonatal	neonatal	ADJ
ajlm-2362	73	16	and	and	CCONJ
ajlm-2362	73	17	adolescent	adolescent	ADJ
ajlm-2362	73	18	groups	group	NOUN
ajlm-2362	73	19	(	(	PUNCT
ajlm-2362	73	20	both	both	PRON
ajlm-2362	73	21	0.6	0.6	NUM
ajlm-2362	73	22	%	%	NOUN
ajlm-2362	73	23	)	)	PUNCT
ajlm-2362	73	24	.	.	PUNCT
ajlm-2362	74	1	streptococcus	streptococcus	NOUN
ajlm-2362	74	2	spp	spp	NOUN
ajlm-2362	74	3	.	.	PUNCT
ajlm-2362	74	4	was	be	AUX
ajlm-2362	74	5	not	not	PART
ajlm-2362	74	6	detected	detect	VERB
ajlm-2362	74	7	in	in	ADP
ajlm-2362	74	8	the	the	DET
ajlm-2362	74	9	adolescent	adolescent	ADJ
ajlm-2362	74	10	group	group	NOUN
ajlm-2362	74	11	as	as	SCONJ
ajlm-2362	74	12	compared	compare	VERB
ajlm-2362	74	13	to	to	ADP
ajlm-2362	74	14	the	the	DET
ajlm-2362	74	15	younger	young	ADJ
ajlm-2362	74	16	age	age	NOUN
ajlm-2362	74	17	groups	group	NOUN
ajlm-2362	74	18	.	.	PUNCT
ajlm-2362	75	1	table	table	NOUN
ajlm-2362	75	2	2	2	NUM
ajlm-2362	75	3	:	:	PUNCT
ajlm-2362	75	4	 	 	SPACE
ajlm-2362	75	5	age	age	NOUN
ajlm-2362	75	6	distribution	distribution	NOUN
ajlm-2362	75	7	among	among	ADP
ajlm-2362	75	8	culture	culture	NOUN
ajlm-2362	75	9	positive	positive	ADJ
ajlm-2362	75	10	samples	sample	NOUN
ajlm-2362	75	11	and	and	CCONJ
ajlm-2362	75	12	in	in	ADP
ajlm-2362	75	13	relation	relation	NOUN
ajlm-2362	75	14	to	to	ADP
ajlm-2362	75	15	gender	gender	NOUN
ajlm-2362	75	16	,	,	PUNCT
ajlm-2362	75	17	lagos	lago	NOUN
ajlm-2362	75	18	,	,	PUNCT
ajlm-2362	75	19	nigeria	nigeria	PROPN
ajlm-2362	75	20	,	,	PUNCT
ajlm-2362	75	21	from	from	ADP
ajlm-2362	75	22	december	december	PROPN
ajlm-2362	75	23	2021	2021	NUM
ajlm-2362	75	24	to	to	ADP
ajlm-2362	75	25	march	march	PROPN
ajlm-2362	75	26	2022	2022	NUM
ajlm-2362	75	27	.	.	PUNCT
ajlm-2362	76	1	pattern	pattern	NOUN
ajlm-2362	76	2	of	of	ADP
ajlm-2362	76	3	drug	drug	NOUN
ajlm-2362	76	4	resistance	resistance	NOUN
ajlm-2362	76	5	among	among	ADP
ajlm-2362	76	6	detected	detect	VERB
ajlm-2362	76	7	isolates	isolate	NOUN
ajlm-2362	76	8	the	the	DET
ajlm-2362	76	9	most	most	ADV
ajlm-2362	76	10	frequently	frequently	ADV
ajlm-2362	76	11	recovered	recover	VERB
ajlm-2362	76	12	isolates	isolate	NOUN
ajlm-2362	76	13	,	,	PUNCT
ajlm-2362	76	14	including	include	VERB
ajlm-2362	76	15	s.	s.	PROPN
ajlm-2362	76	16	aureus	aureus	PROPN
ajlm-2362	76	17	(	(	PUNCT
ajlm-2362	76	18	n	n	NOUN
ajlm-2362	76	19	=	=	SYM
ajlm-2362	76	20	50	50	NUM
ajlm-2362	76	21	)	)	PUNCT
ajlm-2362	76	22	,	,	PUNCT
ajlm-2362	76	23	e.	e.	PROPN
ajlm-2362	76	24	coli	coli	PROPN
ajlm-2362	76	25	(	(	PUNCT
ajlm-2362	76	26	n	n	NOUN
ajlm-2362	76	27	=	=	SYM
ajlm-2362	76	28	44	44	NUM
ajlm-2362	76	29	)	)	PUNCT
ajlm-2362	76	30	and	and	CCONJ
ajlm-2362	76	31	klebsiella	klebsiella	PROPN
ajlm-2362	76	32	spp	spp	PROPN
ajlm-2362	76	33	.	.	PUNCT
ajlm-2362	77	1	(	(	PUNCT
ajlm-2362	77	2	n	n	NOUN
ajlm-2362	77	3	=	=	SYM
ajlm-2362	77	4	32	32	NUM
ajlm-2362	77	5	)	)	PUNCT
ajlm-2362	77	6	,	,	PUNCT
ajlm-2362	77	7	were	be	AUX
ajlm-2362	77	8	also	also	ADV
ajlm-2362	77	9	the	the	DET
ajlm-2362	77	10	most	most	ADV
ajlm-2362	77	11	often	often	ADV
ajlm-2362	77	12	resistant	resistant	ADJ
ajlm-2362	77	13	to	to	ADP
ajlm-2362	77	14	the	the	DET
ajlm-2362	77	15	tested	test	VERB
ajlm-2362	77	16	antibiotics	antibiotic	NOUN
ajlm-2362	77	17	(	(	PUNCT
ajlm-2362	77	18	table	table	NOUN
ajlm-2362	77	19	3	3	NUM
ajlm-2362	77	20	)	)	PUNCT
ajlm-2362	77	21	.	.	PUNCT
ajlm-2362	78	1	isolates	isolate	NOUN
ajlm-2362	78	2	were	be	AUX
ajlm-2362	78	3	most	most	ADV
ajlm-2362	78	4	often	often	ADV
ajlm-2362	78	5	resistant	resistant	ADJ
ajlm-2362	78	6	to	to	ADP
ajlm-2362	78	7	ampicillin	ampicillin	NOUN
ajlm-2362	78	8	(	(	PUNCT
ajlm-2362	78	9	n	n	NOUN
ajlm-2362	78	10	=	=	SYM
ajlm-2362	78	11	58	58	NUM
ajlm-2362	78	12	)	)	PUNCT
ajlm-2362	78	13	,	,	PUNCT
ajlm-2362	78	14	amoxicillin	amoxicillin	PROPN
ajlm-2362	78	15	+	+	CCONJ
ajlm-2362	78	16	clavulanic	clavulanic	ADJ
ajlm-2362	78	17	acid	acid	NOUN
ajlm-2362	78	18	(	(	PUNCT
ajlm-2362	78	19	n	n	NOUN
ajlm-2362	78	20	=	=	SYM
ajlm-2362	78	21	54	54	NUM
ajlm-2362	78	22	)	)	PUNCT
ajlm-2362	78	23	,	,	PUNCT
ajlm-2362	78	24	and	and	CCONJ
ajlm-2362	78	25	cefepime	cefepime	NOUN
ajlm-2362	78	26	(	(	PUNCT
ajlm-2362	78	27	n	n	NOUN
ajlm-2362	78	28	=	=	SYM
ajlm-2362	78	29	53	53	NUM
ajlm-2362	78	30	)	)	PUNCT
ajlm-2362	78	31	,	,	PUNCT
ajlm-2362	78	32	compared	compare	VERB
ajlm-2362	78	33	to	to	ADP
ajlm-2362	78	34	the	the	DET
ajlm-2362	78	35	other	other	ADJ
ajlm-2362	78	36	antibiotics	antibiotic	NOUN
ajlm-2362	78	37	tested	test	VERB
ajlm-2362	78	38	.	.	PUNCT
ajlm-2362	79	1	table	table	NOUN
ajlm-2362	79	2	3	3	NUM
ajlm-2362	79	3	:	:	PUNCT
ajlm-2362	79	4	 	 	SPACE
ajlm-2362	79	5	pattern	pattern	NOUN
ajlm-2362	79	6	of	of	ADP
ajlm-2362	79	7	drug	drug	NOUN
ajlm-2362	79	8	resistance	resistance	NOUN
ajlm-2362	79	9	in	in	ADP
ajlm-2362	79	10	culture	culture	NOUN
ajlm-2362	79	11	positive	positive	ADJ
ajlm-2362	79	12	samples	sample	NOUN
ajlm-2362	79	13	of	of	ADP
ajlm-2362	79	14	children	child	NOUN
ajlm-2362	79	15	in	in	ADP
ajlm-2362	79	16	lagos	lago	NOUN
ajlm-2362	79	17	,	,	PUNCT
ajlm-2362	79	18	south	south	ADJ
ajlm-2362	79	19	-	-	PUNCT
ajlm-2362	79	20	western	western	ADJ
ajlm-2362	79	21	nigeria	nigeria	PROPN
ajlm-2362	79	22	,	,	PUNCT
ajlm-2362	79	23	from	from	ADP
ajlm-2362	79	24	december	december	PROPN
ajlm-2362	79	25	2021	2021	NUM
ajlm-2362	79	26	to	to	ADP
ajlm-2362	79	27	march	march	PROPN
ajlm-2362	79	28	2022	2022	NUM
ajlm-2362	79	29	.	.	PUNCT
ajlm-2362	80	1	antibiotic	antibiotic	ADJ
ajlm-2362	80	2	susceptibility	susceptibility	NOUN
ajlm-2362	80	3	pattern	pattern	NOUN
ajlm-2362	80	4	among	among	ADP
ajlm-2362	80	5	different	different	ADJ
ajlm-2362	80	6	age	age	NOUN
ajlm-2362	80	7	groups	group	NOUN
ajlm-2362	80	8	antibiotic	antibiotic	ADJ
ajlm-2362	80	9	susceptibility	susceptibility	NOUN
ajlm-2362	80	10	patterns	pattern	NOUN
ajlm-2362	80	11	varied	vary	VERB
ajlm-2362	80	12	by	by	ADP
ajlm-2362	80	13	age	age	NOUN
ajlm-2362	80	14	group	group	NOUN
ajlm-2362	80	15	and	and	CCONJ
ajlm-2362	80	16	isolate	isolate	NOUN
ajlm-2362	80	17	(	(	PUNCT
ajlm-2362	80	18	table	table	NOUN
ajlm-2362	80	19	4	4	NUM
ajlm-2362	80	20	)	)	PUNCT
ajlm-2362	80	21	.	.	PUNCT
ajlm-2362	81	1	younger	young	ADJ
ajlm-2362	81	2	age	age	NOUN
ajlm-2362	81	3	groups	group	NOUN
ajlm-2362	81	4	were	be	AUX
ajlm-2362	81	5	more	more	ADV
ajlm-2362	81	6	resistant	resistant	ADJ
ajlm-2362	81	7	to	to	ADP
ajlm-2362	81	8	the	the	DET
ajlm-2362	81	9	antibiotics	antibiotic	NOUN
ajlm-2362	81	10	tested	test	VERB
ajlm-2362	81	11	as	as	ADP
ajlm-2362	81	12	compared	compare	VERB
ajlm-2362	81	13	to	to	ADP
ajlm-2362	81	14	isolates	isolate	NOUN
ajlm-2362	81	15	from	from	ADP
ajlm-2362	81	16	the	the	DET
ajlm-2362	81	17	older	old	ADJ
ajlm-2362	81	18	school	school	NOUN
ajlm-2362	81	19	-	-	PUNCT
ajlm-2362	81	20	age	age	NOUN
ajlm-2362	81	21	and	and	CCONJ
ajlm-2362	81	22	adolescent	adolescent	ADJ
ajlm-2362	81	23	groups	group	NOUN
ajlm-2362	81	24	.	.	PUNCT
ajlm-2362	82	1	isolates	isolate	NOUN
ajlm-2362	82	2	were	be	AUX
ajlm-2362	82	3	resistant	resistant	ADJ
ajlm-2362	82	4	to	to	ADP
ajlm-2362	82	5	11	11	NUM
ajlm-2362	82	6	of	of	ADP
ajlm-2362	82	7	15	15	NUM
ajlm-2362	82	8	drugs	drug	NOUN
ajlm-2362	82	9	tested	test	VERB
ajlm-2362	82	10	in	in	ADP
ajlm-2362	82	11	the	the	DET
ajlm-2362	82	12	neonatal	neonatal	ADJ
ajlm-2362	82	13	group	group	NOUN
ajlm-2362	82	14	in	in	ADP
ajlm-2362	82	15	contrast	contrast	NOUN
ajlm-2362	82	16	to	to	ADP
ajlm-2362	82	17	isolates	isolate	NOUN
ajlm-2362	82	18	from	from	ADP
ajlm-2362	82	19	the	the	DET
ajlm-2362	82	20	school	school	NOUN
ajlm-2362	82	21	-	-	PUNCT
ajlm-2362	82	22	age	age	NOUN
ajlm-2362	82	23	group	group	NOUN
ajlm-2362	82	24	,	,	PUNCT
ajlm-2362	82	25	which	which	PRON
ajlm-2362	82	26	were	be	AUX
ajlm-2362	82	27	more	more	ADV
ajlm-2362	82	28	sensitive	sensitive	ADJ
ajlm-2362	82	29	to	to	ADP
ajlm-2362	82	30	10	10	NUM
ajlm-2362	82	31	of	of	ADP
ajlm-2362	82	32	15	15	NUM
ajlm-2362	82	33	drugs	drug	NOUN
ajlm-2362	82	34	tested	test	VERB
ajlm-2362	82	35	.	.	PUNCT
ajlm-2362	83	1	among	among	ADP
ajlm-2362	83	2	all	all	DET
ajlm-2362	83	3	the	the	DET
ajlm-2362	83	4	drugs	drug	NOUN
ajlm-2362	83	5	tested	test	VERB
ajlm-2362	83	6	,	,	PUNCT
ajlm-2362	83	7	isolates	isolate	NOUN
ajlm-2362	83	8	demonstrated	demonstrate	VERB
ajlm-2362	83	9	more	more	ADJ
ajlm-2362	83	10	resistance	resistance	NOUN
ajlm-2362	83	11	to	to	ADP
ajlm-2362	83	12	ampicillin	ampicillin	NOUN
ajlm-2362	83	13	(	(	PUNCT
ajlm-2362	83	14	neonate	neonate	NOUN
ajlm-2362	83	15	73.7	73.7	NUM
ajlm-2362	83	16	%	%	NOUN
ajlm-2362	83	17	,	,	PUNCT
ajlm-2362	83	18	infant	infant	NOUN
ajlm-2362	83	19	88.7	88.7	NUM
ajlm-2362	83	20	%	%	NOUN
ajlm-2362	83	21	,	,	PUNCT
ajlm-2362	83	22	preschool	preschool	ADJ
ajlm-2362	83	23	82.4	82.4	NUM
ajlm-2362	83	24	%	%	NOUN
ajlm-2362	83	25	,	,	PUNCT
ajlm-2362	83	26	school	school	NOUN
ajlm-2362	83	27	age	age	NOUN
ajlm-2362	83	28	85.7	85.7	NUM
ajlm-2362	83	29	%	%	NOUN
ajlm-2362	83	30	)	)	PUNCT
ajlm-2362	83	31	and	and	CCONJ
ajlm-2362	83	32	cefuroxime	cefuroxime	ADJ
ajlm-2362	83	33	(	(	PUNCT
ajlm-2362	83	34	neonate	neonate	NOUN
ajlm-2362	83	35	56.7	56.7	NUM
ajlm-2362	83	36	%	%	NOUN
ajlm-2362	83	37	,	,	PUNCT
ajlm-2362	83	38	infant	infant	NOUN
ajlm-2362	83	39	73.3	73.3	NUM
ajlm-2362	83	40	%	%	NOUN
ajlm-2362	83	41	,	,	PUNCT
ajlm-2362	83	42	preschool	preschool	NOUN
ajlm-2362	83	43	52.4	52.4	NUM
ajlm-2362	83	44	%	%	NOUN
ajlm-2362	83	45	)	)	PUNCT
ajlm-2362	83	46	.	.	PUNCT
ajlm-2362	84	1	in	in	ADP
ajlm-2362	84	2	contrast	contrast	NOUN
ajlm-2362	84	3	,	,	PUNCT
ajlm-2362	84	4	isolates	isolate	NOUN
ajlm-2362	84	5	showed	show	VERB
ajlm-2362	84	6	more	more	ADJ
ajlm-2362	84	7	sensitivity	sensitivity	NOUN
ajlm-2362	84	8	to	to	PART
ajlm-2362	84	9	meropenem	meropenem	PROPN
ajlm-2362	84	10	(	(	PUNCT
ajlm-2362	84	11	neonate	neonate	NOUN
ajlm-2362	84	12	84.6	84.6	NUM
ajlm-2362	84	13	%	%	NOUN
ajlm-2362	84	14	,	,	PUNCT
ajlm-2362	84	15	infant	infant	NOUN
ajlm-2362	84	16	88.2	88.2	NUM
ajlm-2362	84	17	%	%	NOUN
ajlm-2362	84	18	,	,	PUNCT
ajlm-2362	84	19	preschool	preschool	ADJ
ajlm-2362	84	20	84.2	84.2	NUM
ajlm-2362	84	21	%	%	NOUN
ajlm-2362	84	22	,	,	PUNCT
ajlm-2362	84	23	school	school	NOUN
ajlm-2362	84	24	age	age	NOUN
ajlm-2362	84	25	85.7	85.7	NUM
ajlm-2362	84	26	%	%	NOUN
ajlm-2362	84	27	,	,	PUNCT
ajlm-2362	84	28	adolescent	adolescent	ADJ
ajlm-2362	84	29	100.0	100.0	NUM
ajlm-2362	84	30	%	%	NOUN
ajlm-2362	84	31	)	)	PUNCT
ajlm-2362	84	32	and	and	CCONJ
ajlm-2362	84	33	erythromycin	erythromycin	NOUN
ajlm-2362	84	34	(	(	PUNCT
ajlm-2362	84	35	neonate	neonate	NOUN
ajlm-2362	84	36	81.2	81.2	NUM
ajlm-2362	84	37	%	%	NOUN
ajlm-2362	84	38	,	,	PUNCT
ajlm-2362	84	39	infant	infant	NOUN
ajlm-2362	84	40	100.0	100.0	NUM
ajlm-2362	84	41	%	%	NOUN
ajlm-2362	84	42	,	,	PUNCT
ajlm-2362	84	43	preschool	preschool	ADJ
ajlm-2362	84	44	66.7	66.7	NUM
ajlm-2362	84	45	%	%	NOUN
ajlm-2362	84	46	,	,	PUNCT
ajlm-2362	84	47	school	school	NOUN
ajlm-2362	84	48	age	age	NOUN
ajlm-2362	84	49	100.0	100.0	NUM
ajlm-2362	84	50	%	%	NOUN
ajlm-2362	84	51	,	,	PUNCT
ajlm-2362	84	52	adolescent	adolescent	ADJ
ajlm-2362	84	53	75.0	75.0	NUM
ajlm-2362	84	54	%	%	NOUN
ajlm-2362	84	55	)	)	PUNCT
ajlm-2362	84	56	in	in	ADP
ajlm-2362	84	57	the	the	DET
ajlm-2362	84	58	majority	majority	NOUN
ajlm-2362	84	59	of	of	ADP
ajlm-2362	84	60	the	the	DET
ajlm-2362	84	61	age	age	NOUN
ajlm-2362	84	62	groups	group	NOUN
ajlm-2362	84	63	.	.	PUNCT
ajlm-2362	85	1	isolates	isolate	NOUN
ajlm-2362	85	2	from	from	ADP
ajlm-2362	85	3	the	the	DET
ajlm-2362	85	4	preschool	preschool	ADJ
ajlm-2362	85	5	group	group	NOUN
ajlm-2362	85	6	were	be	AUX
ajlm-2362	85	7	more	more	ADV
ajlm-2362	85	8	resistant	resistant	ADJ
ajlm-2362	85	9	to	to	ADP
ajlm-2362	85	10	amoxicillin	amoxicillin	PROPN
ajlm-2362	85	11	+	+	CCONJ
ajlm-2362	85	12	clavulanic	clavulanic	ADJ
ajlm-2362	85	13	acid	acid	NOUN
ajlm-2362	85	14	(	(	PUNCT
ajlm-2362	85	15	58.3	58.3	NUM
ajlm-2362	85	16	%	%	NOUN
ajlm-2362	85	17	)	)	PUNCT
ajlm-2362	85	18	,	,	PUNCT
ajlm-2362	85	19	cefotaxime	cefotaxime	NOUN
ajlm-2362	85	20	(	(	PUNCT
ajlm-2362	85	21	54.5	54.5	NUM
ajlm-2362	85	22	%	%	NOUN
ajlm-2362	85	23	)	)	PUNCT
ajlm-2362	85	24	,	,	PUNCT
ajlm-2362	85	25	and	and	CCONJ
ajlm-2362	85	26	cefuroxime	cefuroxime	ADJ
ajlm-2362	85	27	(	(	PUNCT
ajlm-2362	85	28	52.4	52.4	NUM
ajlm-2362	85	29	%	%	NOUN
ajlm-2362	85	30	)	)	PUNCT
ajlm-2362	85	31	.	.	PUNCT
ajlm-2362	86	1	this	this	PRON
ajlm-2362	86	2	differed	differ	VERB
ajlm-2362	86	3	from	from	ADP
ajlm-2362	86	4	the	the	DET
ajlm-2362	86	5	infant	infant	NOUN
ajlm-2362	86	6	group	group	NOUN
ajlm-2362	86	7	which	which	PRON
ajlm-2362	86	8	exhibited	exhibit	VERB
ajlm-2362	86	9	more	more	ADJ
ajlm-2362	86	10	resistance	resistance	NOUN
ajlm-2362	86	11	pattern	pattern	NOUN
ajlm-2362	86	12	to	to	ADP
ajlm-2362	86	13	cefepime	cefepime	NOUN
ajlm-2362	86	14	(	(	PUNCT
ajlm-2362	86	15	52.0	52.0	NUM
ajlm-2362	86	16	%	%	NOUN
ajlm-2362	86	17	)	)	PUNCT
ajlm-2362	86	18	,	,	PUNCT
ajlm-2362	86	19	azithromycin	azithromycin	PROPN
ajlm-2362	86	20	(	(	PUNCT
ajlm-2362	86	21	66.7	66.7	NUM
ajlm-2362	86	22	%	%	NOUN
ajlm-2362	86	23	)	)	PUNCT
ajlm-2362	86	24	,	,	PUNCT
ajlm-2362	86	25	and	and	CCONJ
ajlm-2362	86	26	cefuroxime	cefuroxime	ADJ
ajlm-2362	86	27	(	(	PUNCT
ajlm-2362	86	28	73.3	73.3	NUM
ajlm-2362	86	29	%	%	NOUN
ajlm-2362	86	30	)	)	PUNCT
ajlm-2362	86	31	.	.	PUNCT
ajlm-2362	87	1	likewise	likewise	ADV
ajlm-2362	87	2	,	,	PUNCT
ajlm-2362	87	3	isolates	isolate	NOUN
ajlm-2362	87	4	detected	detect	VERB
ajlm-2362	87	5	in	in	ADP
ajlm-2362	87	6	the	the	DET
ajlm-2362	87	7	neonatal	neonatal	ADJ
ajlm-2362	87	8	group	group	NOUN
ajlm-2362	87	9	were	be	AUX
ajlm-2362	87	10	more	more	ADV
ajlm-2362	87	11	resistant	resistant	ADJ
ajlm-2362	87	12	to	to	ADP
ajlm-2362	87	13	ceftriaxone	ceftriaxone	NOUN
ajlm-2362	87	14	(	(	PUNCT
ajlm-2362	87	15	57.1	57.1	NUM
ajlm-2362	87	16	%	%	NOUN
ajlm-2362	87	17	)	)	PUNCT
ajlm-2362	87	18	and	and	CCONJ
ajlm-2362	87	19	ofloxacin	ofloxacin	NOUN
ajlm-2362	87	20	(	(	PUNCT
ajlm-2362	87	21	66.7	66.7	NUM
ajlm-2362	87	22	%	%	NOUN
ajlm-2362	87	23	)	)	PUNCT
ajlm-2362	87	24	,	,	PUNCT
ajlm-2362	87	25	as	as	SCONJ
ajlm-2362	87	26	compared	compare	VERB
ajlm-2362	87	27	to	to	ADP
ajlm-2362	87	28	the	the	DET
ajlm-2362	87	29	rest	rest	NOUN
ajlm-2362	87	30	of	of	ADP
ajlm-2362	87	31	the	the	DET
ajlm-2362	87	32	subgroups	subgroup	NOUN
ajlm-2362	87	33	.	.	PUNCT
ajlm-2362	88	1	table	table	NOUN
ajlm-2362	88	2	4	4	NUM
ajlm-2362	88	3	:	:	PUNCT
ajlm-2362	88	4	 	 	SPACE
ajlm-2362	88	5	susceptibility	susceptibility	NOUN
ajlm-2362	88	6	pattern	pattern	NOUN
ajlm-2362	88	7	from	from	ADP
ajlm-2362	88	8	positive	positive	ADJ
ajlm-2362	88	9	samples	sample	NOUN
ajlm-2362	88	10	among	among	ADP
ajlm-2362	88	11	different	different	ADJ
ajlm-2362	88	12	age	age	NOUN
ajlm-2362	88	13	groups	group	NOUN
ajlm-2362	88	14	from	from	ADP
ajlm-2362	88	15	lagos	lago	NOUN
ajlm-2362	88	16	,	,	PUNCT
ajlm-2362	88	17	south	south	ADJ
ajlm-2362	88	18	-	-	PUNCT
ajlm-2362	88	19	western	western	ADJ
ajlm-2362	88	20	nigeria	nigeria	PROPN
ajlm-2362	88	21	,	,	PUNCT
ajlm-2362	88	22	from	from	ADP
ajlm-2362	88	23	december	december	PROPN
ajlm-2362	88	24	2021	2021	NUM
ajlm-2362	88	25	to	to	ADP
ajlm-2362	88	26	march	march	PROPN
ajlm-2362	88	27	2022	2022	NUM
ajlm-2362	88	28	.	.	PUNCT
ajlm-2362	89	1	discussion	discussion	NOUN
ajlm-2362	89	2	this	this	DET
ajlm-2362	89	3	retrospective	retrospective	ADJ
ajlm-2362	89	4	study	study	NOUN
ajlm-2362	89	5	demonstrated	demonstrate	VERB
ajlm-2362	89	6	the	the	DET
ajlm-2362	89	7	varying	vary	VERB
ajlm-2362	89	8	pattern	pattern	NOUN
ajlm-2362	89	9	of	of	ADP
ajlm-2362	89	10	antibiotic	antibiotic	ADJ
ajlm-2362	89	11	susceptibility	susceptibility	NOUN
ajlm-2362	89	12	in	in	ADP
ajlm-2362	89	13	children	child	NOUN
ajlm-2362	89	14	.	.	PUNCT
ajlm-2362	90	1	the	the	DET
ajlm-2362	90	2	bacterial	bacterial	ADJ
ajlm-2362	90	3	species	specie	NOUN
ajlm-2362	90	4	studied	study	VERB
ajlm-2362	90	5	have	have	AUX
ajlm-2362	90	6	shown	show	VERB
ajlm-2362	90	7	strong	strong	ADJ
ajlm-2362	90	8	associations	association	NOUN
ajlm-2362	90	9	with	with	ADP
ajlm-2362	90	10	drug	drug	NOUN
ajlm-2362	90	11	resistance	resistance	NOUN
ajlm-2362	90	12	globally	globally	ADV
ajlm-2362	90	13	and	and	CCONJ
ajlm-2362	90	14	are	be	AUX
ajlm-2362	90	15	part	part	NOUN
ajlm-2362	90	16	of	of	ADP
ajlm-2362	90	17	the	the	DET
ajlm-2362	90	18	most	most	ADV
ajlm-2362	90	19	important	important	ADJ
ajlm-2362	90	20	consideration	consideration	NOUN
ajlm-2362	90	21	of	of	ADP
ajlm-2362	90	22	the	the	PRON
ajlm-2362	90	23	who	who	PRON
ajlm-2362	90	24	’s	’	VERB
ajlm-2362	90	25	research	research	NOUN
ajlm-2362	90	26	for	for	ADP
ajlm-2362	90	27	new	new	ADJ
ajlm-2362	90	28	antimicrobial	antimicrobial	ADJ
ajlm-2362	90	29	discovery	discovery	NOUN
ajlm-2362	90	30	and	and	CCONJ
ajlm-2362	90	31	development.15	development.15	NOUN
ajlm-2362	90	32	our	our	PRON
ajlm-2362	90	33	results	result	NOUN
ajlm-2362	90	34	show	show	VERB
ajlm-2362	90	35	that	that	SCONJ
ajlm-2362	90	36	the	the	DET
ajlm-2362	90	37	highest	high	ADJ
ajlm-2362	90	38	number	number	NOUN
ajlm-2362	90	39	of	of	ADP
ajlm-2362	90	40	positive	positive	ADJ
ajlm-2362	90	41	samples	sample	NOUN
ajlm-2362	90	42	were	be	AUX
ajlm-2362	90	43	from	from	ADP
ajlm-2362	90	44	the	the	DET
ajlm-2362	90	45	neonatal	neonatal	ADJ
ajlm-2362	90	46	group	group	NOUN
ajlm-2362	90	47	,	,	PUNCT
ajlm-2362	90	48	and	and	CCONJ
ajlm-2362	90	49	blood	blood	NOUN
ajlm-2362	90	50	specimens	specimen	NOUN
ajlm-2362	90	51	contributed	contribute	VERB
ajlm-2362	90	52	to	to	ADP
ajlm-2362	90	53	more	more	ADJ
ajlm-2362	90	54	than	than	ADP
ajlm-2362	90	55	half	half	NOUN
ajlm-2362	90	56	of	of	ADP
ajlm-2362	90	57	specimens	specimen	NOUN
ajlm-2362	90	58	processed	process	VERB
ajlm-2362	90	59	.	.	PUNCT
ajlm-2362	91	1	this	this	DET
ajlm-2362	91	2	observation	observation	NOUN
ajlm-2362	91	3	probably	probably	ADV
ajlm-2362	91	4	points	point	VERB
ajlm-2362	91	5	to	to	ADP
ajlm-2362	91	6	the	the	DET
ajlm-2362	91	7	alarming	alarming	ADJ
ajlm-2362	91	8	rate	rate	NOUN
ajlm-2362	91	9	of	of	ADP
ajlm-2362	91	10	neonatal	neonatal	ADJ
ajlm-2362	91	11	sepsis	sepsis	NOUN
ajlm-2362	91	12	and	and	CCONJ
ajlm-2362	91	13	the	the	DET
ajlm-2362	91	14	rising	rise	VERB
ajlm-2362	91	15	cases	case	NOUN
ajlm-2362	91	16	of	of	ADP
ajlm-2362	91	17	septicaemia	septicaemia	NOUN
ajlm-2362	91	18	among	among	ADP
ajlm-2362	91	19	children	child	NOUN
ajlm-2362	91	20	,	,	PUNCT
ajlm-2362	91	21	especially	especially	ADV
ajlm-2362	91	22	in	in	ADP
ajlm-2362	91	23	sub	sub	ADJ
ajlm-2362	91	24	-	-	ADJ
ajlm-2362	91	25	saharan	saharan	ADJ
ajlm-2362	91	26	africa	africa	PROPN
ajlm-2362	91	27	.	.	PUNCT
ajlm-2362	92	1	our	our	PRON
ajlm-2362	92	2	findings	finding	NOUN
ajlm-2362	92	3	are	be	AUX
ajlm-2362	92	4	in	in	ADP
ajlm-2362	92	5	agreement	agreement	NOUN
ajlm-2362	92	6	with	with	ADP
ajlm-2362	92	7	previous	previous	ADJ
ajlm-2362	92	8	reports	report	NOUN
ajlm-2362	92	9	from	from	ADP
ajlm-2362	92	10	nigeria	nigeria	PROPN
ajlm-2362	92	11	and	and	CCONJ
ajlm-2362	92	12	gambia.16,17	gambia.16,17	VERB
ajlm-2362	92	13	the	the	DET
ajlm-2362	92	14	pathogenic	pathogenic	ADJ
ajlm-2362	92	15	organisms	organism	NOUN
ajlm-2362	92	16	studied	study	VERB
ajlm-2362	92	17	are	be	AUX
ajlm-2362	92	18	part	part	NOUN
ajlm-2362	92	19	of	of	ADP
ajlm-2362	92	20	the	the	DET
ajlm-2362	92	21	list	list	NOUN
ajlm-2362	92	22	of	of	ADP
ajlm-2362	92	23	emerging	emerge	VERB
ajlm-2362	92	24	bacteria	bacteria	NOUN
ajlm-2362	92	25	threats	threat	NOUN
ajlm-2362	92	26	as	as	SCONJ
ajlm-2362	92	27	highlighted	highlight	VERB
ajlm-2362	92	28	by	by	ADP
ajlm-2362	92	29	fair	fair	ADJ
ajlm-2362	92	30	et	et	NOUN
ajlm-2362	92	31	al.18	al.18	VERB
ajlm-2362	92	32	we	we	PRON
ajlm-2362	92	33	agree	agree	VERB
ajlm-2362	92	34	with	with	ADP
ajlm-2362	92	35	this	this	DET
ajlm-2362	92	36	report	report	NOUN
ajlm-2362	92	37	,	,	PUNCT
ajlm-2362	92	38	as	as	SCONJ
ajlm-2362	92	39	our	our	PRON
ajlm-2362	92	40	findings	finding	NOUN
ajlm-2362	92	41	revealed	reveal	VERB
ajlm-2362	92	42	similar	similar	ADJ
ajlm-2362	92	43	trends	trend	NOUN
ajlm-2362	92	44	,	,	PUNCT
ajlm-2362	92	45	with	with	ADP
ajlm-2362	92	46	s.	s.	PROPN
ajlm-2362	92	47	aureus	aureus	PROPN
ajlm-2362	92	48	,	,	PUNCT
ajlm-2362	92	49	e.	e.	PROPN
ajlm-2362	92	50	coli	coli	PROPN
ajlm-2362	92	51	and	and	CCONJ
ajlm-2362	92	52	klebsiella	klebsiella	PROPN
ajlm-2362	92	53	spp	spp	PROPN
ajlm-2362	92	54	.	.	PUNCT
ajlm-2362	93	1	having	have	VERB
ajlm-2362	93	2	the	the	DET
ajlm-2362	93	3	highest	high	ADJ
ajlm-2362	93	4	resistance	resistance	NOUN
ajlm-2362	93	5	profile	profile	NOUN
ajlm-2362	93	6	among	among	ADP
ajlm-2362	93	7	the	the	DET
ajlm-2362	93	8	drugs	drug	NOUN
ajlm-2362	93	9	tested.18	tested.18	PROPN
ajlm-2362	93	10	staphylococcus	staphylococcus	NOUN
ajlm-2362	93	11	aureus	aureus	NOUN
ajlm-2362	93	12	,	,	PUNCT
ajlm-2362	93	13	which	which	PRON
ajlm-2362	93	14	was	be	AUX
ajlm-2362	93	15	the	the	DET
ajlm-2362	93	16	most	most	ADV
ajlm-2362	93	17	isolated	isolated	ADJ
ajlm-2362	93	18	organism	organism	NOUN
ajlm-2362	93	19	among	among	ADP
ajlm-2362	93	20	all	all	DET
ajlm-2362	93	21	the	the	DET
ajlm-2362	93	22	subjects	subject	NOUN
ajlm-2362	93	23	studied	study	VERB
ajlm-2362	93	24	,	,	PUNCT
ajlm-2362	93	25	also	also	ADV
ajlm-2362	93	26	had	have	VERB
ajlm-2362	93	27	the	the	DET
ajlm-2362	93	28	highest	high	ADJ
ajlm-2362	93	29	resistance	resistance	NOUN
ajlm-2362	93	30	profile	profile	NOUN
ajlm-2362	93	31	.	.	PUNCT
ajlm-2362	94	1	cassat	cassat	PROPN
ajlm-2362	94	2	et	et	NOUN
ajlm-2362	94	3	al.19	al.19	PROPN
ajlm-2362	94	4	in	in	ADP
ajlm-2362	94	5	their	their	PRON
ajlm-2362	94	6	review	review	NOUN
ajlm-2362	94	7	emphasised	emphasise	VERB
ajlm-2362	94	8	the	the	DET
ajlm-2362	94	9	rapidly	rapidly	ADV
ajlm-2362	94	10	evolving	evolve	VERB
ajlm-2362	94	11	nature	nature	NOUN
ajlm-2362	94	12	of	of	ADP
ajlm-2362	94	13	s.	s.	PROPN
ajlm-2362	94	14	aureus	aureus	PROPN
ajlm-2362	94	15	,	,	PUNCT
ajlm-2362	94	16	producing	produce	VERB
ajlm-2362	94	17	aggressive	aggressive	ADJ
ajlm-2362	94	18	resistant	resistant	ADJ
ajlm-2362	94	19	strains.19	strains.19	NOUN
ajlm-2362	94	20	this	this	DET
ajlm-2362	94	21	organism	organism	NOUN
ajlm-2362	94	22	is	be	AUX
ajlm-2362	94	23	also	also	ADV
ajlm-2362	94	24	believed	believe	VERB
ajlm-2362	94	25	to	to	PART
ajlm-2362	94	26	be	be	AUX
ajlm-2362	94	27	the	the	DET
ajlm-2362	94	28	most	most	ADV
ajlm-2362	94	29	prevalent	prevalent	ADJ
ajlm-2362	94	30	infective	infective	ADJ
ajlm-2362	94	31	paediatric	paediatric	ADJ
ajlm-2362	94	32	pathogen	pathogen	NOUN
ajlm-2362	94	33	in	in	ADP
ajlm-2362	94	34	several	several	ADJ
ajlm-2362	94	35	parts	part	NOUN
ajlm-2362	94	36	of	of	ADP
ajlm-2362	94	37	the	the	DET
ajlm-2362	94	38	world	world	NOUN
ajlm-2362	94	39	,	,	PUNCT
ajlm-2362	94	40	posing	pose	VERB
ajlm-2362	94	41	a	a	DET
ajlm-2362	94	42	significant	significant	ADJ
ajlm-2362	94	43	threat	threat	NOUN
ajlm-2362	94	44	without	without	ADP
ajlm-2362	94	45	newer	new	ADJ
ajlm-2362	94	46	therapeutic	therapeutic	ADJ
ajlm-2362	94	47	options.18,19	options.18,19	NOUN
ajlm-2362	94	48	the	the	DET
ajlm-2362	94	49	isolates	isolate	NOUN
ajlm-2362	94	50	included	include	VERB
ajlm-2362	94	51	in	in	ADP
ajlm-2362	94	52	this	this	DET
ajlm-2362	94	53	study	study	NOUN
ajlm-2362	94	54	also	also	ADV
ajlm-2362	94	55	exhibited	exhibit	VERB
ajlm-2362	94	56	more	more	ADJ
ajlm-2362	94	57	resistance	resistance	NOUN
ajlm-2362	94	58	to	to	ADP
ajlm-2362	94	59	ampicillin	ampicillin	PROPN
ajlm-2362	94	60	,	,	PUNCT
ajlm-2362	94	61	amoxicillin	amoxicillin	PROPN
ajlm-2362	94	62	+	+	CCONJ
ajlm-2362	94	63	clavulanic	clavulanic	ADJ
ajlm-2362	94	64	acid	acid	NOUN
ajlm-2362	94	65	,	,	PUNCT
ajlm-2362	94	66	cefuroxime	cefuroxime	ADJ
ajlm-2362	94	67	and	and	CCONJ
ajlm-2362	94	68	cefepime	cefepime	NOUN
ajlm-2362	94	69	.	.	PUNCT
ajlm-2362	95	1	previous	previous	ADJ
ajlm-2362	95	2	african	african	ADJ
ajlm-2362	95	3	studies	study	NOUN
ajlm-2362	95	4	have	have	AUX
ajlm-2362	95	5	reported	report	VERB
ajlm-2362	95	6	high	high	ADJ
ajlm-2362	95	7	resistance	resistance	NOUN
ajlm-2362	95	8	to	to	ADP
ajlm-2362	95	9	all	all	DET
ajlm-2362	95	10	the	the	DET
ajlm-2362	95	11	drugs	drug	NOUN
ajlm-2362	95	12	except	except	SCONJ
ajlm-2362	95	13	for	for	ADP
ajlm-2362	95	14	cefepime.20,21,22,23	cefepime.20,21,22,23	PROPN
ajlm-2362	95	15	the	the	DET
ajlm-2362	95	16	high	high	ADJ
ajlm-2362	95	17	prevalence	prevalence	NOUN
ajlm-2362	95	18	observed	observe	VERB
ajlm-2362	95	19	in	in	ADP
ajlm-2362	95	20	our	our	PRON
ajlm-2362	95	21	study	study	NOUN
ajlm-2362	95	22	may	may	AUX
ajlm-2362	95	23	be	be	AUX
ajlm-2362	95	24	explained	explain	VERB
ajlm-2362	95	25	by	by	ADP
ajlm-2362	95	26	the	the	DET
ajlm-2362	95	27	fact	fact	NOUN
ajlm-2362	95	28	that	that	SCONJ
ajlm-2362	95	29	information	information	NOUN
ajlm-2362	95	30	obtained	obtain	VERB
ajlm-2362	95	31	were	be	AUX
ajlm-2362	95	32	from	from	ADP
ajlm-2362	95	33	records	record	NOUN
ajlm-2362	95	34	of	of	ADP
ajlm-2362	95	35	patients	patient	NOUN
ajlm-2362	95	36	on	on	ADP
ajlm-2362	95	37	admission	admission	NOUN
ajlm-2362	95	38	who	who	PRON
ajlm-2362	95	39	were	be	AUX
ajlm-2362	95	40	more	more	ADV
ajlm-2362	95	41	likely	likely	ADJ
ajlm-2362	95	42	to	to	PART
ajlm-2362	95	43	require	require	VERB
ajlm-2362	95	44	antimicrobials	antimicrobial	NOUN
ajlm-2362	95	45	compared	compare	VERB
ajlm-2362	95	46	with	with	ADP
ajlm-2362	95	47	outpatients	outpatient	NOUN
ajlm-2362	95	48	.	.	PUNCT
ajlm-2362	96	1	likewise	likewise	ADV
ajlm-2362	96	2	,	,	PUNCT
ajlm-2362	96	3	the	the	DET
ajlm-2362	96	4	observed	observe	VERB
ajlm-2362	96	5	high	high	ADJ
ajlm-2362	96	6	rate	rate	NOUN
ajlm-2362	96	7	of	of	ADP
ajlm-2362	96	8	resistance	resistance	NOUN
ajlm-2362	96	9	could	could	AUX
ajlm-2362	96	10	be	be	AUX
ajlm-2362	96	11	associated	associate	VERB
ajlm-2362	96	12	with	with	ADP
ajlm-2362	96	13	pre	pre	NOUN
ajlm-2362	96	14	-	-	NOUN
ajlm-2362	96	15	exposure	exposure	ADJ
ajlm-2362	96	16	to	to	ADP
ajlm-2362	96	17	a	a	DET
ajlm-2362	96	18	wide	wide	ADJ
ajlm-2362	96	19	variety	variety	NOUN
ajlm-2362	96	20	of	of	ADP
ajlm-2362	96	21	antibiotics	antibiotic	NOUN
ajlm-2362	96	22	with	with	ADP
ajlm-2362	96	23	optimal	optimal	ADJ
ajlm-2362	96	24	or	or	CCONJ
ajlm-2362	96	25	sub	sub	ADJ
ajlm-2362	96	26	-	-	ADJ
ajlm-2362	96	27	optimal	optimal	ADJ
ajlm-2362	96	28	dosages	dosage	NOUN
ajlm-2362	96	29	before	before	ADP
ajlm-2362	96	30	their	their	PRON
ajlm-2362	96	31	referral	referral	NOUN
ajlm-2362	96	32	to	to	ADP
ajlm-2362	96	33	our	our	PRON
ajlm-2362	96	34	hospital	hospital	NOUN
ajlm-2362	96	35	.	.	PUNCT
ajlm-2362	97	1	we	we	PRON
ajlm-2362	97	2	also	also	ADV
ajlm-2362	97	3	note	note	VERB
ajlm-2362	97	4	that	that	SCONJ
ajlm-2362	97	5	ampicillin	ampicillin	PROPN
ajlm-2362	97	6	,	,	PUNCT
ajlm-2362	97	7	amoxicillin	amoxicillin	PROPN
ajlm-2362	97	8	+	+	CCONJ
ajlm-2362	97	9	clavulanic	clavulanic	ADJ
ajlm-2362	97	10	acid	acid	NOUN
ajlm-2362	97	11	,	,	PUNCT
ajlm-2362	97	12	cefuroxime	cefuroxime	ADJ
ajlm-2362	97	13	and	and	CCONJ
ajlm-2362	97	14	cefepime	cefepime	NOUN
ajlm-2362	97	15	are	be	AUX
ajlm-2362	97	16	all	all	ADV
ajlm-2362	97	17	under	under	ADP
ajlm-2362	97	18	the	the	DET
ajlm-2362	97	19	who	who	PRON
ajlm-2362	97	20	access	access	NOUN
ajlm-2362	97	21	,	,	PUNCT
ajlm-2362	97	22	watch	watch	NOUN
ajlm-2362	97	23	,	,	PUNCT
ajlm-2362	97	24	reserve	reserve	VERB
ajlm-2362	97	25	classification	classification	NOUN
ajlm-2362	97	26	of	of	ADP
ajlm-2362	97	27	antibiotics	antibiotic	NOUN
ajlm-2362	97	28	to	to	PART
ajlm-2362	97	29	support	support	VERB
ajlm-2362	97	30	antimicrobial	antimicrobial	ADJ
ajlm-2362	97	31	stewardship	stewardship	NOUN
ajlm-2362	97	32	programmes	programme	NOUN
ajlm-2362	97	33	in	in	ADP
ajlm-2362	97	34	the	the	DET
ajlm-2362	97	35	hospitals.24	hospitals.24	NOUN
ajlm-2362	97	36	these	these	DET
ajlm-2362	97	37	drugs	drug	NOUN
ajlm-2362	97	38	,	,	PUNCT
ajlm-2362	97	39	recommended	recommend	VERB
ajlm-2362	97	40	by	by	ADP
ajlm-2362	97	41	the	the	PRON
ajlm-2362	97	42	who	who	PRON
ajlm-2362	97	43	,	,	PUNCT
ajlm-2362	97	44	are	be	AUX
ajlm-2362	97	45	the	the	DET
ajlm-2362	97	46	most	most	ADV
ajlm-2362	97	47	prescribed	prescribe	VERB
ajlm-2362	97	48	to	to	ADP
ajlm-2362	97	49	children	child	NOUN
ajlm-2362	97	50	currently	currently	ADV
ajlm-2362	97	51	by	by	ADP
ajlm-2362	97	52	physicians	physician	NOUN
ajlm-2362	97	53	,	,	PUNCT
ajlm-2362	97	54	especially	especially	ADV
ajlm-2362	97	55	in	in	ADP
ajlm-2362	97	56	suburban	suburban	ADJ
ajlm-2362	97	57	and	and	CCONJ
ajlm-2362	97	58	rural	rural	ADJ
ajlm-2362	97	59	nigeria	nigeria	PROPN
ajlm-2362	97	60	.	.	PUNCT
ajlm-2362	98	1	resistance	resistance	NOUN
ajlm-2362	98	2	to	to	ADP
ajlm-2362	98	3	these	these	DET
ajlm-2362	98	4	drugs	drug	NOUN
ajlm-2362	98	5	suggests	suggest	VERB
ajlm-2362	98	6	a	a	DET
ajlm-2362	98	7	disturbing	disturbing	ADJ
ajlm-2362	98	8	shift	shift	NOUN
ajlm-2362	98	9	to	to	ADP
ajlm-2362	98	10	antibiotics	antibiotic	NOUN
ajlm-2362	98	11	considered	consider	VERB
ajlm-2362	98	12	reserved	reserve	VERB
ajlm-2362	98	13	under	under	ADP
ajlm-2362	98	14	the	the	PRON
ajlm-2362	98	15	who	who	PRON
ajlm-2362	98	16	classification	classification	NOUN
ajlm-2362	98	17	intended	intend	VERB
ajlm-2362	98	18	for	for	ADP
ajlm-2362	98	19	severe	severe	ADJ
ajlm-2362	98	20	infections.24,25	infections.24,25	NOUN
ajlm-2362	98	21	we	we	PRON
ajlm-2362	98	22	recorded	record	VERB
ajlm-2362	98	23	a	a	DET
ajlm-2362	98	24	higher	high	ADJ
ajlm-2362	98	25	resistance	resistance	NOUN
ajlm-2362	98	26	pattern	pattern	NOUN
ajlm-2362	98	27	in	in	ADP
ajlm-2362	98	28	younger	young	ADJ
ajlm-2362	98	29	children	child	NOUN
ajlm-2362	98	30	compared	compare	VERB
ajlm-2362	98	31	with	with	ADP
ajlm-2362	98	32	school	school	NOUN
ajlm-2362	98	33	aged	age	VERB
ajlm-2362	98	34	children	child	NOUN
ajlm-2362	98	35	and	and	CCONJ
ajlm-2362	98	36	adolescents	adolescent	NOUN
ajlm-2362	98	37	.	.	PUNCT
ajlm-2362	99	1	this	this	PRON
ajlm-2362	99	2	is	be	AUX
ajlm-2362	99	3	similar	similar	ADJ
ajlm-2362	99	4	to	to	ADP
ajlm-2362	99	5	previous	previous	ADJ
ajlm-2362	99	6	documented	document	VERB
ajlm-2362	99	7	reports	report	NOUN
ajlm-2362	99	8	from	from	ADP
ajlm-2362	99	9	different	different	ADJ
ajlm-2362	99	10	parts	part	NOUN
ajlm-2362	99	11	of	of	ADP
ajlm-2362	99	12	africa.3,10,17,26,27,28,29	africa.3,10,17,26,27,28,29	NOUN
ajlm-2362	99	13	children	child	NOUN
ajlm-2362	99	14	,	,	PUNCT
ajlm-2362	99	15	especially	especially	ADV
ajlm-2362	99	16	those	those	DET
ajlm-2362	99	17	under	under	ADP
ajlm-2362	99	18	5	5	NUM
ajlm-2362	99	19	years	year	NOUN
ajlm-2362	99	20	of	of	ADP
ajlm-2362	99	21	age	age	NOUN
ajlm-2362	99	22	,	,	PUNCT
ajlm-2362	99	23	receive	receive	VERB
ajlm-2362	99	24	more	more	ADJ
ajlm-2362	99	25	antibiotics	antibiotic	NOUN
ajlm-2362	99	26	than	than	ADP
ajlm-2362	99	27	adults	adult	NOUN
ajlm-2362	99	28	due	due	ADJ
ajlm-2362	99	29	to	to	ADP
ajlm-2362	99	30	frequent	frequent	ADJ
ajlm-2362	99	31	bouts	bout	NOUN
ajlm-2362	99	32	of	of	ADP
ajlm-2362	99	33	infections	infection	NOUN
ajlm-2362	99	34	.	.	PUNCT
ajlm-2362	100	1	furthermore	furthermore	ADV
ajlm-2362	100	2	,	,	PUNCT
ajlm-2362	100	3	blurring	blur	VERB
ajlm-2362	100	4	insights	insight	NOUN
ajlm-2362	100	5	to	to	ADP
ajlm-2362	100	6	mechanism	mechanism	NOUN
ajlm-2362	100	7	of	of	ADP
ajlm-2362	100	8	paediatric	paediatric	ADJ
ajlm-2362	100	9	pathogenic	pathogenic	ADJ
ajlm-2362	100	10	organism	organism	NOUN
ajlm-2362	100	11	,	,	PUNCT
ajlm-2362	100	12	coupled	couple	VERB
ajlm-2362	100	13	with	with	ADP
ajlm-2362	100	14	scarce	scarce	ADJ
ajlm-2362	100	15	data	datum	NOUN
ajlm-2362	100	16	on	on	ADP
ajlm-2362	100	17	resistance	resistance	NOUN
ajlm-2362	100	18	patterns	pattern	NOUN
ajlm-2362	100	19	in	in	ADP
ajlm-2362	100	20	this	this	DET
ajlm-2362	100	21	age	age	NOUN
ajlm-2362	100	22	group	group	NOUN
ajlm-2362	100	23	,	,	PUNCT
ajlm-2362	100	24	may	may	AUX
ajlm-2362	100	25	increase	increase	VERB
ajlm-2362	100	26	antibiotic	antibiotic	ADJ
ajlm-2362	100	27	resistance	resistance	NOUN
ajlm-2362	100	28	in	in	ADP
ajlm-2362	100	29	these	these	DET
ajlm-2362	100	30	age	age	NOUN
ajlm-2362	100	31	groups.30	groups.30	NOUN
ajlm-2362	100	32	this	this	PRON
ajlm-2362	100	33	may	may	AUX
ajlm-2362	100	34	be	be	AUX
ajlm-2362	100	35	especially	especially	ADV
ajlm-2362	100	36	true	true	ADJ
ajlm-2362	100	37	in	in	ADP
ajlm-2362	100	38	sub	sub	ADJ
ajlm-2362	100	39	-	-	ADJ
ajlm-2362	100	40	saharan	saharan	ADJ
ajlm-2362	100	41	africa	africa	PROPN
ajlm-2362	100	42	,	,	PUNCT
ajlm-2362	100	43	which	which	PRON
ajlm-2362	100	44	is	be	AUX
ajlm-2362	100	45	considered	consider	VERB
ajlm-2362	100	46	a	a	DET
ajlm-2362	100	47	resource	resource	NOUN
ajlm-2362	100	48	-	-	PUNCT
ajlm-2362	100	49	poor	poor	ADJ
ajlm-2362	100	50	region	region	NOUN
ajlm-2362	100	51	.	.	PUNCT
ajlm-2362	101	1	this	this	DET
ajlm-2362	101	2	study	study	NOUN
ajlm-2362	101	3	also	also	ADV
ajlm-2362	101	4	noted	note	VERB
ajlm-2362	101	5	the	the	DET
ajlm-2362	101	6	high	high	ADJ
ajlm-2362	101	7	resistance	resistance	NOUN
ajlm-2362	101	8	profile	profile	NOUN
ajlm-2362	101	9	of	of	ADP
ajlm-2362	101	10	isolates	isolate	NOUN
ajlm-2362	101	11	within	within	ADP
ajlm-2362	101	12	the	the	DET
ajlm-2362	101	13	neonatal	neonatal	ADJ
ajlm-2362	101	14	group	group	NOUN
ajlm-2362	101	15	.	.	PUNCT
ajlm-2362	102	1	this	this	DET
ajlm-2362	102	2	observation	observation	NOUN
ajlm-2362	102	3	is	be	AUX
ajlm-2362	102	4	in	in	ADP
ajlm-2362	102	5	resonance	resonance	NOUN
ajlm-2362	102	6	with	with	ADP
ajlm-2362	102	7	previous	previous	ADJ
ajlm-2362	102	8	reports	report	NOUN
ajlm-2362	102	9	on	on	ADP
ajlm-2362	102	10	the	the	DET
ajlm-2362	102	11	mounting	mount	VERB
ajlm-2362	102	12	resistance	resistance	NOUN
ajlm-2362	102	13	pattern	pattern	NOUN
ajlm-2362	102	14	in	in	ADP
ajlm-2362	102	15	neonatal	neonatal	ADJ
ajlm-2362	102	16	sepsis.31,32	sepsis.31,32	NOUN
ajlm-2362	102	17	these	these	DET
ajlm-2362	102	18	authors	author	NOUN
ajlm-2362	102	19	have	have	AUX
ajlm-2362	102	20	also	also	ADV
ajlm-2362	102	21	noted	note	VERB
ajlm-2362	102	22	that	that	SCONJ
ajlm-2362	102	23	e.	e.	PROPN
ajlm-2362	102	24	coli	coli	PROPN
ajlm-2362	102	25	and	and	CCONJ
ajlm-2362	102	26	klebsiella	klebsiella	PROPN
ajlm-2362	102	27	spp	spp	PROPN
ajlm-2362	102	28	.	.	PROPN
ajlm-2362	102	29	are	be	AUX
ajlm-2362	102	30	dominant	dominant	ADJ
ajlm-2362	102	31	resistant	resistant	ADJ
ajlm-2362	102	32	pathogens	pathogen	NOUN
ajlm-2362	102	33	isolated	isolate	VERB
ajlm-2362	102	34	in	in	ADP
ajlm-2362	102	35	neonatal	neonatal	ADJ
ajlm-2362	102	36	sepsis	sepsis	NOUN
ajlm-2362	102	37	.	.	PUNCT
ajlm-2362	103	1	from	from	ADP
ajlm-2362	103	2	our	our	PRON
ajlm-2362	103	3	results	result	NOUN
ajlm-2362	103	4	,	,	PUNCT
ajlm-2362	103	5	meropenem	meropenem	PROPN
ajlm-2362	103	6	remains	remain	VERB
ajlm-2362	103	7	an	an	DET
ajlm-2362	103	8	available	available	ADJ
ajlm-2362	103	9	option	option	NOUN
ajlm-2362	103	10	as	as	SCONJ
ajlm-2362	103	11	it	it	PRON
ajlm-2362	103	12	shows	show	VERB
ajlm-2362	103	13	a	a	DET
ajlm-2362	103	14	high	high	ADJ
ajlm-2362	103	15	sensitivity	sensitivity	NOUN
ajlm-2362	103	16	rate	rate	NOUN
ajlm-2362	103	17	;	;	PUNCT
ajlm-2362	103	18	however	however	ADV
ajlm-2362	103	19	,	,	PUNCT
ajlm-2362	103	20	this	this	DET
ajlm-2362	103	21	drug	drug	NOUN
ajlm-2362	103	22	has	have	AUX
ajlm-2362	103	23	been	be	AUX
ajlm-2362	103	24	designated	designate	VERB
ajlm-2362	103	25	by	by	ADP
ajlm-2362	103	26	who	who	PRON
ajlm-2362	103	27	as	as	ADP
ajlm-2362	103	28	a	a	DET
ajlm-2362	103	29	reserved	reserved	ADJ
ajlm-2362	103	30	drug	drug	NOUN
ajlm-2362	103	31	and	and	CCONJ
ajlm-2362	103	32	should	should	AUX
ajlm-2362	103	33	be	be	AUX
ajlm-2362	103	34	used	use	VERB
ajlm-2362	103	35	under	under	ADP
ajlm-2362	103	36	strict	strict	ADJ
ajlm-2362	103	37	antibiotic	antibiotic	ADJ
ajlm-2362	103	38	policy.24	policy.24	NOUN
ajlm-2362	103	39	limitations	limitation	NOUN
ajlm-2362	103	40	the	the	DET
ajlm-2362	103	41	data	datum	NOUN
ajlm-2362	103	42	used	use	VERB
ajlm-2362	103	43	in	in	ADP
ajlm-2362	103	44	this	this	DET
ajlm-2362	103	45	retrospective	retrospective	ADJ
ajlm-2362	103	46	study	study	NOUN
ajlm-2362	103	47	were	be	AUX
ajlm-2362	103	48	from	from	ADP
ajlm-2362	103	49	records	record	NOUN
ajlm-2362	103	50	of	of	ADP
ajlm-2362	103	51	hospitalised	hospitalise	VERB
ajlm-2362	103	52	children	child	NOUN
ajlm-2362	103	53	in	in	ADP
ajlm-2362	103	54	our	our	PRON
ajlm-2362	103	55	facility	facility	NOUN
ajlm-2362	103	56	who	who	PRON
ajlm-2362	103	57	may	may	AUX
ajlm-2362	103	58	have	have	AUX
ajlm-2362	103	59	been	be	AUX
ajlm-2362	103	60	infected	infect	VERB
ajlm-2362	103	61	with	with	ADP
ajlm-2362	103	62	multi	multi	ADJ
ajlm-2362	103	63	-	-	ADJ
ajlm-2362	103	64	drug	drug	ADJ
ajlm-2362	103	65	resistant	resistant	ADJ
ajlm-2362	103	66	bacterial	bacterial	ADJ
ajlm-2362	103	67	pathogens	pathogen	NOUN
ajlm-2362	103	68	not	not	PART
ajlm-2362	103	69	reported	report	VERB
ajlm-2362	103	70	in	in	ADP
ajlm-2362	103	71	our	our	PRON
ajlm-2362	103	72	study	study	NOUN
ajlm-2362	103	73	.	.	PUNCT
ajlm-2362	104	1	the	the	DET
ajlm-2362	104	2	presence	presence	NOUN
ajlm-2362	104	3	of	of	ADP
ajlm-2362	104	4	additional	additional	ADJ
ajlm-2362	104	5	multi	multi	ADJ
ajlm-2362	104	6	-	-	ADJ
ajlm-2362	104	7	drug	drug	ADJ
ajlm-2362	104	8	resistant	resistant	ADJ
ajlm-2362	104	9	pathogens	pathogen	NOUN
ajlm-2362	104	10	not	not	PART
ajlm-2362	104	11	included	include	VERB
ajlm-2362	104	12	in	in	ADP
ajlm-2362	104	13	our	our	PRON
ajlm-2362	104	14	analyses	analysis	NOUN
ajlm-2362	104	15	could	could	AUX
ajlm-2362	104	16	have	have	AUX
ajlm-2362	104	17	altered	alter	VERB
ajlm-2362	104	18	the	the	DET
ajlm-2362	104	19	susceptibility	susceptibility	NOUN
ajlm-2362	104	20	pattern	pattern	NOUN
ajlm-2362	104	21	reported	report	VERB
ajlm-2362	104	22	here	here	ADV
ajlm-2362	104	23	.	.	PUNCT
ajlm-2362	105	1	however	however	ADV
ajlm-2362	105	2	,	,	PUNCT
ajlm-2362	105	3	our	our	PRON
ajlm-2362	105	4	findings	finding	NOUN
ajlm-2362	105	5	can	can	AUX
ajlm-2362	105	6	be	be	AUX
ajlm-2362	105	7	used	use	VERB
ajlm-2362	105	8	as	as	ADP
ajlm-2362	105	9	part	part	NOUN
ajlm-2362	105	10	of	of	ADP
ajlm-2362	105	11	ongoing	ongoing	ADJ
ajlm-2362	105	12	arguments	argument	NOUN
ajlm-2362	105	13	on	on	ADP
ajlm-2362	105	14	national	national	ADJ
ajlm-2362	105	15	awareness	awareness	NOUN
ajlm-2362	105	16	programmes	programme	NOUN
ajlm-2362	105	17	on	on	ADP
ajlm-2362	105	18	antimicrobial	antimicrobial	ADJ
ajlm-2362	105	19	resistance	resistance	NOUN
ajlm-2362	105	20	in	in	ADP
ajlm-2362	105	21	nigeria	nigeria	PROPN
ajlm-2362	105	22	.	.	PUNCT
ajlm-2362	106	1	conclusion	conclusion	NOUN
ajlm-2362	106	2	our	our	PRON
ajlm-2362	106	3	study	study	NOUN
ajlm-2362	106	4	demonstrated	demonstrate	VERB
ajlm-2362	106	5	a	a	DET
ajlm-2362	106	6	higher	high	ADJ
ajlm-2362	106	7	antibiotic	antibiotic	ADJ
ajlm-2362	106	8	resistance	resistance	NOUN
ajlm-2362	106	9	in	in	ADP
ajlm-2362	106	10	younger	young	ADJ
ajlm-2362	106	11	children	child	NOUN
ajlm-2362	106	12	compared	compare	VERB
ajlm-2362	106	13	with	with	ADP
ajlm-2362	106	14	school	school	NOUN
ajlm-2362	106	15	aged	age	VERB
ajlm-2362	106	16	children	child	NOUN
ajlm-2362	106	17	and	and	CCONJ
ajlm-2362	106	18	adolescents	adolescent	NOUN
ajlm-2362	106	19	.	.	PUNCT
ajlm-2362	107	1	the	the	DET
ajlm-2362	107	2	pathogens	pathogen	NOUN
ajlm-2362	107	3	studied	study	VERB
ajlm-2362	107	4	were	be	AUX
ajlm-2362	107	5	resistant	resistant	ADJ
ajlm-2362	107	6	in	in	ADP
ajlm-2362	107	7	all	all	DET
ajlm-2362	107	8	age	age	NOUN
ajlm-2362	107	9	groups	group	NOUN
ajlm-2362	107	10	to	to	ADP
ajlm-2362	107	11	the	the	DET
ajlm-2362	107	12	most	most	ADV
ajlm-2362	107	13	available	available	ADJ
ajlm-2362	107	14	and	and	CCONJ
ajlm-2362	107	15	empirically	empirically	ADV
ajlm-2362	107	16	used	use	VERB
ajlm-2362	107	17	antibacterial	antibacterial	ADJ
ajlm-2362	107	18	agents	agent	NOUN
ajlm-2362	107	19	in	in	ADP
ajlm-2362	107	20	nigeria	nigeria	PROPN
ajlm-2362	107	21	:	:	PUNCT
ajlm-2362	108	1	ampicillin	ampicillin	PROPN
ajlm-2362	108	2	,	,	PUNCT
ajlm-2362	108	3	amoxicillin	amoxicillin	PROPN
ajlm-2362	108	4	+	+	CCONJ
ajlm-2362	108	5	clavulanic	clavulanic	ADJ
ajlm-2362	108	6	acid	acid	NOUN
ajlm-2362	108	7	,	,	PUNCT
ajlm-2362	108	8	cefuroxime	cefuroxime	ADJ
ajlm-2362	108	9	,	,	PUNCT
ajlm-2362	108	10	and	and	CCONJ
ajlm-2362	108	11	cefepime	cefepime	NOUN
ajlm-2362	108	12	.	.	PUNCT
ajlm-2362	109	1	in	in	ADP
ajlm-2362	109	2	awareness	awareness	NOUN
ajlm-2362	109	3	of	of	ADP
ajlm-2362	109	4	this	this	DET
ajlm-2362	109	5	emerging	emerge	VERB
ajlm-2362	109	6	threat	threat	NOUN
ajlm-2362	109	7	,	,	PUNCT
ajlm-2362	109	8	we	we	PRON
ajlm-2362	109	9	believe	believe	VERB
ajlm-2362	109	10	this	this	PRON
ajlm-2362	109	11	is	be	AUX
ajlm-2362	109	12	a	a	DET
ajlm-2362	109	13	stimulation	stimulation	NOUN
ajlm-2362	109	14	towards	towards	ADP
ajlm-2362	109	15	strengthening	strengthen	VERB
ajlm-2362	109	16	antimicrobial	antimicrobial	ADJ
ajlm-2362	109	17	stewardship	stewardship	NOUN
ajlm-2362	109	18	programmes	programme	NOUN
ajlm-2362	109	19	and	and	CCONJ
ajlm-2362	109	20	effective	effective	ADJ
ajlm-2362	109	21	surveillance	surveillance	NOUN
ajlm-2362	109	22	systems	system	NOUN
ajlm-2362	109	23	following	follow	VERB
ajlm-2362	109	24	current	current	NOUN
ajlm-2362	109	25	who	who	PRON
ajlm-2362	109	26	guidelines	guideline	VERB
ajlm-2362	109	27	at	at	ADP
ajlm-2362	109	28	local	local	ADJ
ajlm-2362	109	29	,	,	PUNCT
ajlm-2362	109	30	state	state	NOUN
ajlm-2362	109	31	and	and	CCONJ
ajlm-2362	109	32	national	national	ADJ
ajlm-2362	109	33	levels	level	NOUN
ajlm-2362	109	34	in	in	ADP
ajlm-2362	109	35	nigeria	nigeria	PROPN
ajlm-2362	109	36	.	.	PUNCT
ajlm-2362	110	1	acknowledgements	acknowledgement	NOUN
ajlm-2362	110	2	the	the	DET
ajlm-2362	110	3	authors	author	NOUN
ajlm-2362	110	4	would	would	AUX
ajlm-2362	110	5	like	like	VERB
ajlm-2362	110	6	to	to	PART
ajlm-2362	110	7	thank	thank	VERB
ajlm-2362	110	8	the	the	DET
ajlm-2362	110	9	microbiology	microbiology	NOUN
ajlm-2362	110	10	unit	unit	NOUN
ajlm-2362	110	11	of	of	ADP
ajlm-2362	110	12	the	the	DET
ajlm-2362	110	13	laboratory	laboratory	NOUN
ajlm-2362	110	14	department	department	NOUN
ajlm-2362	110	15	,	,	PUNCT
ajlm-2362	110	16	and	and	CCONJ
ajlm-2362	110	17	the	the	DET
ajlm-2362	110	18	health	health	NOUN
ajlm-2362	110	19	information	information	NOUN
ajlm-2362	110	20	and	and	CCONJ
ajlm-2362	110	21	medical	medical	ADJ
ajlm-2362	110	22	records	record	NOUN
ajlm-2362	110	23	department	department	PROPN
ajlm-2362	110	24	at	at	ADP
ajlm-2362	110	25	massey	massey	PROPN
ajlm-2362	110	26	street	street	PROPN
ajlm-2362	110	27	children	child	NOUN
ajlm-2362	110	28	’s	’s	PART
ajlm-2362	110	29	hospital	hospital	NOUN
ajlm-2362	110	30	for	for	ADP
ajlm-2362	110	31	their	their	PRON
ajlm-2362	110	32	contributions	contribution	NOUN
ajlm-2362	110	33	.	.	PUNCT
ajlm-2362	111	1	competing	compete	VERB
ajlm-2362	111	2	interests	interest	NOUN
ajlm-2362	111	3	the	the	DET
ajlm-2362	111	4	authors	author	NOUN
ajlm-2362	111	5	declare	declare	VERB
ajlm-2362	111	6	that	that	SCONJ
ajlm-2362	111	7	they	they	PRON
ajlm-2362	111	8	have	have	VERB
ajlm-2362	111	9	no	no	DET
ajlm-2362	111	10	financial	financial	ADJ
ajlm-2362	111	11	or	or	CCONJ
ajlm-2362	111	12	personal	personal	ADJ
ajlm-2362	111	13	relationships	relationship	NOUN
ajlm-2362	111	14	that	that	PRON
ajlm-2362	111	15	may	may	AUX
ajlm-2362	111	16	have	have	AUX
ajlm-2362	111	17	inappropriately	inappropriately	ADV
ajlm-2362	111	18	influenced	influence	VERB
ajlm-2362	111	19	them	they	PRON
ajlm-2362	111	20	in	in	ADP
ajlm-2362	111	21	writing	write	VERB
ajlm-2362	111	22	this	this	DET
ajlm-2362	111	23	article	article	NOUN
ajlm-2362	111	24	.	.	PUNCT
ajlm-2362	112	1	authors	author	NOUN
ajlm-2362	112	2	’	'	PUNCT
ajlm-2362	112	3	contributions	contribution	NOUN
ajlm-2362	112	4	this	this	DET
ajlm-2362	112	5	work	work	NOUN
ajlm-2362	112	6	was	be	AUX
ajlm-2362	112	7	carried	carry	VERB
ajlm-2362	112	8	out	out	ADP
ajlm-2362	112	9	in	in	ADP
ajlm-2362	112	10	collaboration	collaboration	NOUN
ajlm-2362	112	11	between	between	ADP
ajlm-2362	112	12	all	all	DET
ajlm-2362	112	13	authors	author	NOUN
ajlm-2362	112	14	.	.	PUNCT
ajlm-2362	113	1	all	all	PRON
ajlm-2362	113	2	of	of	ADP
ajlm-2362	113	3	the	the	DET
ajlm-2362	113	4	authors	author	NOUN
ajlm-2362	113	5	have	have	AUX
ajlm-2362	113	6	accepted	accept	VERB
ajlm-2362	113	7	responsibility	responsibility	NOUN
ajlm-2362	113	8	for	for	ADP
ajlm-2362	113	9	the	the	DET
ajlm-2362	113	10	entire	entire	ADJ
ajlm-2362	113	11	content	content	NOUN
ajlm-2362	113	12	of	of	ADP
ajlm-2362	113	13	this	this	DET
ajlm-2362	113	14	submitted	submit	VERB
ajlm-2362	113	15	article	article	NOUN
ajlm-2362	113	16	and	and	CCONJ
ajlm-2362	113	17	approved	approve	VERB
ajlm-2362	113	18	the	the	DET
ajlm-2362	113	19	submission	submission	NOUN
ajlm-2362	113	20	.	.	PUNCT
ajlm-2362	114	1	a.o.o	a.o.o	PROPN
ajlm-2362	114	2	.	.	PROPN
ajlm-2362	114	3	and	and	CCONJ
ajlm-2362	114	4	m.a.l	m.a.l	PROPN
ajlm-2362	114	5	.	.	PROPN
ajlm-2362	114	6	conceived	conceive	VERB
ajlm-2362	114	7	,	,	PUNCT
ajlm-2362	114	8	designed	design	VERB
ajlm-2362	114	9	and	and	CCONJ
ajlm-2362	114	10	planned	plan	VERB
ajlm-2362	114	11	the	the	DET
ajlm-2362	114	12	study	study	NOUN
ajlm-2362	114	13	.	.	PUNCT
ajlm-2362	115	1	a.o.o	a.o.o	PROPN
ajlm-2362	115	2	.	.	PROPN
ajlm-2362	115	3	collated	collate	VERB
ajlm-2362	115	4	the	the	DET
ajlm-2362	115	5	data	datum	NOUN
ajlm-2362	115	6	and	and	CCONJ
ajlm-2362	115	7	performed	perform	VERB
ajlm-2362	115	8	the	the	DET
ajlm-2362	115	9	analysis	analysis	NOUN
ajlm-2362	115	10	and	and	CCONJ
ajlm-2362	115	11	acted	act	VERB
ajlm-2362	115	12	for	for	ADP
ajlm-2362	115	13	all	all	DET
ajlm-2362	115	14	correspondence	correspondence	NOUN
ajlm-2362	115	15	.	.	PUNCT
ajlm-2362	116	1	a.o.o	a.o.o	PROPN
ajlm-2362	116	2	.	.	PROPN
ajlm-2362	116	3	and	and	CCONJ
ajlm-2362	116	4	o.t.o	o.t.o	ADJ
ajlm-2362	116	5	.	.	PUNCT
ajlm-2362	116	6	designed	design	VERB
ajlm-2362	116	7	the	the	DET
ajlm-2362	116	8	methods	method	NOUN
ajlm-2362	116	9	.	.	PUNCT
ajlm-2362	117	1	a.o.o	a.o.o	PROPN
ajlm-2362	117	2	.	.	PROPN
ajlm-2362	117	3	,	,	PUNCT
ajlm-2362	117	4	m.a.l	m.a.l	PROPN
ajlm-2362	117	5	.	.	PROPN
ajlm-2362	117	6	,	,	PUNCT
ajlm-2362	117	7	o.t.o	o.t.o	ADJ
ajlm-2362	117	8	.	.	PUNCT
ajlm-2362	117	9	,	,	PUNCT
ajlm-2362	117	10	and	and	CCONJ
ajlm-2362	117	11	c.a.m	c.a.m	PUNCT
ajlm-2362	117	12	.	.	PUNCT
ajlm-2362	117	13	participated	participate	VERB
ajlm-2362	117	14	in	in	ADP
ajlm-2362	117	15	drafting	draft	VERB
ajlm-2362	117	16	the	the	DET
ajlm-2362	117	17	article	article	NOUN
ajlm-2362	117	18	and	and	CCONJ
ajlm-2362	117	19	have	have	AUX
ajlm-2362	117	20	thoroughly	thoroughly	ADV
ajlm-2362	117	21	checked	check	VERB
ajlm-2362	117	22	and	and	CCONJ
ajlm-2362	117	23	revised	revise	VERB
ajlm-2362	117	24	the	the	DET
ajlm-2362	117	25	article	article	NOUN
ajlm-2362	117	26	for	for	ADP
ajlm-2362	117	27	necessary	necessary	ADJ
ajlm-2362	117	28	changes	change	NOUN
ajlm-2362	117	29	in	in	ADP
ajlm-2362	117	30	format	format	NOUN
ajlm-2362	117	31	,	,	PUNCT
ajlm-2362	117	32	grammar	grammar	NOUN
ajlm-2362	117	33	and	and	CCONJ
ajlm-2362	117	34	english	english	PROPN
ajlm-2362	117	35	standard	standard	NOUN
ajlm-2362	117	36	.	.	PUNCT
ajlm-2362	118	1	all	all	DET
ajlm-2362	118	2	authors	author	NOUN
ajlm-2362	118	3	read	read	VERB
ajlm-2362	118	4	and	and	CCONJ
ajlm-2362	118	5	approved	approve	VERB
ajlm-2362	118	6	the	the	DET
ajlm-2362	118	7	final	final	ADJ
ajlm-2362	118	8	version	version	NOUN
ajlm-2362	118	9	of	of	ADP
ajlm-2362	118	10	the	the	DET
ajlm-2362	118	11	article	article	NOUN
ajlm-2362	118	12	.	.	PUNCT
ajlm-2362	119	1	all	all	DET
ajlm-2362	119	2	authors	author	NOUN
ajlm-2362	119	3	read	read	VERB
ajlm-2362	119	4	and	and	CCONJ
ajlm-2362	119	5	approved	approve	VERB
ajlm-2362	119	6	the	the	DET
ajlm-2362	119	7	article	article	NOUN
ajlm-2362	119	8	.	.	PUNCT
ajlm-2362	120	1	sources	source	NOUN
ajlm-2362	120	2	of	of	ADP
ajlm-2362	120	3	support	support	NOUN
ajlm-2362	120	4	the	the	DET
ajlm-2362	120	5	authors	author	NOUN
ajlm-2362	120	6	received	receive	VERB
ajlm-2362	120	7	no	no	DET
ajlm-2362	120	8	financial	financial	ADJ
ajlm-2362	120	9	support	support	NOUN
ajlm-2362	120	10	for	for	ADP
ajlm-2362	120	11	the	the	DET
ajlm-2362	120	12	research	research	NOUN
ajlm-2362	120	13	,	,	PUNCT
ajlm-2362	120	14	authorship	authorship	NOUN
ajlm-2362	120	15	,	,	PUNCT
ajlm-2362	120	16	and/or	and/or	CCONJ
ajlm-2362	120	17	publication	publication	NOUN
ajlm-2362	120	18	of	of	ADP
ajlm-2362	120	19	this	this	DET
ajlm-2362	120	20	article	article	NOUN
ajlm-2362	120	21	.	.	PUNCT
ajlm-2362	121	1	data	datum	NOUN
ajlm-2362	121	2	availability	availability	NOUN
ajlm-2362	121	3	the	the	DET
ajlm-2362	121	4	authors	author	NOUN
ajlm-2362	121	5	confirm	confirm	VERB
ajlm-2362	121	6	that	that	SCONJ
ajlm-2362	121	7	the	the	DET
ajlm-2362	121	8	data	datum	NOUN
ajlm-2362	121	9	supporting	support	VERB
ajlm-2362	121	10	the	the	DET
ajlm-2362	121	11	findings	finding	NOUN
ajlm-2362	121	12	of	of	ADP
ajlm-2362	121	13	this	this	DET
ajlm-2362	121	14	study	study	NOUN
ajlm-2362	121	15	are	be	AUX
ajlm-2362	121	16	available	available	ADJ
ajlm-2362	121	17	within	within	ADP
ajlm-2362	121	18	the	the	DET
ajlm-2362	121	19	article	article	NOUN
ajlm-2362	121	20	.	.	PUNCT
ajlm-2362	122	1	disclaimer	disclaimer	VERB
ajlm-2362	122	2	the	the	DET
ajlm-2362	122	3	views	view	NOUN
ajlm-2362	122	4	and	and	CCONJ
ajlm-2362	122	5	opinions	opinion	NOUN
ajlm-2362	122	6	expressed	express	VERB
ajlm-2362	122	7	in	in	ADP
ajlm-2362	122	8	this	this	DET
ajlm-2362	122	9	article	article	NOUN
ajlm-2362	122	10	are	be	AUX
ajlm-2362	122	11	those	those	PRON
ajlm-2362	122	12	of	of	ADP
ajlm-2362	122	13	the	the	DET
ajlm-2362	122	14	authors	author	NOUN
ajlm-2362	122	15	and	and	CCONJ
ajlm-2362	122	16	are	be	AUX
ajlm-2362	122	17	the	the	DET
ajlm-2362	122	18	product	product	NOUN
ajlm-2362	122	19	of	of	ADP
ajlm-2362	122	20	professional	professional	ADJ
ajlm-2362	122	21	research	research	NOUN
ajlm-2362	122	22	.	.	PUNCT
ajlm-2362	123	1	it	it	PRON
ajlm-2362	123	2	does	do	AUX
ajlm-2362	123	3	not	not	PART
ajlm-2362	123	4	necessarily	necessarily	ADV
ajlm-2362	123	5	reflect	reflect	VERB
ajlm-2362	123	6	the	the	DET
ajlm-2362	123	7	official	official	ADJ
ajlm-2362	123	8	policy	policy	NOUN
ajlm-2362	123	9	or	or	CCONJ
ajlm-2362	123	10	position	position	NOUN
ajlm-2362	123	11	of	of	ADP
ajlm-2362	123	12	any	any	DET
ajlm-2362	123	13	affiliated	affiliated	ADJ
ajlm-2362	123	14	institution	institution	NOUN
ajlm-2362	123	15	,	,	PUNCT
ajlm-2362	123	16	funder	funder	NOUN
ajlm-2362	123	17	,	,	PUNCT
ajlm-2362	123	18	agency	agency	NOUN
ajlm-2362	123	19	,	,	PUNCT
ajlm-2362	123	20	or	or	CCONJ
ajlm-2362	123	21	that	that	PRON
ajlm-2362	123	22	of	of	ADP
ajlm-2362	123	23	the	the	DET
ajlm-2362	123	24	publisher	publisher	NOUN
ajlm-2362	123	25	.	.	PUNCT
ajlm-2362	124	1	the	the	DET
ajlm-2362	124	2	authors	author	NOUN
ajlm-2362	124	3	are	be	AUX
ajlm-2362	124	4	responsible	responsible	ADJ
ajlm-2362	124	5	for	for	ADP
ajlm-2362	124	6	this	this	DET
ajlm-2362	124	7	article	article	NOUN
ajlm-2362	124	8	’s	’s	PART
ajlm-2362	124	9	results	result	NOUN
ajlm-2362	124	10	,	,	PUNCT
ajlm-2362	124	11	findings	finding	NOUN
ajlm-2362	124	12	,	,	PUNCT
ajlm-2362	124	13	and	and	CCONJ
ajlm-2362	124	14	content	content	NOUN
ajlm-2362	124	15	.	.	PUNCT
ajlm-2362	125	1	references	reference	NOUN
ajlm-2362	125	2	antoñanzas	antoñanzas	ADP
ajlm-2362	125	3	f	f	NOUN
ajlm-2362	125	4	,	,	PUNCT
ajlm-2362	125	5	goossens	goossens	PROPN
ajlm-2362	125	6	h.	h.	PROPN
ajlm-2362	125	7	the	the	DET
ajlm-2362	125	8	economics	economic	NOUN
ajlm-2362	125	9	of	of	ADP
ajlm-2362	125	10	antibiotic	antibiotic	ADJ
ajlm-2362	125	11	resistance	resistance	NOUN
ajlm-2362	125	12	:	:	PUNCT
ajlm-2362	125	13	a	a	DET
ajlm-2362	125	14	claim	claim	NOUN
ajlm-2362	125	15	for	for	ADP
ajlm-2362	125	16	personalised	personalised	ADJ
ajlm-2362	125	17	treatments	treatment	NOUN
ajlm-2362	125	18	.	.	PUNCT
ajlm-2362	126	1	eur	eur	PROPN
ajlm-2362	126	2	j	j	PROPN
ajlm-2362	126	3	health	health	PROPN
ajlm-2362	126	4	econ	econ	PROPN
ajlm-2362	126	5	.	.	PUNCT
ajlm-2362	127	1	2019;20:483–485	2019;20:483–485	PROPN
ajlm-2362	127	2	.	.	PUNCT
ajlm-2362	128	1	https://doi.org/10.1007/s10198-018-1021-z	https://doi.org/10.1007/s10198-018-1021-z	PROPN
ajlm-2362	128	2	fight	fight	VERB
ajlm-2362	128	3	antimicrobial	antimicrobial	ADJ
ajlm-2362	128	4	resistance	resistance	NOUN
ajlm-2362	128	5	:	:	PUNCT
ajlm-2362	128	6	protect	protect	NOUN
ajlm-2362	128	7	mothers	mother	NOUN
ajlm-2362	128	8	and	and	CCONJ
ajlm-2362	128	9	newborns	newborn	NOUN
ajlm-2362	128	10	.	.	PUNCT
ajlm-2362	129	1	in	in	ADP
ajlm-2362	129	2	4th	4th	ADJ
ajlm-2362	129	3	global	global	ADJ
ajlm-2362	129	4	conference	conference	NOUN
ajlm-2362	129	5	of	of	ADP
ajlm-2362	129	6	women	woman	NOUN
ajlm-2362	129	7	deliver	deliver	VERB
ajlm-2362	129	8	.	.	PUNCT
ajlm-2362	130	1	copenhagen	copenhagen	PROPN
ajlm-2362	130	2	:	:	PUNCT
ajlm-2362	130	3	who	who	PRON
ajlm-2362	130	4	regional	regional	ADJ
ajlm-2362	130	5	office	office	NOUN
ajlm-2362	130	6	for	for	ADP
ajlm-2362	130	7	europe	europe	PROPN
ajlm-2362	130	8	;	;	PUNCT
ajlm-2362	130	9	2016	2016	NUM
ajlm-2362	130	10	.	.	PUNCT
ajlm-2362	131	1	fadare	fadare	VERB
ajlm-2362	131	2	j	j	PROPN
ajlm-2362	131	3	,	,	PUNCT
ajlm-2362	131	4	olatunya	olatunya	ADJ
ajlm-2362	131	5	o	o	NOUN
ajlm-2362	131	6	,	,	PUNCT
ajlm-2362	131	7	oluwayemi	oluwayemi	NOUN
ajlm-2362	131	8	o	o	NOUN
ajlm-2362	131	9	,	,	PUNCT
ajlm-2362	131	10	ogundare	ogundare	NOUN
ajlm-2362	131	11	o.	o.	PROPN
ajlm-2362	131	12	drug	drug	NOUN
ajlm-2362	131	13	prescribing	prescribing	NOUN
ajlm-2362	131	14	pattern	pattern	NOUN
ajlm-2362	131	15	for	for	ADP
ajlm-2362	131	16	under	under	NOUN
ajlm-2362	131	17	-	-	PUNCT
ajlm-2362	131	18	fives	five	NOUN
ajlm-2362	131	19	in	in	ADP
ajlm-2362	131	20	a	a	DET
ajlm-2362	131	21	paediatric	paediatric	ADJ
ajlm-2362	131	22	clinic	clinic	NOUN
ajlm-2362	131	23	in	in	ADP
ajlm-2362	131	24	south	south	ADJ
ajlm-2362	131	25	-	-	PUNCT
ajlm-2362	131	26	western	western	ADJ
ajlm-2362	131	27	nigeria	nigeria	PROPN
ajlm-2362	131	28	.	.	PUNCT
ajlm-2362	132	1	ethiopian	ethiopian	PROPN
ajlm-2362	132	2	j	j	PROPN
ajlm-2362	132	3	health	health	PROPN
ajlm-2362	132	4	sci	sci	PROPN
ajlm-2362	132	5	.	.	PUNCT
ajlm-2362	133	1	2015;25(1):73–78	2015;25(1):73–78	X
ajlm-2362	133	2	.	.	PUNCT
ajlm-2362	134	1	https://doi.org/10.4314/ejhs.v25i1.10	https://doi.org/10.4314/ejhs.v25i1.10	PROPN
ajlm-2362	134	2	james	james	PROPN
ajlm-2362	134	3	pb	pb	PROPN
ajlm-2362	134	4	,	,	PUNCT
ajlm-2362	134	5	wardle	wardle	PROPN
ajlm-2362	134	6	j	j	PROPN
ajlm-2362	134	7	,	,	PUNCT
ajlm-2362	134	8	steel	steel	NOUN
ajlm-2362	134	9	a	a	PRON
ajlm-2362	134	10	,	,	PUNCT
ajlm-2362	134	11	adams	adams	PROPN
ajlm-2362	134	12	j.	j.	PROPN
ajlm-2362	134	13	traditional	traditional	PROPN
ajlm-2362	134	14	,	,	PUNCT
ajlm-2362	134	15	complementary	complementary	ADJ
ajlm-2362	134	16	and	and	CCONJ
ajlm-2362	134	17	alternative	alternative	ADJ
ajlm-2362	134	18	medicine	medicine	NOUN
ajlm-2362	134	19	use	use	NOUN
ajlm-2362	134	20	in	in	ADP
ajlm-2362	134	21	sub	sub	ADJ
ajlm-2362	134	22	-	-	ADJ
ajlm-2362	134	23	saharan	saharan	ADJ
ajlm-2362	134	24	africa	africa	PROPN
ajlm-2362	134	25	:	:	PUNCT
ajlm-2362	134	26	a	a	DET
ajlm-2362	134	27	systematic	systematic	ADJ
ajlm-2362	134	28	review	review	NOUN
ajlm-2362	134	29	.	.	PUNCT
ajlm-2362	135	1	bmj	bmj	PROPN
ajlm-2362	135	2	global	global	ADJ
ajlm-2362	135	3	health	health	NOUN
ajlm-2362	135	4	.	.	PUNCT
ajlm-2362	136	1	2018;3(5):e000895	2018;3(5):e000895	X
ajlm-2362	136	2	.	.	PUNCT
ajlm-2362	137	1	https://doi.org/10.1136/bmjgh-2018-000895	https://doi.org/10.1136/bmjgh-2018-000895	PROPN
ajlm-2362	137	2	le	le	PROPN
ajlm-2362	137	3	doare	doare	PROPN
ajlm-2362	137	4	k	k	PROPN
ajlm-2362	137	5	,	,	PUNCT
ajlm-2362	137	6	barker	barker	PROPN
ajlm-2362	137	7	ci	ci	PROPN
ajlm-2362	137	8	,	,	PUNCT
ajlm-2362	137	9	irwin	irwin	VERB
ajlm-2362	137	10	a	a	PRON
ajlm-2362	137	11	,	,	PUNCT
ajlm-2362	137	12	sharland	sharland	NOUN
ajlm-2362	137	13	m.	m.	NOUN
ajlm-2362	137	14	improving	improve	VERB
ajlm-2362	137	15	antibiotic	antibiotic	ADJ
ajlm-2362	137	16	prescribing	prescribing	NOUN
ajlm-2362	137	17	for	for	ADP
ajlm-2362	137	18	children	child	NOUN
ajlm-2362	137	19	in	in	ADP
ajlm-2362	137	20	the	the	DET
ajlm-2362	137	21	resource	resource	NOUN
ajlm-2362	137	22	-	-	PUNCT
ajlm-2362	137	23	poor	poor	ADJ
ajlm-2362	137	24	setting	setting	NOUN
ajlm-2362	137	25	.	.	PUNCT
ajlm-2362	138	1	br	br	PROPN
ajlm-2362	139	1	j	j	PROPN
ajlm-2362	139	2	clin	clin	PROPN
ajlm-2362	139	3	pharmacol	pharmacol	PROPN
ajlm-2362	139	4	.	.	PUNCT
ajlm-2362	140	1	2015;79(3):446–455	2015;79(3):446–455	NUM
ajlm-2362	140	2	.	.	X
ajlm-2362	141	1	https://doi.org/10.1111/bcp.12320	https://doi.org/10.1111/bcp.12320	PROPN
ajlm-2362	141	2	collignon	collignon	PROPN
ajlm-2362	141	3	p.	p.	PROPN
ajlm-2362	141	4	antibiotic	antibiotic	ADJ
ajlm-2362	141	5	resistance	resistance	NOUN
ajlm-2362	141	6	:	:	PUNCT
ajlm-2362	141	7	are	be	AUX
ajlm-2362	141	8	we	we	PRON
ajlm-2362	141	9	all	all	PRON
ajlm-2362	141	10	doomed	doom	VERB
ajlm-2362	141	11	?	?	PUNCT
ajlm-2362	142	1	intern	intern	NOUN
ajlm-2362	142	2	med	med	PROPN
ajlm-2362	142	3	j.	j.	PROPN
ajlm-2362	142	4	2015;45(11):1109–1115	2015;45(11):1109–1115	PROPN
ajlm-2362	142	5	.	.	PUNCT
ajlm-2362	143	1	mahmoud	mahmoud	PROPN
ajlm-2362	143	2	m	m	PROPN
ajlm-2362	143	3	,	,	PUNCT
ajlm-2362	143	4	yahyaoui	yahyaoui	ADV
ajlm-2362	143	5	g	g	PROPN
ajlm-2362	143	6	,	,	PUNCT
ajlm-2362	143	7	benseddik	benseddik	PROPN
ajlm-2362	143	8	n.	n.	PROPN
ajlm-2362	143	9	hemocultures	hemocultures	PROPN
ajlm-2362	143	10	:	:	PUNCT
ajlm-2362	143	11	profil	profil	NOUN
ajlm-2362	143	12	bactériologique	bactériologique	NOUN
ajlm-2362	143	13	et	et	PROPN
ajlm-2362	143	14	sensibilité	sensibilité	PROPN
ajlm-2362	143	15	aux	aux	PROPN
ajlm-2362	143	16	antibiotiques	antibiotique	NOUN
ajlm-2362	143	17	.	.	PUNCT
ajlm-2362	144	1	maroc	maroc	PROPN
ajlm-2362	144	2	méd	méd	PROPN
ajlm-2362	144	3	.	.	PUNCT
ajlm-2362	145	1	2010;32(2):117–120	2010;32(2):117–120	NUM
ajlm-2362	145	2	.	.	X
ajlm-2362	146	1	https://doi.org/10.48408/imist.prsm/mm-v32i2.1231	https://doi.org/10.48408/imist.prsm/mm-v32i2.1231	PROPN
ajlm-2362	146	2	lee	lee	PROPN
ajlm-2362	146	3	ac	ac	PROPN
ajlm-2362	146	4	,	,	PUNCT
ajlm-2362	146	5	chandran	chandran	PROPN
ajlm-2362	146	6	a	a	PROPN
ajlm-2362	146	7	,	,	PUNCT
ajlm-2362	146	8	herbert	herbert	PROPN
ajlm-2362	146	9	hk	hk	PROPN
ajlm-2362	146	10	,	,	PUNCT
ajlm-2362	146	11	et	et	PROPN
ajlm-2362	146	12	al	al	PROPN
ajlm-2362	146	13	.	.	PUNCT
ajlm-2362	146	14	treatment	treatment	NOUN
ajlm-2362	146	15	of	of	ADP
ajlm-2362	146	16	infections	infection	NOUN
ajlm-2362	146	17	in	in	ADP
ajlm-2362	146	18	young	young	ADJ
ajlm-2362	146	19	infants	infant	NOUN
ajlm-2362	146	20	in	in	ADP
ajlm-2362	146	21	lowand	lowand	ADJ
ajlm-2362	146	22	middle	middle	ADJ
ajlm-2362	146	23	-	-	PUNCT
ajlm-2362	146	24	income	income	NOUN
ajlm-2362	146	25	countries	country	NOUN
ajlm-2362	146	26	:	:	PUNCT
ajlm-2362	146	27	a	a	DET
ajlm-2362	146	28	systematic	systematic	ADJ
ajlm-2362	146	29	review	review	NOUN
ajlm-2362	146	30	and	and	CCONJ
ajlm-2362	146	31	meta	meta	ADJ
ajlm-2362	146	32	-	-	PUNCT
ajlm-2362	146	33	analysis	analysis	NOUN
ajlm-2362	146	34	of	of	ADP
ajlm-2362	146	35	frontline	frontline	NOUN
ajlm-2362	146	36	health	health	NOUN
ajlm-2362	146	37	worker	worker	NOUN
ajlm-2362	146	38	diagnosis	diagnosis	NOUN
ajlm-2362	146	39	and	and	CCONJ
ajlm-2362	146	40	antibiotic	antibiotic	ADJ
ajlm-2362	146	41	access	access	NOUN
ajlm-2362	146	42	.	.	PUNCT
ajlm-2362	147	1	plos	plos	PROPN
ajlm-2362	147	2	med	med	PROPN
ajlm-2362	147	3	.	.	PUNCT
ajlm-2362	148	1	2014;11(10):e1001741	2014;11(10):e1001741	NUM
ajlm-2362	148	2	.	.	PUNCT
ajlm-2362	149	1	https://doi.org/10.1371/journal.pmed.1001741	https://doi.org/10.1371/journal.pmed.1001741	VERB
ajlm-2362	149	2	anejo	anejo	NOUN
ajlm-2362	149	3	-	-	PUNCT
ajlm-2362	149	4	okopi	okopi	NOUN
ajlm-2362	149	5	ja	ja	PROPN
ajlm-2362	149	6	,	,	PUNCT
ajlm-2362	149	7	okojokwu	okojokwu	PROPN
ajlm-2362	149	8	oj	oj	PROPN
ajlm-2362	149	9	,	,	PUNCT
ajlm-2362	149	10	ramyil	ramyil	NOUN
ajlm-2362	149	11	sm	sm	PROPN
ajlm-2362	149	12	,	,	PUNCT
ajlm-2362	149	13	et	et	PROPN
ajlm-2362	149	14	al	al	PROPN
ajlm-2362	149	15	.	.	PROPN
ajlm-2362	150	1	bacterial	bacterial	ADJ
ajlm-2362	150	2	and	and	CCONJ
ajlm-2362	150	3	antibiotic	antibiotic	ADJ
ajlm-2362	150	4	susceptibility	susceptibility	NOUN
ajlm-2362	150	5	pattern	pattern	NOUN
ajlm-2362	150	6	of	of	ADP
ajlm-2362	150	7	urinary	urinary	ADJ
ajlm-2362	150	8	tract	tract	NOUN
ajlm-2362	150	9	infection	infection	NOUN
ajlm-2362	150	10	isolated	isolate	VERB
ajlm-2362	150	11	from	from	ADP
ajlm-2362	150	12	asymptomatic	asymptomatic	ADJ
ajlm-2362	150	13	and	and	CCONJ
ajlm-2362	150	14	symptomatic	symptomatic	ADJ
ajlm-2362	150	15	diabetic	diabetic	ADJ
ajlm-2362	150	16	patients	patient	NOUN
ajlm-2362	150	17	attending	attend	VERB
ajlm-2362	150	18	tertiary	tertiary	ADJ
ajlm-2362	150	19	hospital	hospital	NOUN
ajlm-2362	150	20	in	in	ADP
ajlm-2362	150	21	jos	jos	PROPN
ajlm-2362	150	22	,	,	PUNCT
ajlm-2362	150	23	nigeria	nigeria	PROPN
ajlm-2362	150	24	.	.	PUNCT
ajlm-2362	151	1	trends	trend	NOUN
ajlm-2362	151	2	med	me	VERB
ajlm-2362	151	3	.	.	PUNCT
ajlm-2362	152	1	2017;17(1):1–5	2017;17(1):1–5	PROPN
ajlm-2362	152	2	.	.	PUNCT
ajlm-2362	153	1	https://doi.org/10.15761/tim.1000108	https://doi.org/10.15761/tim.1000108	PROPN
ajlm-2362	153	2	williams	williams	PROPN
ajlm-2362	153	3	pc	pc	PROPN
ajlm-2362	153	4	,	,	PUNCT
ajlm-2362	153	5	isaacs	isaacs	PROPN
ajlm-2362	153	6	d	d	PROPN
ajlm-2362	153	7	,	,	PUNCT
ajlm-2362	153	8	berkley	berkley	PROPN
ajlm-2362	153	9	ja	ja	PROPN
ajlm-2362	153	10	.	.	PUNCT
ajlm-2362	153	11	antimicrobial	antimicrobial	ADJ
ajlm-2362	153	12	resistance	resistance	NOUN
ajlm-2362	153	13	among	among	ADP
ajlm-2362	153	14	children	child	NOUN
ajlm-2362	153	15	in	in	ADP
ajlm-2362	153	16	sub	sub	ADJ
ajlm-2362	153	17	-	-	ADJ
ajlm-2362	153	18	saharan	saharan	ADJ
ajlm-2362	153	19	africa	africa	PROPN
ajlm-2362	153	20	.	.	PUNCT
ajlm-2362	154	1	lancet	lancet	PROPN
ajlm-2362	154	2	infect	infect	PROPN
ajlm-2362	154	3	dis	dis	PROPN
ajlm-2362	154	4	.	.	PUNCT
ajlm-2362	155	1	2018;18(2):e33	2018;18(2):e33	NUM
ajlm-2362	155	2	–	–	PUNCT
ajlm-2362	155	3	e44	e44	NOUN
ajlm-2362	155	4	.	.	PUNCT
ajlm-2362	156	1	https://doi.org/10.1016/s1473-3099(17)30467-x	https://doi.org/10.1016/s1473-3099(17)30467-x	PROPN
ajlm-2362	156	2	world	world	PROPN
ajlm-2362	156	3	health	health	NOUN
ajlm-2362	156	4	organization	organization	NOUN
ajlm-2362	156	5	.	.	PUNCT
ajlm-2362	157	1	antimicrobial	antimicrobial	ADJ
ajlm-2362	157	2	resistance	resistance	NOUN
ajlm-2362	157	3	global	global	ADJ
ajlm-2362	157	4	report	report	NOUN
ajlm-2362	157	5	on	on	ADP
ajlm-2362	157	6	surveillance	surveillance	NOUN
ajlm-2362	157	7	:	:	PUNCT
ajlm-2362	157	8	2014	2014	NUM
ajlm-2362	157	9	summary	summary	NOUN
ajlm-2362	157	10	.	.	PUNCT
ajlm-2362	158	1	world	world	PROPN
ajlm-2362	158	2	health	health	PROPN
ajlm-2362	158	3	organization	organization	PROPN
ajlm-2362	158	4	:	:	PUNCT
ajlm-2362	158	5	geneva	geneva	PROPN
ajlm-2362	158	6	,	,	PUNCT
ajlm-2362	158	7	switzerland	switzerland	PROPN
ajlm-2362	158	8	;	;	PUNCT
ajlm-2362	158	9	2014	2014	NUM
ajlm-2362	158	10	.	.	PUNCT
ajlm-2362	159	1	world	world	PROPN
ajlm-2362	159	2	health	health	PROPN
ajlm-2362	159	3	organization	organization	PROPN
ajlm-2362	159	4	.	.	PUNCT
ajlm-2362	160	1	antimicrobial	antimicrobial	ADJ
ajlm-2362	160	2	resistance	resistance	NOUN
ajlm-2362	160	3	status	status	NOUN
ajlm-2362	160	4	in	in	ADP
ajlm-2362	160	5	africa	africa	PROPN
ajlm-2362	160	6	from	from	ADP
ajlm-2362	160	7	the	the	DET
ajlm-2362	160	8	one	one	NUM
ajlm-2362	160	9	health	health	NOUN
ajlm-2362	160	10	approach	approach	NOUN
ajlm-2362	160	11	perspective	perspective	NOUN
ajlm-2362	160	12	:	:	PUNCT
ajlm-2362	160	13	analytical	analytical	ADJ
ajlm-2362	160	14	facts	fact	NOUN
ajlm-2362	160	15	sheet:2024	sheet:2024	NOUN
ajlm-2362	160	16	.	.	PUNCT
ajlm-2362	161	1	integrated	integrate	VERB
ajlm-2362	161	2	african	african	ADJ
ajlm-2362	161	3	health	health	NOUN
ajlm-2362	161	4	observatory	observatory	NOUN
ajlm-2362	161	5	,	,	PUNCT
ajlm-2362	161	6	who	who	PRON
ajlm-2362	161	7	african	african	ADJ
ajlm-2362	161	8	region	region	NOUN
ajlm-2362	161	9	.	.	PUNCT
ajlm-2362	162	1	wangai	wangai	PROPN
ajlm-2362	162	2	fk	fk	INTJ
ajlm-2362	162	3	,	,	PUNCT
ajlm-2362	162	4	masika	masika	NOUN
ajlm-2362	162	5	mm	mm	PROPN
ajlm-2362	162	6	,	,	PUNCT
ajlm-2362	162	7	lule	lule	PROPN
ajlm-2362	162	8	gn	gn	PROPN
ajlm-2362	162	9	,	,	PUNCT
ajlm-2362	162	10	et	et	PROPN
ajlm-2362	162	11	al	al	PROPN
ajlm-2362	162	12	.	.	PUNCT
ajlm-2362	163	1	bridging	bridge	VERB
ajlm-2362	163	2	antimicrobial	antimicrobial	ADJ
ajlm-2362	163	3	resistance	resistance	NOUN
ajlm-2362	163	4	knowledge	knowledge	NOUN
ajlm-2362	163	5	gaps	gap	VERB
ajlm-2362	163	6	:	:	PUNCT
ajlm-2362	163	7	the	the	DET
ajlm-2362	163	8	east	east	ADJ
ajlm-2362	163	9	african	african	ADJ
ajlm-2362	163	10	perspective	perspective	NOUN
ajlm-2362	163	11	on	on	ADP
ajlm-2362	163	12	a	a	DET
ajlm-2362	163	13	global	global	ADJ
ajlm-2362	163	14	problem	problem	NOUN
ajlm-2362	163	15	.	.	PUNCT
ajlm-2362	164	1	plos	plos	PROPN
ajlm-2362	164	2	one	one	NUM
ajlm-2362	164	3	.	.	PUNCT
ajlm-2362	165	1	2019;14(2):e0212131	2019;14(2):e0212131	NUM
ajlm-2362	165	2	.	.	PUNCT
ajlm-2362	166	1	https://doi.org/10.1371/journal.pone.0212131	https://doi.org/10.1371/journal.pone.0212131	PROPN
ajlm-2362	166	2	clsi	clsi	PROPN
ajlm-2362	166	3	.	.	PUNCT
ajlm-2362	167	1	performance	performance	NOUN
ajlm-2362	167	2	standards	standard	NOUN
ajlm-2362	167	3	for	for	ADP
ajlm-2362	167	4	antimicrobial	antimicrobial	ADJ
ajlm-2362	167	5	susceptibility	susceptibility	NOUN
ajlm-2362	167	6	testing	testing	NOUN
ajlm-2362	167	7	,	,	PUNCT
ajlm-2362	167	8	2020	2020	NUM
ajlm-2362	167	9	.	.	PUNCT
ajlm-2362	168	1	30th	30th	ADJ
ajlm-2362	168	2	ed	ed	NOUN
ajlm-2362	168	3	.	.	PUNCT
ajlm-2362	168	4	clsi	clsi	PROPN
ajlm-2362	168	5	supplement	supplement	NOUN
ajlm-2362	168	6	m100	m100	PROPN
ajlm-2362	168	7	.	.	PUNCT
ajlm-2362	169	1	clinical	clinical	ADJ
ajlm-2362	169	2	and	and	CCONJ
ajlm-2362	169	3	laboratory	laboratory	NOUN
ajlm-2362	169	4	standards	standards	PROPN
ajlm-2362	169	5	institute	institute	PROPN
ajlm-2362	169	6	:	:	PUNCT
ajlm-2362	169	7	wayne	wayne	PROPN
ajlm-2362	169	8	,	,	PUNCT
ajlm-2362	169	9	pa	pa	PROPN
ajlm-2362	169	10	,	,	PUNCT
ajlm-2362	169	11	usa	usa	PROPN
ajlm-2362	169	12	.	.	PROPN
ajlm-2362	169	13	available	available	ADJ
ajlm-2362	169	14	at	at	ADP
ajlm-2362	169	15	https://www.nih.org.pk/wp-content/uploads/2021/02/clsi-2020.pdf	https://www.nih.org.pk/wp-content/uploads/2021/02/clsi-2020.pdf	PUNCT
ajlm-2362	169	16	world	world	NOUN
ajlm-2362	169	17	health	health	NOUN
ajlm-2362	169	18	organization	organization	NOUN
ajlm-2362	169	19	.	.	PUNCT
ajlm-2362	170	1	prioritization	prioritization	NOUN
ajlm-2362	170	2	of	of	ADP
ajlm-2362	170	3	pathogens	pathogen	NOUN
ajlm-2362	170	4	to	to	PART
ajlm-2362	170	5	guide	guide	VERB
ajlm-2362	170	6	discovery	discovery	NOUN
ajlm-2362	170	7	,	,	PUNCT
ajlm-2362	170	8	research	research	NOUN
ajlm-2362	170	9	and	and	CCONJ
ajlm-2362	170	10	development	development	NOUN
ajlm-2362	170	11	of	of	ADP
ajlm-2362	170	12	new	new	ADJ
ajlm-2362	170	13	antibiotics	antibiotic	NOUN
ajlm-2362	170	14	for	for	ADP
ajlm-2362	170	15	drug	drug	NOUN
ajlm-2362	170	16	-	-	PUNCT
ajlm-2362	170	17	resistant	resistant	ADJ
ajlm-2362	170	18	bacterial	bacterial	ADJ
ajlm-2362	170	19	infections	infection	NOUN
ajlm-2362	170	20	,	,	PUNCT
ajlm-2362	170	21	including	include	VERB
ajlm-2362	170	22	tuberculosis	tuberculosis	NOUN
ajlm-2362	170	23	.	.	PUNCT
ajlm-2362	171	1	world	world	PROPN
ajlm-2362	171	2	health	health	PROPN
ajlm-2362	171	3	organization	organization	PROPN
ajlm-2362	171	4	:	:	PUNCT
ajlm-2362	171	5	geneva	geneva	PROPN
ajlm-2362	171	6	,	,	PUNCT
ajlm-2362	171	7	switzerland	switzerland	PROPN
ajlm-2362	171	8	;	;	PUNCT
ajlm-2362	171	9	2017	2017	NUM
ajlm-2362	171	10	.	.	PUNCT
ajlm-2362	172	1	meremikwu	meremikwu	PROPN
ajlm-2362	172	2	mm	mm	PROPN
ajlm-2362	172	3	,	,	PUNCT
ajlm-2362	172	4	nwachukwu	nwachukwu	PROPN
ajlm-2362	172	5	ce	ce	PROPN
ajlm-2362	172	6	,	,	PUNCT
ajlm-2362	172	7	asuquo	asuquo	PROPN
ajlm-2362	172	8	ae	ae	PROPN
ajlm-2362	172	9	,	,	PUNCT
ajlm-2362	172	10	okebe	okebe	NOUN
ajlm-2362	172	11	ju	ju	PROPN
ajlm-2362	172	12	,	,	PUNCT
ajlm-2362	172	13	utsalo	utsalo	NOUN
ajlm-2362	172	14	sj	sj	PROPN
ajlm-2362	172	15	.	.	PUNCT
ajlm-2362	173	1	bacterial	bacterial	ADJ
ajlm-2362	173	2	isolates	isolate	NOUN
ajlm-2362	173	3	from	from	ADP
ajlm-2362	173	4	blood	blood	NOUN
ajlm-2362	173	5	cultures	culture	NOUN
ajlm-2362	173	6	of	of	ADP
ajlm-2362	173	7	children	child	NOUN
ajlm-2362	173	8	with	with	ADP
ajlm-2362	173	9	suspected	suspect	VERB
ajlm-2362	173	10	septicaemia	septicaemia	NOUN
ajlm-2362	173	11	in	in	ADP
ajlm-2362	173	12	calabar	calabar	PROPN
ajlm-2362	173	13	,	,	PUNCT
ajlm-2362	173	14	nigeria	nigeria	PROPN
ajlm-2362	173	15	.	.	PUNCT
ajlm-2362	174	1	bmc	bmc	PROPN
ajlm-2362	174	2	infect	infect	PROPN
ajlm-2362	174	3	dis	dis	PROPN
ajlm-2362	174	4	.	.	PUNCT
ajlm-2362	175	1	2005;8(5):110	2005;8(5):110	X
ajlm-2362	175	2	.	.	PUNCT
ajlm-2362	176	1	https://doi.org/10.1186/1471-2334-5-110	https://doi.org/10.1186/1471-2334-5-110	PROPN
ajlm-2362	176	2	chaw	chaw	PROPN
ajlm-2362	176	3	ps	ps	PROPN
ajlm-2362	176	4	,	,	PUNCT
ajlm-2362	176	5	schlinkmann	schlinkmann	PROPN
ajlm-2362	176	6	km	km	PROPN
ajlm-2362	176	7	,	,	PUNCT
ajlm-2362	176	8	raupach	raupach	NOUN
ajlm-2362	176	9	-	-	PUNCT
ajlm-2362	176	10	rosin	rosin	NOUN
ajlm-2362	176	11	h	h	NOUN
ajlm-2362	176	12	,	,	PUNCT
ajlm-2362	176	13	et	et	PROPN
ajlm-2362	176	14	al	al	PROPN
ajlm-2362	176	15	.	.	PUNCT
ajlm-2362	177	1	antibiotic	antibiotic	ADJ
ajlm-2362	177	2	use	use	NOUN
ajlm-2362	177	3	on	on	ADP
ajlm-2362	177	4	paediatric	paediatric	ADJ
ajlm-2362	177	5	inpatients	inpatient	NOUN
ajlm-2362	177	6	in	in	ADP
ajlm-2362	177	7	a	a	DET
ajlm-2362	177	8	teaching	teaching	NOUN
ajlm-2362	177	9	hospital	hospital	NOUN
ajlm-2362	177	10	in	in	ADP
ajlm-2362	177	11	the	the	DET
ajlm-2362	177	12	gambia	gambia	NOUN
ajlm-2362	177	13	,	,	PUNCT
ajlm-2362	177	14	a	a	DET
ajlm-2362	177	15	retrospective	retrospective	ADJ
ajlm-2362	177	16	study	study	NOUN
ajlm-2362	177	17	.	.	PUNCT
ajlm-2362	178	1	antimicrob	antimicrob	PROPN
ajlm-2362	178	2	resist	resist	VERB
ajlm-2362	178	3	infect	infect	ADJ
ajlm-2362	178	4	control	control	NOUN
ajlm-2362	178	5	.	.	PUNCT
ajlm-2362	179	1	2018;7:1–9	2018;7:1–9	NUM
ajlm-2362	179	2	.	.	NOUN
ajlm-2362	179	3	https://doi.org/10.1186/s13756-018-0380-7	https://doi.org/10.1186/s13756-018-0380-7	NUM
ajlm-2362	179	4	fair	fair	PROPN
ajlm-2362	179	5	rj	rj	PROPN
ajlm-2362	179	6	,	,	PUNCT
ajlm-2362	179	7	tor	tor	PROPN
ajlm-2362	179	8	y.	y.	NOUN
ajlm-2362	179	9	antibiotics	antibiotic	NOUN
ajlm-2362	179	10	and	and	CCONJ
ajlm-2362	179	11	bacterial	bacterial	ADJ
ajlm-2362	179	12	resistance	resistance	NOUN
ajlm-2362	179	13	in	in	ADP
ajlm-2362	179	14	the	the	DET
ajlm-2362	179	15	21st	21st	ADJ
ajlm-2362	179	16	century	century	NOUN
ajlm-2362	179	17	.	.	PUNCT
ajlm-2362	180	1	perspect	perspect	VERB
ajlm-2362	180	2	med	med	ADJ
ajlm-2362	180	3	chem	chem	NOUN
ajlm-2362	180	4	.	.	PUNCT
ajlm-2362	181	1	2014;6	2014;6	NOUN
ajlm-2362	181	2	:	:	PUNCT
ajlm-2362	181	3	pmc	pmc	PROPN
ajlm-2362	181	4	-	-	PUNCT
ajlm-2362	181	5	s14459	s14459	NOUN
ajlm-2362	181	6	.	.	PUNCT
ajlm-2362	182	1	https://doi.org/10.4137/pmc.s14459	https://doi.org/10.4137/pmc.s14459	PROPN
ajlm-2362	182	2	cassat	cassat	VERB
ajlm-2362	182	3	je	je	PROPN
ajlm-2362	182	4	,	,	PUNCT
ajlm-2362	182	5	thomsen	thomsen	PROPN
ajlm-2362	182	6	i.	i.	PROPN
ajlm-2362	182	7	staphylococcus	staphylococcus	PROPN
ajlm-2362	182	8	aureus	aureus	PROPN
ajlm-2362	182	9	infections	infection	NOUN
ajlm-2362	182	10	in	in	ADP
ajlm-2362	182	11	children	child	NOUN
ajlm-2362	182	12	.	.	PUNCT
ajlm-2362	183	1	curr	curr	PROPN
ajlm-2362	183	2	opin	opin	PROPN
ajlm-2362	183	3	infect	infect	PROPN
ajlm-2362	183	4	dis	dis	PROPN
ajlm-2362	183	5	.	.	PUNCT
ajlm-2362	184	1	2021;34(5):510–518	2021;34(5):510–518	X
ajlm-2362	184	2	.	.	PUNCT
ajlm-2362	184	3	https://doi.org/10.1097/qco.0000000000000752	https://doi.org/10.1097/qco.0000000000000752	ADV
ajlm-2362	184	4	kumburu	kumburu	PROPN
ajlm-2362	184	5	hh	hh	PROPN
ajlm-2362	184	6	,	,	PUNCT
ajlm-2362	184	7	sonda	sonda	NOUN
ajlm-2362	184	8	t	t	PROPN
ajlm-2362	184	9	,	,	PUNCT
ajlm-2362	184	10	mmbaga	mmbaga	PROPN
ajlm-2362	184	11	bt	bt	PROPN
ajlm-2362	184	12	,	,	PUNCT
ajlm-2362	184	13	et	et	PROPN
ajlm-2362	184	14	al	al	PROPN
ajlm-2362	184	15	.	.	PUNCT
ajlm-2362	184	16	patterns	pattern	NOUN
ajlm-2362	184	17	of	of	ADP
ajlm-2362	184	18	infections	infection	NOUN
ajlm-2362	184	19	,	,	PUNCT
ajlm-2362	184	20	aetiological	aetiological	ADJ
ajlm-2362	184	21	agents	agent	NOUN
ajlm-2362	184	22	and	and	CCONJ
ajlm-2362	184	23	antimicrobial	antimicrobial	ADJ
ajlm-2362	184	24	resistance	resistance	NOUN
ajlm-2362	184	25	at	at	ADP
ajlm-2362	184	26	a	a	DET
ajlm-2362	184	27	tertiary	tertiary	ADJ
ajlm-2362	184	28	care	care	NOUN
ajlm-2362	184	29	hospital	hospital	NOUN
ajlm-2362	184	30	in	in	ADP
ajlm-2362	184	31	northern	northern	ADJ
ajlm-2362	184	32	tanzania	tanzania	PROPN
ajlm-2362	184	33	.	.	PUNCT
ajlm-2362	185	1	trop	trop	PROPN
ajlm-2362	185	2	med	med	ADJ
ajlm-2362	185	3	int	int	PROPN
ajlm-2362	185	4	health	health	NOUN
ajlm-2362	185	5	.	.	PUNCT
ajlm-2362	186	1	2017;22(4):454–464	2017;22(4):454–464	X
ajlm-2362	186	2	.	.	PUNCT
ajlm-2362	187	1	https://doi.org/10.1111/tmi.12836	https://doi.org/10.1111/tmi.12836	PROPN
ajlm-2362	187	2	moremi	moremi	NOUN
ajlm-2362	187	3	n	n	CCONJ
ajlm-2362	187	4	,	,	PUNCT
ajlm-2362	187	5	claus	claus	PROPN
ajlm-2362	187	6	h	h	NOUN
ajlm-2362	187	7	,	,	PUNCT
ajlm-2362	187	8	mshana	mshana	NOUN
ajlm-2362	187	9	se	se	PROPN
ajlm-2362	187	10	.	.	PUNCT
ajlm-2362	188	1	antimicrobial	antimicrobial	ADJ
ajlm-2362	188	2	resistance	resistance	NOUN
ajlm-2362	188	3	pattern	pattern	NOUN
ajlm-2362	188	4	:	:	PUNCT
ajlm-2362	188	5	a	a	DET
ajlm-2362	188	6	report	report	NOUN
ajlm-2362	188	7	of	of	ADP
ajlm-2362	188	8	microbiological	microbiological	ADJ
ajlm-2362	188	9	cultures	culture	NOUN
ajlm-2362	188	10	at	at	ADP
ajlm-2362	188	11	a	a	DET
ajlm-2362	188	12	tertiary	tertiary	ADJ
ajlm-2362	188	13	hospital	hospital	NOUN
ajlm-2362	188	14	in	in	ADP
ajlm-2362	188	15	tanzania	tanzania	PROPN
ajlm-2362	188	16	.	.	PUNCT
ajlm-2362	189	1	bmc	bmc	PROPN
ajlm-2362	189	2	infect	infect	PROPN
ajlm-2362	189	3	dis	dis	PROPN
ajlm-2362	189	4	.	.	PUNCT
ajlm-2362	190	1	2016;16(1):1–7	2016;16(1):1–7	NUM
ajlm-2362	190	2	.	.	PUNCT
ajlm-2362	191	1	https://doi.org/10.1186/s12879-016-2082-1	https://doi.org/10.1186/s12879-016-2082-1	NUM
ajlm-2362	191	2	mikomangwa	mikomangwa	PROPN
ajlm-2362	191	3	wp	wp	PROPN
ajlm-2362	191	4	,	,	PUNCT
ajlm-2362	191	5	bwire	bwire	VERB
ajlm-2362	191	6	gm	gm	PROPN
ajlm-2362	191	7	,	,	PUNCT
ajlm-2362	191	8	kilonzi	kilonzi	PROPN
ajlm-2362	191	9	m	m	PROPN
ajlm-2362	191	10	,	,	PUNCT
ajlm-2362	191	11	et	et	PROPN
ajlm-2362	191	12	al	al	PROPN
ajlm-2362	191	13	.	.	PUNCT
ajlm-2362	192	1	the	the	DET
ajlm-2362	192	2	existence	existence	NOUN
ajlm-2362	192	3	of	of	ADP
ajlm-2362	192	4	high	high	ADJ
ajlm-2362	192	5	bacterial	bacterial	ADJ
ajlm-2362	192	6	resistance	resistance	NOUN
ajlm-2362	192	7	to	to	ADP
ajlm-2362	192	8	some	some	DET
ajlm-2362	192	9	reserved	reserve	VERB
ajlm-2362	192	10	antibiotics	antibiotic	NOUN
ajlm-2362	192	11	in	in	ADP
ajlm-2362	192	12	tertiary	tertiary	ADJ
ajlm-2362	192	13	hospitals	hospital	NOUN
ajlm-2362	192	14	in	in	ADP
ajlm-2362	192	15	tanzania	tanzania	PROPN
ajlm-2362	192	16	:	:	PUNCT
ajlm-2362	192	17	a	a	DET
ajlm-2362	192	18	call	call	NOUN
ajlm-2362	192	19	to	to	PART
ajlm-2362	192	20	revisit	revisit	VERB
ajlm-2362	192	21	their	their	PRON
ajlm-2362	192	22	use	use	NOUN
ajlm-2362	192	23	.	.	PUNCT
ajlm-2362	193	1	infect	infect	VERB
ajlm-2362	193	2	drug	drug	NOUN
ajlm-2362	193	3	resist	resist	NOUN
ajlm-2362	193	4	.	.	PUNCT
ajlm-2362	194	1	2020:1831–1838	2020:1831–1838	NOUN
ajlm-2362	194	2	.	.	PUNCT
ajlm-2362	195	1	https://doi.org/10.2147/idr.s250158	https://doi.org/10.2147/idr.s250158	NOUN
ajlm-2362	195	2	tadesse	tadesse	VERB
ajlm-2362	195	3	bt	bt	PROPN
ajlm-2362	195	4	,	,	PUNCT
ajlm-2362	195	5	ashley	ashley	PROPN
ajlm-2362	195	6	ea	ea	PROPN
ajlm-2362	195	7	,	,	PUNCT
ajlm-2362	195	8	ongarello	ongarello	PROPN
ajlm-2362	195	9	s	s	PROPN
ajlm-2362	195	10	,	,	PUNCT
ajlm-2362	195	11	et	et	PROPN
ajlm-2362	195	12	al	al	PROPN
ajlm-2362	195	13	.	.	PROPN
ajlm-2362	195	14	antimicrobial	antimicrobial	ADJ
ajlm-2362	195	15	resistance	resistance	NOUN
ajlm-2362	195	16	in	in	ADP
ajlm-2362	195	17	africa	africa	PROPN
ajlm-2362	195	18	:	:	PUNCT
ajlm-2362	195	19	a	a	DET
ajlm-2362	195	20	systematic	systematic	ADJ
ajlm-2362	195	21	review	review	NOUN
ajlm-2362	195	22	.	.	PUNCT
ajlm-2362	196	1	bmc	bmc	PROPN
ajlm-2362	196	2	infect	infect	PROPN
ajlm-2362	196	3	dis	dis	PROPN
ajlm-2362	196	4	.	.	PUNCT
ajlm-2362	197	1	2017;17:1–7	2017;17:1–7	NUM
ajlm-2362	197	2	.	.	PUNCT
ajlm-2362	198	1	https://doi.org/10.1186/s12879-017-2713-1	https://doi.org/10.1186/s12879-017-2713-1	NUM
ajlm-2362	198	2	world	world	PROPN
ajlm-2362	198	3	health	health	NOUN
ajlm-2362	198	4	organization	organization	NOUN
ajlm-2362	198	5	.	.	PUNCT
ajlm-2362	199	1	the	the	DET
ajlm-2362	199	2	selection	selection	NOUN
ajlm-2362	199	3	and	and	CCONJ
ajlm-2362	199	4	use	use	NOUN
ajlm-2362	199	5	of	of	ADP
ajlm-2362	199	6	essential	essential	ADJ
ajlm-2362	199	7	medicines	medicine	NOUN
ajlm-2362	199	8	:	:	PUNCT
ajlm-2362	199	9	report	report	NOUN
ajlm-2362	199	10	of	of	ADP
ajlm-2362	199	11	the	the	DET
ajlm-2362	199	12	who	who	PRON
ajlm-2362	199	13	expert	expert	PROPN
ajlm-2362	199	14	committee	committee	NOUN
ajlm-2362	199	15	on	on	ADP
ajlm-2362	199	16	selection	selection	NOUN
ajlm-2362	199	17	and	and	CCONJ
ajlm-2362	199	18	use	use	NOUN
ajlm-2362	199	19	of	of	ADP
ajlm-2362	199	20	essential	essential	ADJ
ajlm-2362	199	21	medicines	medicine	NOUN
ajlm-2362	199	22	,	,	PUNCT
ajlm-2362	199	23	2021	2021	NUM
ajlm-2362	199	24	(	(	PUNCT
ajlm-2362	199	25	including	include	VERB
ajlm-2362	199	26	the	the	DET
ajlm-2362	199	27	22nd	22nd	NOUN
ajlm-2362	199	28	who	who	PRON
ajlm-2362	199	29	model	model	NOUN
ajlm-2362	199	30	list	list	NOUN
ajlm-2362	199	31	of	of	ADP
ajlm-2362	199	32	essential	essential	ADJ
ajlm-2362	199	33	medicines	medicine	NOUN
ajlm-2362	199	34	and	and	CCONJ
ajlm-2362	199	35	the	the	DET
ajlm-2362	199	36	8th	8th	NOUN
ajlm-2362	199	37	who	who	PRON
ajlm-2362	199	38	model	model	NOUN
ajlm-2362	199	39	list	list	NOUN
ajlm-2362	199	40	of	of	ADP
ajlm-2362	199	41	essential	essential	ADJ
ajlm-2362	199	42	medicines	medicine	NOUN
ajlm-2362	199	43	for	for	ADP
ajlm-2362	199	44	children	child	NOUN
ajlm-2362	199	45	)	)	PUNCT
ajlm-2362	199	46	.	.	PUNCT
ajlm-2362	200	1	geneva	geneva	PROPN
ajlm-2362	200	2	:	:	PUNCT
ajlm-2362	200	3	world	world	PROPN
ajlm-2362	200	4	health	health	PROPN
ajlm-2362	200	5	organization	organization	NOUN
ajlm-2362	200	6	,	,	PUNCT
ajlm-2362	200	7	2021	2021	NUM
ajlm-2362	200	8	.	.	PUNCT
ajlm-2362	201	1	available	available	ADJ
ajlm-2362	201	2	at	at	ADP
ajlm-2362	201	3	https://www.who.int/publications-detail-redirect/who-mhp-hps-eml-2023.01	https://www.who.int/publications-detail-redirect/who-mhp-hps-eml-2023.01	VERB
ajlm-2362	201	4	mnyambwa	mnyambwa	ADJ
ajlm-2362	201	5	np	np	NOUN
ajlm-2362	201	6	,	,	PUNCT
ajlm-2362	201	7	mahende	mahende	VERB
ajlm-2362	201	8	c	c	PROPN
ajlm-2362	201	9	,	,	PUNCT
ajlm-2362	201	10	wilfred	wilfre	VERB
ajlm-2362	201	11	a	a	PRON
ajlm-2362	201	12	,	,	PUNCT
ajlm-2362	201	13	et	et	PROPN
ajlm-2362	201	14	al	al	PROPN
ajlm-2362	201	15	.	.	PUNCT
ajlm-2362	202	1	antibiotic	antibiotic	ADJ
ajlm-2362	202	2	susceptibility	susceptibility	NOUN
ajlm-2362	202	3	patterns	pattern	NOUN
ajlm-2362	202	4	of	of	ADP
ajlm-2362	202	5	bacterial	bacterial	ADJ
ajlm-2362	202	6	isolates	isolate	NOUN
ajlm-2362	202	7	from	from	ADP
ajlm-2362	202	8	routine	routine	ADJ
ajlm-2362	202	9	clinical	clinical	ADJ
ajlm-2362	202	10	specimens	specimen	NOUN
ajlm-2362	202	11	from	from	ADP
ajlm-2362	202	12	referral	referral	ADJ
ajlm-2362	202	13	hospitals	hospital	NOUN
ajlm-2362	202	14	in	in	ADP
ajlm-2362	202	15	tanzania	tanzania	PROPN
ajlm-2362	202	16	:	:	PUNCT
ajlm-2362	202	17	a	a	DET
ajlm-2362	202	18	prospective	prospective	ADJ
ajlm-2362	202	19	hospital	hospital	NOUN
ajlm-2362	202	20	-	-	PUNCT
ajlm-2362	202	21	based	base	VERB
ajlm-2362	202	22	observational	observational	ADJ
ajlm-2362	202	23	study	study	NOUN
ajlm-2362	202	24	.	.	PUNCT
ajlm-2362	203	1	infect	infect	VERB
ajlm-2362	203	2	drug	drug	NOUN
ajlm-2362	203	3	resist	resist	NOUN
ajlm-2362	203	4	.	.	PUNCT
ajlm-2362	204	1	2021;3:869–878	2021;3:869–878	NUM
ajlm-2362	204	2	.	.	PUNCT
ajlm-2362	205	1	https://doi.org/10.2147/idr.s294575	https://doi.org/10.2147/idr.s294575	X
ajlm-2362	205	2	olivier	olivier	PROPN
ajlm-2362	205	3	bm	bm	PROPN
ajlm-2362	205	4	,	,	PUNCT
ajlm-2362	205	5	ngatimo	ngatimo	VERB
ajlm-2362	205	6	v	v	NOUN
ajlm-2362	205	7	,	,	PUNCT
ajlm-2362	205	8	chrysostome	chrysostome	PROPN
ajlm-2362	205	9	gj	gj	PROPN
ajlm-2362	205	10	.	.	PUNCT
ajlm-2362	205	11	epidemiology	epidemiology	NOUN
ajlm-2362	205	12	and	and	CCONJ
ajlm-2362	205	13	sensitivity	sensitivity	NOUN
ajlm-2362	205	14	profile	profile	NOUN
ajlm-2362	205	15	of	of	ADP
ajlm-2362	205	16	blood	blood	NOUN
ajlm-2362	205	17	culture	culture	NOUN
ajlm-2362	205	18	isolates	isolate	NOUN
ajlm-2362	205	19	at	at	ADP
ajlm-2362	205	20	the	the	DET
ajlm-2362	205	21	pediatric	pediatric	ADJ
ajlm-2362	205	22	university	university	NOUN
ajlm-2362	205	23	hospital	hospital	NOUN
ajlm-2362	205	24	of	of	ADP
ajlm-2362	205	25	bangui	bangui	NOUN
ajlm-2362	205	26	.	.	PUNCT
ajlm-2362	206	1	j	j	PROPN
ajlm-2362	206	2	pediatr	pediatr	ADJ
ajlm-2362	206	3	neonatal	neonatal	ADJ
ajlm-2362	206	4	biol	biol	NOUN
ajlm-2362	206	5	.	.	PUNCT
ajlm-2362	207	1	2022;7(2):87–96	2022;7(2):87–96	X
ajlm-2362	207	2	.	.	PUNCT
ajlm-2362	208	1	https://doi.org/10.33140/jpnb.07.02.02	https://doi.org/10.33140/jpnb.07.02.02	PROPN
ajlm-2362	208	2	nebbioso	nebbioso	PROPN
ajlm-2362	208	3	a	a	NOUN
ajlm-2362	208	4	,	,	PUNCT
ajlm-2362	208	5	ogundipe	ogundipe	NOUN
ajlm-2362	208	6	of	of	ADP
ajlm-2362	208	7	,	,	PUNCT
ajlm-2362	208	8	repetto	repetto	PROPN
ajlm-2362	208	9	ec	ec	PROPN
ajlm-2362	208	10	,	,	PUNCT
ajlm-2362	208	11	et	et	PROPN
ajlm-2362	208	12	al	al	PROPN
ajlm-2362	208	13	.	.	PUNCT
ajlm-2362	209	1	when	when	SCONJ
ajlm-2362	209	2	first	first	ADJ
ajlm-2362	209	3	line	line	NOUN
ajlm-2362	209	4	treatment	treatment	NOUN
ajlm-2362	209	5	of	of	ADP
ajlm-2362	209	6	neonatal	neonatal	ADJ
ajlm-2362	209	7	infection	infection	NOUN
ajlm-2362	209	8	is	be	AUX
ajlm-2362	209	9	not	not	PART
ajlm-2362	209	10	enough	enough	ADJ
ajlm-2362	209	11	:	:	PUNCT
ajlm-2362	209	12	blood	blood	NOUN
ajlm-2362	209	13	culture	culture	NOUN
ajlm-2362	209	14	and	and	CCONJ
ajlm-2362	209	15	resistance	resistance	NOUN
ajlm-2362	209	16	patterns	pattern	NOUN
ajlm-2362	209	17	in	in	ADP
ajlm-2362	209	18	neonates	neonate	NOUN
ajlm-2362	209	19	requiring	require	VERB
ajlm-2362	209	20	second	second	ADJ
ajlm-2362	209	21	line	line	NOUN
ajlm-2362	209	22	antibiotic	antibiotic	ADJ
ajlm-2362	209	23	therapy	therapy	NOUN
ajlm-2362	209	24	in	in	ADP
ajlm-2362	209	25	bangui	bangui	NOUN
ajlm-2362	209	26	,	,	PUNCT
ajlm-2362	209	27	central	central	ADJ
ajlm-2362	209	28	african	african	ADJ
ajlm-2362	209	29	republic	republic	NOUN
ajlm-2362	209	30	.	.	PUNCT
ajlm-2362	210	1	bmc	bmc	PROPN
ajlm-2362	210	2	pediatr	pediatr	PROPN
ajlm-2362	210	3	.	.	PUNCT
ajlm-2362	211	1	2021;21(1):1–1	2021;21(1):1–1	NOUN
ajlm-2362	211	2	.	.	PUNCT
ajlm-2362	212	1	https://doi.org/10.1186/s12887-021-02911-w	https://doi.org/10.1186/s12887-021-02911-w	PROPN
ajlm-2362	212	2	berkley	berkley	PROPN
ajlm-2362	212	3	ja	ja	PROPN
ajlm-2362	212	4	,	,	PUNCT
ajlm-2362	212	5	lowe	lowe	PROPN
ajlm-2362	212	6	bs	bs	PROPN
ajlm-2362	212	7	,	,	PUNCT
ajlm-2362	212	8	mwangi	mwangi	PROPN
ajlm-2362	212	9	i	i	PROPN
ajlm-2362	212	10	,	,	PUNCT
ajlm-2362	212	11	et	et	PROPN
ajlm-2362	212	12	al	al	PROPN
ajlm-2362	212	13	.	.	PUNCT
ajlm-2362	212	14	bacteremia	bacteremia	NOUN
ajlm-2362	212	15	among	among	ADP
ajlm-2362	212	16	children	child	NOUN
ajlm-2362	212	17	admitted	admit	VERB
ajlm-2362	212	18	to	to	ADP
ajlm-2362	212	19	a	a	DET
ajlm-2362	212	20	rural	rural	ADJ
ajlm-2362	212	21	hospital	hospital	NOUN
ajlm-2362	212	22	in	in	ADP
ajlm-2362	212	23	kenya	kenya	PROPN
ajlm-2362	212	24	.	.	PUNCT
ajlm-2362	213	1	n	n	PROPN
ajlm-2362	213	2	engl	engl	PROPN
ajlm-2362	213	3	j	j	PROPN
ajlm-2362	213	4	med	med	PROPN
ajlm-2362	213	5	.	.	PUNCT
ajlm-2362	214	1	2005;352(1):39–47	2005;352(1):39–47	X
ajlm-2362	214	2	.	.	PROPN
ajlm-2362	214	3	https://doi.org/10.1056/nejmoa040275	https://doi.org/10.1056/nejmoa040275	PROPN
ajlm-2362	214	4	brent	brent	PROPN
ajlm-2362	214	5	aj	aj	PROPN
ajlm-2362	214	6	,	,	PUNCT
ajlm-2362	214	7	ahmed	ahme	VERB
ajlm-2362	214	8	i	i	PROPN
ajlm-2362	214	9	,	,	PUNCT
ajlm-2362	214	10	ndiritu	ndiritu	PROPN
ajlm-2362	214	11	m	m	PROPN
ajlm-2362	214	12	,	,	PUNCT
ajlm-2362	214	13	et	et	PROPN
ajlm-2362	214	14	al	al	PROPN
ajlm-2362	214	15	.	.	PROPN
ajlm-2362	214	16	incidence	incidence	NOUN
ajlm-2362	214	17	of	of	ADP
ajlm-2362	214	18	clinically	clinically	ADV
ajlm-2362	214	19	significant	significant	ADJ
ajlm-2362	214	20	bacteraemia	bacteraemia	NOUN
ajlm-2362	214	21	in	in	ADP
ajlm-2362	214	22	children	child	NOUN
ajlm-2362	214	23	who	who	PRON
ajlm-2362	214	24	present	present	VERB
ajlm-2362	214	25	to	to	ADP
ajlm-2362	214	26	hospital	hospital	NOUN
ajlm-2362	214	27	in	in	ADP
ajlm-2362	214	28	kenya	kenya	PROPN
ajlm-2362	214	29	:	:	PUNCT
ajlm-2362	214	30	community	community	NOUN
ajlm-2362	214	31	-	-	PUNCT
ajlm-2362	214	32	based	base	VERB
ajlm-2362	214	33	observational	observational	ADJ
ajlm-2362	214	34	study	study	NOUN
ajlm-2362	214	35	.	.	PUNCT
ajlm-2362	215	1	lancet	lancet	NOUN
ajlm-2362	215	2	.	.	PUNCT
ajlm-2362	216	1	2006;367(9509):482–488	2006;367(9509):482–488	NUM
ajlm-2362	216	2	.	.	PUNCT
ajlm-2362	216	3	https://doi.org/10.1016/s0140-6736(06)68180-4	https://doi.org/10.1016/s0140-6736(06)68180-4	PROPN
ajlm-2362	216	4	yu	yu	PROPN
ajlm-2362	217	1	d	d	PROPN
ajlm-2362	217	2	,	,	PUNCT
ajlm-2362	217	3	zheng	zheng	PROPN
ajlm-2362	217	4	y	y	PROPN
ajlm-2362	217	5	,	,	PUNCT
ajlm-2362	217	6	shen	shen	PROPN
ajlm-2362	217	7	a	a	X
ajlm-2362	217	8	,	,	PUNCT
ajlm-2362	217	9	et	et	PROPN
ajlm-2362	217	10	al	al	PROPN
ajlm-2362	217	11	.	.	PUNCT
ajlm-2362	217	12	antimicrobial	antimicrobial	ADJ
ajlm-2362	217	13	resistance	resistance	NOUN
ajlm-2362	217	14	in	in	ADP
ajlm-2362	217	15	pediatric	pediatric	ADJ
ajlm-2362	217	16	infectious	infectious	ADJ
ajlm-2362	217	17	diseases	disease	NOUN
ajlm-2362	217	18	:	:	PUNCT
ajlm-2362	217	19	antimicrobial	antimicrobial	ADJ
ajlm-2362	217	20	resistance	resistance	NOUN
ajlm-2362	217	21	,	,	PUNCT
ajlm-2362	217	22	resistance	resistance	NOUN
ajlm-2362	217	23	mechanisms	mechanism	NOUN
ajlm-2362	217	24	and	and	CCONJ
ajlm-2362	217	25	antimicrobial	antimicrobial	ADJ
ajlm-2362	217	26	use	use	NOUN
ajlm-2362	217	27	.	.	PUNCT
ajlm-2362	218	1	front	front	ADJ
ajlm-2362	218	2	cell	cell	NOUN
ajlm-2362	218	3	infect	infect	VERB
ajlm-2362	218	4	microbiol	microbiol	NOUN
ajlm-2362	218	5	.	.	PUNCT
ajlm-2362	219	1	2023;13:1287051	2023;13:1287051	NUM
ajlm-2362	219	2	.	.	X
ajlm-2362	219	3	https://doi.org/10.3389/fcimb.2023.1287051	https://doi.org/10.3389/fcimb.2023.1287051	NOUN
ajlm-2362	219	4	rallis	ralli	VERB
ajlm-2362	219	5	d	d	PROPN
ajlm-2362	219	6	,	,	PUNCT
ajlm-2362	219	7	giapros	giapro	NOUN
ajlm-2362	219	8	v	v	PROPN
ajlm-2362	219	9	,	,	PUNCT
ajlm-2362	219	10	serbis	serbi	VERB
ajlm-2362	219	11	a	a	PRON
ajlm-2362	219	12	,	,	PUNCT
ajlm-2362	219	13	kosmeri	kosmeri	PROPN
ajlm-2362	219	14	c	c	NOUN
ajlm-2362	219	15	,	,	PUNCT
ajlm-2362	219	16	baltogianni	baltogianni	PROPN
ajlm-2362	219	17	m.	m.	NOUN
ajlm-2362	219	18	fighting	fight	VERB
ajlm-2362	219	19	antimicrobial	antimicrobial	ADJ
ajlm-2362	219	20	resistance	resistance	NOUN
ajlm-2362	219	21	in	in	ADP
ajlm-2362	219	22	neonatal	neonatal	ADJ
ajlm-2362	219	23	intensive	intensive	ADJ
ajlm-2362	219	24	care	care	NOUN
ajlm-2362	219	25	units	unit	NOUN
ajlm-2362	219	26	:	:	PUNCT
ajlm-2362	219	27	rational	rational	ADJ
ajlm-2362	219	28	use	use	NOUN
ajlm-2362	219	29	of	of	ADP
ajlm-2362	219	30	antibiotics	antibiotic	NOUN
ajlm-2362	219	31	in	in	ADP
ajlm-2362	219	32	neonatal	neonatal	ADJ
ajlm-2362	219	33	sepsis	sepsis	NOUN
ajlm-2362	219	34	.	.	PUNCT
ajlm-2362	220	1	antibiotics	antibiotic	NOUN
ajlm-2362	220	2	.	.	PUNCT
ajlm-2362	221	1	2023;12(3):508	2023;12(3):508	NUM
ajlm-2362	221	2	.	.	PUNCT
ajlm-2362	222	1	https://doi.org/10.3390/antibiotics12030508	https://doi.org/10.3390/antibiotics12030508	PROPN
ajlm-2362	222	2	tam	tam	PROPN
ajlm-2362	222	3	py	py	PROPN
ajlm-2362	222	4	,	,	PUNCT
ajlm-2362	222	5	bekker	bekker	PROPN
ajlm-2362	222	6	a	a	PRON
ajlm-2362	222	7	,	,	PUNCT
ajlm-2362	222	8	bolaji	bolaji	PROPN
ajlm-2362	222	9	ob	ob	NOUN
ajlm-2362	222	10	,	,	PUNCT
ajlm-2362	222	11	et	et	PROPN
ajlm-2362	222	12	al	al	PROPN
ajlm-2362	222	13	.	.	PROPN
ajlm-2362	222	14	neonatal	neonatal	ADJ
ajlm-2362	222	15	sepsis	sepsis	NOUN
ajlm-2362	222	16	and	and	CCONJ
ajlm-2362	222	17	antimicrobial	antimicrobial	ADJ
ajlm-2362	222	18	resistance	resistance	NOUN
ajlm-2362	222	19	in	in	ADP
ajlm-2362	222	20	africa	africa	PROPN
ajlm-2362	222	21	.	.	PUNCT
ajlm-2362	223	1	lancet	lancet	PROPN
ajlm-2362	223	2	child	child	PROPN
ajlm-2362	223	3	adolesc	adolesc	PROPN
ajlm-2362	223	4	health	health	NOUN
ajlm-2362	223	5	.	.	PUNCT
ajlm-2362	224	1	2023;7(10):677–679	2023;7(10):677–679	X
ajlm-2362	224	2	.	.	PUNCT
ajlm-2362	225	1	https://doi.org/10.1016/s2352-4642(23)00167-0	https://doi.org/10.1016/s2352-4642(23)00167-0	PROPN